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Abstract
Traumatic brain injury (TBI) is a major and costly epidemic in the United States and around the world.
There are little treatment options and currently no cure. Past research aimed at treating neurons as a
therapeutic target have not been successful treatments clinically. Recent interest has turned to another
cell type, the astrocyte, as a potential therapeutic target. In this dissertation, we expand upon past
findings by further exploring the role of astrocytes and astrocytic signaling in TBI in vivo. Creating a new
mild TBI model based on human mild TBI biomechanics, we produced behavioral deficits and
histopathological changes similar to mild human TBI. We modified and applied the new TBI model to see
if the in vitro astrocytic response to mild mechanical injury could be reproduced in vivo. By imaging the
intracellular calcium in cortical astrocytes after mechanical impact in vivo with a 2-photon microscope,
we found that mild mechanical injury produced a strong intercellular calcium wave originating from the
site of injury. Drug applications to determine the mechanism of calcium wave showed that ATP signaling,
and not gap junction coupling among the astrocytes, was responsible for this immediate effect of mild
mechanical injury. Next we tested two transgenic animals, each with a different aspect of inhibited
astrocyte signaling to determine the effect on TBI recovery. The first transgenic line, VIPP, had an over
expression of IP3 phosphatase and was able to reduce the injury induced intercellular calcium wave in
astrocytes. Reducing IP3 signaling specifically in astrocytes led to a worse behavioral outcome in a more
severe TBI model and no significant difference in the mild TBI model. The second transgenic line,
dnSNARE, was used to study the role of inhibited vesicular release from astrocytes. Reducing
gliotransmission in this manner improved outcome in both the severe and the mild TBI models. In both
cases, baseline behavior did not differ from wildtype littermates suggesting that targeting either pathway
may have limited side effects. Histopathologies revealed significant reduction of astrogliosis in both VIPP
and dnSNARE injured mice compared to WT. Together these results suggest that injury level can affect
the effectiveness of a particular pathway as a therapeutic target and that overall targeting
gliotransmission is an effective strategy.
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ABSTRACT
ASTROCYTE SIGNALING IN TRAUMATIC BRAIN INJURY

YungChia Chen

David F. Meaney

Traumatic brain injury (TBI) is a major and costly epidemic in the United States and around the
world. There are little treatment options and currently no cure. Past research aimed at treating
neurons as a therapeutic target have not been successful treatments clinically. Recent interest has
turned to another cell type, the astrocyte, as a potential therapeutic target. In this dissertation, we
expand upon past findings by further exploring the role of astrocytes and astrocytic signaling in
TBI in vivo. Creating a new mild TBI model based on human mild TBI biomechanics, we
produced behavioral deficits and histopathological changes similar to mild human TBI. We
modified and applied the new TBI model to see if the in vitro astrocytic response to mild
mechanical injury could be reproduced in vivo. By imaging the intracellular calcium in cortical
astrocytes after mechanical impact in vivo with a 2-photon microscope, we found that mild
mechanical injury produced a strong intercellular calcium wave originating from the site of injury.
Drug applications to determine the mechanism of calcium wave showed that ATP signaling, and
not gap junction coupling among the astrocytes, was responsible for this immediate effect of mild
mechanical injury. Next we tested two transgenic animals, each with a different aspect of
inhibited astrocyte signaling to determine the effect on TBI recovery. The first transgenic line,
VIPP, had an over expression of IP3 phosphatase and was able to reduce the injury induced
v

intercellular calcium wave in astrocytes. Reducing IP3 signaling specifically in astrocytes led to a
worse behavioral outcome in a more severe TBI model and no significant difference in the mild
TBI model. The second transgenic line, dnSNARE, was used to study the role of inhibited
vesicular release from astrocytes. Reducing gliotransmission in this manner improved outcome in
both the severe and the mild TBI models. In both cases, baseline behavior did not differ from
wildtype littermates suggesting that targeting either pathway may have limited side effects.
Histopathologies revealed significant reduction of astrogliosis in both VIPP and dnSNARE
injured mice compared to WT. Together these results suggest that injury level can affect the
effectiveness of a particular pathway as a therapeutic target and that overall targeting
gliotransmission is an effective strategy.
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Chapter 1 Background and Significance
INTRODUCTION
According to the Center for Disease Control (CDC), there are currently 1.7 million new cases of
traumatic brain injury (TBI) annually (Faul et al., 2010) with about 75% of these cases being
diagnosed as mild (mTBI) (National Center for Injury Prevention and Control, 2003). Typical
symptoms include headache, nausea, slurred speech, imbalance, sleep disturbance, and fatigue
(Kushner, 1998). Even mTBI sufferers can experience symptoms for years (Signoretti et al.,
2010). This is especially true in pediatric populations where there is a higher risk of developing
negative psychosocial behavior such as mood disorder and substance abuse later in life (Hamilton
and Keller, 2010). Current diagnosis for TBI relies on clinical assessment and neuroimaging
techniques. Computed axial tomography (CT), magnetic resonance imaging (MRI), and diffusion
tensor imaging (DTI) can help identify intracranial injuries that may require surgical intervention
(Andriessen et al., 2010). Once diagnosed however, there is no cure for TBI; the only recourse is
rehabilitation. Many of the therapeutic treatments found in animal models have yet to translate
clinically (Andriessen et al., 2010). A major reason for this is the limitation of animal TBI models
to accurately mimic clinical conditions as well as a suitable therapeutic target.

BACKGROUND
Traumatic Brain Injury – mechanical causation
The most common causes of TBI are from falls followed by motor vehicular accidents (Faul et al.,
2010). Head injuries can be categorized into three groups based on the manner of insult loading
(Goldmsith, 1972). The first is an impact or blow involving a collision with another object. The
second is an impulsive loading causing a sudden change in head motion without direct impact.
Sudden acceleration/deceleration loading of a car accident is one such example. The third is static
1

or quasi-static loading to the head. Generally, contusions and focal injuries are produced by the
first type of loading and diffuse injuries are produced by the second.
The mechanical loading to the head results in cellular dysfunction and degeneration
stemming from physical damage and chemical overstimulation (Lusardi et al., 2003; Spaethling et
al., 2007). Primary brain injury occurs during the moment of impact or loading and can only be
prevented through precautionary safety measures. Secondary brain injury is the degeneration
resulting from pathological processes that arise from primary injury (Werner and Engelhard,
2007). Much of the subsequent biochemical and behavioral changes after TBI that have been
elucidated were done so with a variety of in vitro and in vivo models.

Animal models of traumatic brain injury
Animal models of TBI have been vital to our understanding of TBI pathology sequelae and
behavioral changes. A “good” animal model will be able to capture the biochemical changes and
some of the behavioral alterations seen in the human condition. However, there is widespread
recognition that no one animal model captures the whole spectrum of human TBI (Cernak, 2005;
Gennarelli, 1994; Xiong et al., 2013). Past animal models have focused on specific injury factors
such as location and type of damage, injury severity, and time course. The guiding hypotheses in
developing an animal model were
“…(1) human TBI can be duplicated in nonhumans and (2) nonhuman TBI replicates human
injury.” And “…the assumptions implicit in animal models are (1) that the mechanism of
production of the traumatic brain injury is not important and (2) that species differences can be
ignored…it may be argued that so long as the end result type of brain injury can be produced, the
mechanism by which that injury is produced can be ignored…” (Gennarelli, 1994).
This guiding theme produced many different animal TBI models, involving different
species, each replicating a specific injury type. As a result, in many of these models, the manner
of inducing was not based on human TBI biomechanics. Here, we will focus on rodent TBI
models. These models can be classified into groups based on the mechanism of injury. They are
2

(1) direct brain deformation, (2) closed head impact, (3) acceleration only, (4) cryogenic injury,
and (5) blast injury. However, blast TBI is not a typical civilian injury and the exact
biomechanics of loading on the brain is unknown. Therefore blast TBI will not be discussed here.
Direct Brain Deformation Models: There are several animal TBI models where the main
mechanism of injury is from direct deformation to the brain. The two most commonly used
models are the fluid percussion injury (FPI) and the controlled cortical impact (CCI) models.
Other brain injury models that directly deform the brain are the dynamic cortical deformation
(DCD) and a penetrating ballistic-like model.
With FPI, a pulse of fluid is used to dynamically deform the cortex through a craniotomy.
The severity of injury is controlled through increasing the volume and velocity of the fluid pulse.
Initially developed in the rabbit (Lindgren and Rinder, 1966), it has since been adapted for cat
(Sullivan et al., 1976), rat (McIntosh et al., 1987, 1989), mouse (Carbonell et al., 1998), pig, dog
and sheep (Gennarelli, 1994). Histopathologically, this model generates a number of changes
seen in human TBI such as vascular permeability changes, neuronal degeneration, and petechial
hemorrhaging1 (Thompson et al., 2005). Studies into the biomechanics of FPI have shown that
most of the strain is localized in the brain stem region (Thibault et al., 1992) which potentially
explains the concussion symptoms of FPI (C. Edward Dixon et al., 1987; Gennarelli, 1994;
Thompson et al., 2005). A major drawback to this model is the variability in fluid loading (Dixon
et al., 1988) among animals even within a single group where the pressure and duration are
tightly controlled. This variability makes it difficult for a finite element analysis (FEA) simulation
to capture biomechanics in the model limiting further understanding of tissue tolerances. In
addition, it makes the resulting behavioral changes in the model more likely to vary compared to
other models where the biomechanical loading can be controlled more directly.
1

Petechial hemorrhage is a form of hemorrhage which causes distinctive petechiae (pinpoint, round spots)
markings.

3

The CCI model was first developed by Lighthall to induce a controlled injury in the ferret
that could be simulated with FEA (Lighthall, 1988). This injury model has since been adapted to
the rat (Dixon et al., 1991), mouse (Smith et al., 1995), and pig (Manley et al., 2006). A piston
driven by compressed nitrogen impacts the cortex exposed by a craniotomy. The speed and depth
of impact can be controlled independently, unlike with FPI, to create graded injury severity. A
newer version of the CCI that is electromagnetically (EM) controlled was created to reduce the
variability of the pneumatically driven device (Brody et al., 2007). The consistent interaction
between a solid indenter and the brain, allows for the CCI to be modeled with FEA for both rat
and mouse (Mao and Yang, 2011; Mao et al., 2010a, 2010b; Pleasant et al., 2011). These FE
models have helped to further understand the CCI generated stress-strain distribution as well as
understand tissue tolerances by comparing FE results with injury patterns in the brain.
Two other models directly deform the brain, yet with less precise control. The weight
drop model developed by Feeney (1981) involves dropping a weight onto a footplate resting on
the cortex. Like the CCI, this model creates mainly focal contusion injuries. Alternatively, the
dynamic cortical deformation model (DCD) developed by Shreiber (1998) uses a vacuum pulse
through a craniotomy to deform the cortex with the dura removed. Both the vacuum pulse
duration and the vacuum pressure can be independently altered to generate a variety of loading
conditions. This model determined the in vivo threshold for blood brain barrier (BBB) breakdown
using the maximum principal logarithmic strain to be 17.2% (Shreiber et al., 1997). It generates a
hemorrhagic lesion, glial reactivity, and cell death in the CA1 of the hippocampus, a contrast to
the CCI where the neuronal degeneration in the hippocampus occurs in the CA3 (Smith et al.,
1995).
The last type of direct brain deformation model is the penetrating ballistic-like brain
injury (PBBI) (Williams et al., 2005). This model was created to mimic the permanent injury tract
created by a penetrating bullet and the temporary cavity generated by energy dissipation of the
4

bullet. In this model a probe is inserted into the brain and a balloon is rapidly inflated to mimic
the temporary cavity created. This model creates intracerebral hemorrhaging, inflammation, and
neurodegeneration (Williams et al., 2005, 2006, 2007).
Closed Head Impact Models: Closed head Injury (CHI) models do not require much pre-injury
manipulation, and some cite these models as more clinically relevant than direct deformation
models because CHI involve impact to the scalp/skull, often a causative feature of human TBI.
Most CHIs employ the use of weights dropped onto the skull, either directly or over a metal plate
glued to the head. The Marmarou model uses a weight dropped onto a steel helmet placed over
exposed skull (Marmarou et al., 1994). The animal is placed on foam during the injury and the
head is allowed to accelerate downward. The Shohami weight drop model for rats (Shapira et al.,
1988; Shohami et al., 1988) and mice (Chen et al., 1996; Flierl et al., 2009) uses a metal rod
dropped directly onto the skull on one side. The head is placed on a hard surface and not allowed
to move during or after impact. This model creates concussion symptoms, contusions,
hemorrhages and skull fractures. It has been noted that the Shohami weight drop is not highly
reproducible and has a high mortality rate (Albert-Weissenberger and Sirén, 2010). The Maryland
model (Kilbourne et al., 2009) modified the traditional weight drop models to produce a frontal
impact. A steel ball rolls down a ramp and impacts a coupling arm which is in contact with the
malar processes of the rat. The coupling arm prevents direct contact of the steel ball with the rat
and eliminates damage to the rat’s facial bones. This model creates subarachnoid hemorrhages,
concussion symptoms and motor deficits.
Another type of closed head non-acceleration injury model uses the controlled cortical
impact device. However, instead of impacting the cortex through a craniotomy, these models
impact the skull directly. Creed et al used the pneumatic controlled cortical impact device directly
impacting the skull to induce a concussion injury (Creed et al., 2011). Depending on the speed
and depth of impact, contusion and skull fracture can occur. Replacing the metal tip of the CCI
5

device with a silicone tip eliminated skull fractures and contusions creating a milder injury useful
for the study of repetitive brain injury. In these studies a single injury produced no long lasting
behavioral dysfunction (Bennett et al., 2012; Longhi et al., 2005; Shitaka et al., 2011). A second
impact exacerbated both the histopathological and behavioral deficits from the first injury.
Acceleration Only Injury Model: Head acceleration models in the primate (Gennarelli et al., 1982;
Ommaya and Gennarelli, 1974; Ommaya et al., 1966) and later in the swine (Ross et al., 1994)
are difficult to replicate in the rodent model due to the small size of their brains. Holburn
theorized that
“the level of rotational acceleration required to produce injury in brains with similar properties
and shapes is inversely proportional to the 2/3 power of the masses of the brains.”(Ommaya et al.,
1967)
Therefore to reproduce a similar level of injury in the rodent as seen in human mTBI, much
greater the rotational accelerations are needed. However, a rotational acceleration injury model
scaled to the rat (Ellingson et al., 2005; Fijalkowski et al., 2007) based on Holburn’s scaling laws
was successfully created. This model uses a helmet to transfer a linear acceleration into a
rotational acceleration; rats are injured in the coronal rotation. Histopathology of the brain
showed subarachnoid hemorrhaging and intraparenchymal lesions in most of the mice with no
evidence of varicosities in the white matter tracts. Behaviorally, this model did produce
concussion like symptoms.
Cryogenic Injury Model: The cryogenic injury model is unlike other TBI models. It uses either a
chilled copper cylinder (Rákos et al., 2007; Raslan et al., 2010, 2012) or dried ice (Pifarré et al.,
2010) contacted to the cortex or skull to induce a lesion to the brain. The major drawback to this
model is that the injury method has no biomechanical relevance to human TBI. It however does
produce consistent and reproducible lesions, BBB breakdown, subsequent upregulation of
inflammation and gliosis (Albert-Weissenberger and Sirén, 2010).

6

Astrocytes and TBI
Using the above models allows us to study the role of astrocytes in TBI, a field that has been
relatively understudied in the past. This is because astrocytes have historically been viewed as
brain “glue” providing only basic and structural support to neurons, the excitable cells. Since the
1990’s, this view has taken a drastic turn. As the most abundant cell type in the brain, astrocytes
are responsible for a variety of physiological and pathophysiological functions (Agulhon et al.,
2008; Laird et al., 2008; Perea et al., 2009; Sofroniew and Vinters, 2010). Combining animal
model behavior, histopathology, and FEA, we can start to understand how astrocytes respond to a
variety of mechanical insults. This combination of techniques can also allow us to understand the
mechanical thresholds and link the biochemical response from a biomechanical input.
Currently we know that after TBI, astrocytes become reactive, characterized by cellular
hypertrophy and increased expression of glial fibrillary acidic protein (GFAP), and contribute to
the inflammatory response through release of cytokines (Franke et al., 2012). Prolonged,
excessive inflammation in the brain has been shown to be a potential driver for neurodegeneration
and depression (Hashmi et al., 2013; Paradise et al., 2012; Patki et al., 2013). However, studies
that ablated reactive astrocytes in a CCI model resulted in increased lesion due to greater
infiltration of inflammatory agents into the penumbra region (Faulkner et al., 2004; Myer et al.,
2006), possibly due to the lack of a glial scar to wall off the injured region. Reactive astrocytes
are also important in blood brain barrier (BBB) repair. Ablating reactive astrocytes after TBI
prevented repair of the BBB and increased vasogenic edema (Bush et al., 1999; Faulkner et al.,
2004). Grafting astrocytes from nontransgenic animals into transgenic animals with ablated
reactive astrocytes allowed for BBB repair, demonstrating an integral need for reactive astrocytes
in TBI recovery (Faulkner et al., 2004). Increased GFAP expression also reduces the elastic
modulus of astrocytes, making them softer (Miller et al., 2009). Neurons preferentially grow on
softer substrates and an increase in GFAP expression may aid in regeneration after injury.
7

Astrocytes can also promote degeneration and dysfunction and have been linked to
several degenerative diseases. More and more research indicates that astrocytes undergo calcium
excitability, releasing signaling molecules in a calcium dependent process called gliotransmission
that can modulate neuronal activity (Agulhon et al., 2012; Fellin et al., 2004; Perea et al., 2009).
Increased calcium signaling in both frequency and duration has been noted in status epilepticus
(Ding et al., 2007), Alzheimer’s disease (AD) (Kuchibhotla et al., 2009), and cortical spreading
depression (CSD) models (Peters et al., 2003). In vitro studies showed astrocytes produce
intercellular calcium waves (ICW) in response to stretch (Choo et al., 2013; Miller, 2009). Stretch
induced release of extracellular adenosine triphosphase (ATP) from astrcoytes contributes to
neuronal death after injury. Treatment with apyrase reduced ICWs, GFAP expression to naïve
levels (Miller et al., 2009), and subsequent degeneration (Choo et al., 2013; Miller, 2009). The
initial ICWs induce further release of ATP and glutamate from astrocytes, enhancing
excitotoxicity. Inhibition of the purinergic receptors have been shown to be neuroprotective in
vitro and in vivo and improved functional outcome (Choo et al., 2013; Miller, 2009). Blocking the
calcium wave specifically in astrocytes with BAPTA-AM also provided a similar level of
neuroprotection (Choo et al., 2013; Miller, 2009).

SUMMARY OF CHAPTERS
The goal of this dissertation was to determine the effect of astrocytic calcium signaling on the
recovery of TBI in vivo. To achieve these research goals, we first looked at the biomechanics of
the different animal TBI models. We adapted an existing injury model to better mimic the
biomechanics of mild TBI in humans (Chapter 2). We next verified if past in vitro findings with
astrocytes and stretch injury could be validated in vivo (Chapter 3). Using this new and
preexisting model of TBI, we tested two transgenic mice lines each with reduced astrocytic
signaling and studied their recovery (Chapter 4 and 5). The overall hypothesis is that
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gliotransmission (rapid and regulated exocytosis of gliotransmitters by astrocytes in a calciumdependent manner, (Agulhon et al., 2012)), is a source of excitotoxic factors that contribute to
neuronal death post TBI and that blocking this response will improve outcome.
In chapter 2, we adapted the CCI brain injury model and used parameters that would
produce the same injury biomechanics found in human mild TBI in the mouse. In the past, animal
TBI models especially rodent models strived towards replicating specific injury types. Although
all models cite that injury is created by a mechanical event and that species differences were
assumed to be negligent, our review and analysis of common CCI conditions indicate the use of
impact speeds that produce strain rates in the mouse that are twenty to eighty times higher than
strain rates found in human TBI. Slowing down the impact speed and changing the material of the
impactor tip allowed us to create a non-hemorrhagic injury and transient behavioral deficits.
Biomechanically and symptomatically, the modified CCI created an injury that is consistent with
human mild TBI.
In chapter 3, we adapted the mechanism of the newly developed mild TBI model and
made it possible to perform in vivo imaging during injury. We showed that strain induced injury
does cause an astrocytic calcium wave in vivo. Purinergic signaling was the dominant pathway in
the production of this pathophysiologic calcium signaling. Past in vitro research also showed that
purinergic signaling was a dominant pathway in the propagation of calcium signaling after stretch.
Once we validated in vitro findings in vivo, we were able to proceed with further in vivo
studies. In chapter 4, VIPP transgenic mice were subject to both traditional and modified CCI.
With the traditional CCI, VIPP mice performed worse in a hippocampal dependent task on day 7.
There were no behavioral differences in the more immediate time points. This worse outcome
was unexpected and did not support our hypothesis. There was less GFAP expression with VIPP
injured mice than with WT littermates; however, there was no increased lesion volume. With the
modified CCI, behavioral deficits were less apparent in VIPP mice than WT suggesting that the
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difference in injury mechanism may affect subsequent biochemical pathways, highlighting the
importance of accurately modeling injury mechanics.
In chapter 5, dnSNARE transgenic mice were subjected to both traditional and modified
CCI. With the traditional CCI, dnSNARE mice overall performed no differently than WT
littermates except on day 7 in the watermaze. They did also have a slightly improved rate of
spatial learning. There was less GFAP expression in the dnSNARE mice and no difference in
lesion volumes. When subject to the modified CCI, dnSNARE mice showed significant
behavioral improvement over WT mice. In the rotarod, dnSNARE injured mice had the same
latency times as dnSNARE and WT sham mice.
Finally, Chapter 6 provides a summary of the important findings discovered throughout
this research. It highlights some of the limitations, overall conclusions, and future work that could
improve our current understanding.
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Chapter 2 Modifying the Controlled Cortical Impact Based on Mild
TBI Biomechanics in Humans
ABSTRACT
For the past 25 years, controlled cortical impact (CCI) has been a useful tool in traumatic brain
injury (TBI) research, modeling injury patterns that include primary contusion, neuronal loss, and
traumatic axonal damage. However, when CCI was first developed very little was known about
the underlying biomechanics of mild TBI. This paper seeks to use the information generated from
recent computational models of mild TBI to alter the CCI technique to better reflect the
biomechanical conditions of mild TBI. We adjusted three primary features of CCI: the speed of
the impact to achieve strain rates within the range associated with mild TBI, the shape and
material of the impounder to minimize strain concentrations in the brain, and the impact depth to
control the peak deformation that occurred in the cortex and hippocampus. With these modified
cortical impact conditions, we observed breakdown of the blood-brain barrier (BBB) but no
primary hemorrhage. Moreover neuronal degeneration, axonal injury, and both astrocytic and
microglia reactivity were observed up to 8 days after injury. Significant deficits in rotarod
performance appeared early after injury. We observed no impairment in spatial object recognition
or fear conditioning response 5 days and 8 days after injury. Together, these data show that
simulating the biomechanical conditions of mild TBI with a modified cortical impact technique
produces regions of cellular reactivity and neuronal loss that coincide with only a transient
behavioral impairment.
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INTRODUCTION
Traumatic brain injury (TBI) is a significant public health problem. Of the 1.7 million people
diagnosed with TBI, about 75% of them are considered to have experienced mild (mTBI)
(National Center for Injury Prevention and Control, 2003). Although most mTBI patients do not
have long term impairments (Dikmen et al., 2001), approximately 15% may experience
symptoms for years, and these persisting deficits are a major contributor to the morbidity
associated with the disease (Hamilton and Keller, 2010; Signoretti et al., 2010). Current diagnosis
for TBI relies on clinical assessment (Malec et al., 2007; Saatman et al., 2008; Teasdale and
Jennett, 1974); neuroimaging techniques such as computed axial tomography (CT), magnetic
resonance imaging (MRI), and diffusion tensor imaging (DTI) are all used to better detect
structural and functional changes in TBI patients (Bigler and Maxwell, 2012; Le and Gean, 2009;
Lee and Newberg, 2005). Diagnosis for mTBI in particular is more difficult than either moderate
or severe TBI, due in part to the rapid recovery of symptoms and the lack of a universal definition
(McKinlay, 2010; Powell et al., 2008; Ruff et al., 2009; Yeates, 2010). However, once diagnosed,
there are very few treatment options outside of rehabilitation as successful pre-clinical treatments
have yet to translate to the clinical population (Beauchamp et al., 2008).
Creating an experimental model to reproduce faithfully human mTBI is challenging, yet
can offer an important new tool to study mTBI in the laboratory. With differences in the anatomy,
functional organization, and phylogenic development, no one experimental model in a single
species can fully capture human mTBI. Past animal models of TBI often reproduced specific
brain injuries observed, such as contusions, acute subdural hematoma, and diffuse axonal damage
(Duhaime et al., 1994; Gennarelli, 1994; Lighthall, 1988; Lindgren and Rinder, 1966; Marmarou
et al., 1994; Rinder, 1969; Ross et al., 1994; Shreiber et al., 1999; Sullivan et al., 1976). These
injury techniques were used to model mild TBI by adjusting the input parameters (eg, shallower
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impact depth, smaller fluid pulse, smaller weight dropped) or by altering the methodology to
create closed head impact models (Bennett et al., 2012; Creed et al., 2011; Huh et al., 2007;
Longhi et al., 2005; Shitaka et al., 2011; Spain et al., 2010; Ucar et al., 2006). A critique for this
manner of adaptation is that for some models, a smaller load or shallower impact depth,
biomechanically does not equate to generating an mTBI injury. This is because while a smaller
load may reduce the volume of damage, the type of injury produced is less consistent with the
bulk of mTBIs seen in humans.
In the past 10 years, biomechanics research successfully coupled finite element (FE)
analyses (FEA) to existing TBI models and human accident reconstructions to produce a more
detailed picture of the in vivo mechanical loading associated with concussions. (Levchakov et al.,
2006; Ruan et al., 1994; Viano and Pellman, 2005; Viano et al., 2005, 2007; Ward and Thompson,
1975; Willinger et al., 1999) These computational models analyzed the relationship between
mechanical stress/strain and resulting structural/functional damage to tissue(Bain and Meaney,
1999, 2000; Bayly et al., 2006; Elkin and Morrison III, 2007; Margulies and Thibault, 1992;
Margulies et al., 1990; Meaney and Thibault, 1990; Morrison III et al., 2000, 2003, 2006; Pfister
et al., 2003; Rashid et al., 2012; Shreiber et al., 1997; Singh et al., 2006) to provide estimates on
injury volume, and injury thresholds based on strain and strain rate for specific loading
conditions(Dokko et al., 2003; Kimpara and Iwamoto, 2012; Kleiven, 2007; McAllister et al.,
2012; Ruan et al., 1993; Viano et al., 2005; Zhang et al., 2004). In parallel, physical models of the
brain also offered estimates of the tissue biomechanics associated with injury in the white matter
(Margulies and Thibault, 1992; Margulies et al., 1990; Meaney et al., 1995). Among rodent mTBI
models, strain rates of fluid percussion (FPI) and the dynamic cortical deformation (DCD) injury
models have similar ranges estimated in human mTBI (Shreiber et al., 1999; Thibault et al., 1992;
Zhang et al., 2004) (Figure 2.1). Closed head injury (CHI) rodent models may also yield strains
and strain rates in the range of human TBI (Albert-Weissenberger et al., 2012; Chen et al., 1996;
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Creed et al., 2011; Ellingson et al., 2005; Feeney et al., 1981; Fijalkowski et al., 2007; Kilbourne
et al., 2009; Longhi et al., 2005; Marmarou et al., 1994; Shohami et al., 1988). The biggest
drawback to FPI and CHIs is that FE analyses of these models are difficult. Only recently was the
foam used in the Marmarou weight drop test modeled (Zhang et al., 2011). And translating the
FPI to a computational model is difficult because of variability in fluid loading at the dural
surface (Dixon et al., 1988). While DCD has been simulated and used for other 3D FE model
validation (Lamy et al., 2013; Mao et al., 2006; Shreiber et al., 1997), this method of injury
induces hemorrhage in the shape of the craniotomy, likely from the bone cutting into the cortex

Figure 2.1. Comparison of strains and strain rates in human and animal TBI models.
References used: FE-Human (Cloots et al., 2012; Ho and Kleiven, 2007; Kleiven and Hardy,
2002; McAllister et al., 2012; Viano et al., 2005; Zhang et al., 2001, 2002, 2003); FE-Round
(Yoganandan et al., 2008); FE-Porcine (Miller et al., 1998); PM-Human (Meaney and Thibault,
1990); PM-Primate (Margulies et al., 1990); PM-Porcine (Meaney et al., 1995); FE CCI-Rodent
(Mao et al., 2006, 2010a); PM CCI-Cat (Meaney et al., 1994); PM FPI-Cat (Thibault et al., 1992).
FE = Finite Element; PM = Physical Model.
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during the vacuum pulse. A coronal rotational head injury in the rodent that uses accelerations
scaled from human TBI was created and simulated in a 2D FE model (Fijalkowski et al., 2007,
2009). However, this diffuse brain injury (DBI) model failed to show axonal histopathological
changes that are considered the hallmark for human mTBI; over 50% of the animals had
hemorrhaging and lesions, pathologies that are not typical of mTBI.
The bulk of rodent TBI FEMs are of CCI (Levchakov et al., 2006; Mao et al., 2010a,
2010b; Peña et al., 2005). However, CCI loading conditions do not generate similar biomechanics
to human TBI. Currently, even at slower speeds, CCI produces strain rates of 400s-1 and over
(Mao et al., 2006), well over the higher strain rates of moderate to severe human TBI (Figure 2.1).
At more typical CCI speeds, the cortex sees strain rates in the range of 1150-1450s-1 (Mao et al.,
2010a). Therefore, we revisited the biomechanics of traditional rodent CCI and altered it to
produce injury conditions in the rodent that better approximate the loading seen in human mTBI.
In addition, it was important that the injury would induce no hemorrhagic contusions in the cortex,
a common injury in cortical impact models but rarely observed in human mTBI (Alexander,
1995). Finally, it was important to use impact conditions that generated a measurable behavioral
impairment.
To achieve these three design criteria, the impact velocity was reduced to achieve tissue
strain rates more consistent with mild TBI, the cortical impact tip was modified to distribute the
strains throughout the cortex, and the impact depth adjusted (Figure 2.2A-C). CCI was selected
over FPI because the biomechanics of the loading are more directly controllable. With CCI, we
can alter strain rate independently from strain by changing the parameters of the injury. In this
study, the combination of reducing impact velocity (strain rate) while maintain impact depth
(strain) changes the morphology of the injury to include blood brain barrier (BBB) opening, glial
reactivity, neuronal degeneration and microglial activation without significant hemorrhage and
lesions often associated with cortical impact. Moreover, this modification achieves a slight, but
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temporary, behavioral deficit. The improved biomechanical fidelity of this model now provides a
new tool to determine the tissue tolerance criteria associated with neuronal and glial changes in
the brain after mTBI, as well as a scientific tool to compare the effects between a hemorrhagic
and nonhemorrhagic injury.

Figure 2.2. Parameters of mild CCI.
The mild CCI (mCCI) uses a hemi- spherical silicone tip, actuated by a solenoid (A). A
potentiometer was used to measure the displacement of the impactor. The angle of the impactor
and the height of the impactor are adjustable. A comparison of displaced tissue volume between
mild CCI (2mm impact depth) and traditional CCI (1mm impact depth) is shown in B. C shows
the range of impact speeds between tCCI (2.0 -6.0m/s) and the velocity range that would generate
clinical TBI strain rates (17s-1 – 104s-1 for 0.1 -0.6m/s respectively). The red line is the impactor
speed used in this study (0.43m/s for a strain rate of 80s-1). Brains perfused 8 days after a sham
injury (D), mCCI with 2mm impact depth (E), and tCCI with an impact depth and speed of 1mm
and 6.0m/s respectively (F).
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METHODS AND MATERIALS
Modified CCI (mCCI) device
The traditional CCI (tCCI) model scaled down to the mouse as first described by Smith et al
(1995) produces a focal contusion and hemorrhage, symptoms more normally associated with
moderate to severe TBI cases. This model generates reproducible, graded injury that is amenable
to FEA. For these reasons, the pneumatic CCI device was improved upon and a electromagnetic
(EM) version was created (Brody et al., 2007). However, the electromagnetic version uses similar
speeds and creates similar injury profiles. We sought to increase the injury spectrum of CCI to
explore mild TBI injuries. The mCCI model has very many similarities to tCCI (Figure 2.2A).
Two main differences are the use of a rounded silicone tip (4mm in diameter; tip was made by
injecting Sylgard 184 – mixed and vacuumed – into a 3-D printed mold; Figure 2.2A insert) and a
slower impact speed (Fig 2B, C).
To reproduce a mild injury in the rodent, we sought to replicate the lower strain rates
seen in clinical mTBI. A pneumatic CCI and the electromagnetic CCI produced first described by
Brody et al 2007 have similar velocity ranges of 1.5 to 6.0m/s. At these speeds, a deformation of
1-3mm on tissue will have strain rate ranging over 400s-1 (Mao et al., 2006). These are much
higher than those seen in mild TBI which range from 23s-1 to 140s-1 (Zhang et al., 2003). Studies
with physical models have shown strain rates between 10s-1 to 50s-1 to be injurious (Figure 2.1).
Therefore to scale mTBI strain rates to a mouse required velocities well below tCCI
ranges. The mCCI velocity uses an impact velocity that is one-tenth of those used in tCCI (0.20.6m/s versus 2.0 – 6.0m/s, Figure 2.2C). The actual impact speed of the solenoid used in this
study is the line in red at 0.43m/s (Figure 2.2C; the solenoid has a retraction velocity of 0.20m/s;
SoftShift 2EPM, Ledex, USA ), producing during the 2mm impact a calculated 14ms tissue
displacement duration (not including the dwell time). Bayly et al (2006) showed that a 0.34m/s
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impact velocity produced strain rates of around 40s-1 in rat pups. A linear potentiometer (LP803-1,
Omega, USA) measured the actuation of the solenoid and a custom Matlab (Mathworks, MA,
USA) program controlled the solenoid and collected the potentiometer readings. The angle of the
impactor was set to 20° from vertical (measured with a digital angle meter), similar to other
lateral CCI models.
It is important to note that dwell times are a byproduct of the response times of
electromechanical devices. As the effect of varying dwell times on injury have not been studied,
it was important to maintain a similar dwell time to those seen in literature. In this study the dwell
time used was consistently around 72.6ms with an overshoot of 0.19mm. These parameters were
within the dwell time ranges (25ms to 250ms) for rodent CCI as cited in the literature (Cernak,
2005). The overshoot from the solenoid increases the actual impact depth slightly, however, this
overshoot is not larger than the pneumatic or electromagnetic CCI (Brody et al., 2007). The
variability of overshoot from the solenoid did not vary as this was determined by the physical
stroke length of the solenoid.
For simplicity, only one impact velocity was used in combination with one impact depth.
This study uses a 2mm impact depth; 1mm failed to generate measurable behavioral deficits and
3mm caused hemorrhaging upon impact (data not shown). The approximate resulting strain rate
for a 2mm impact depth with this solenoid is 80s-1. We replaced the rounded cylindrical 3mm
metal tip with a custom made silicone, hemispherical tip of 4mm diameter. The larger impact
diameter and increased impact depth creates a larger volume of injury (Figure 2.2B). Despite the
larger injury volume, the slower strain rates used did not result in a necrotic lesion, a contrast
from tCCI (Figure 2.2D-F).
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Cortical Injury
All animal procedures were approved by University of Pennsylvania’s Institutional Animal Care
and Use Committee (IACUC). Sixty C57Bl6 mice (Jackson Laboratory, Maine, USA) were
divided into sham and injured for three different time points: a one hour time point to determine
extravasation (sham=3, injured n=6); 24hr time point to determine early neurodegeneration (sham
n=5, injured n=10 each); 8 day time point to determine longer term behavioral and
histopathological changes (sham n=17, injured n=19).
On the day of injury, mice were anaesthetized with isoflurane (5% induction, 2%
maintenance) and placed in a stereotaxic frame. A 4-mm diameter craniotomy was produced on
the left hemisphere, midway between bregma and lambda. CCI injuries were produced with a
modified impactor at a speed of 0.43m/s to a cortical impact depth of 2mm (Figure 2.2B,C). The
estimated center of the impact was -2.5mm bregma. The solenoid has a full stroke length of 4mm.
The baseline point was set by lowering the impactor tip to the cortex with the solenoid in the fully
actuated position and the linear stage position set to zero. Once baseline was set, the impactor was
retracted and the impact depth was adjusted using 1.0mm shims. After injury, the cranial
exposure was sutured closed and the animals were placed in a warmed cage to recover until
ambulatory.

Histology
Mice were anaesthetized with an overdose of sodium pentobarbital. Animals were transcardially
perfused with 30ml of ice-cold phosphate buffered saline (PBS) (pH 7.4) and then with 40mls of
ice-cold 4% paraformaldehyde. Brains were harvested, post-fixed overnight in 4%
paraformaldehyde at 4°C and then cryoprotected in 24% sucrose. Brains were mounted in TissueTek® and frozen in isopentane cooled with dry ice. Brains were cryosectioned at 20 µm. Sections
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were taken 500µm apart starting from bregma -1.5 to -3.5 mm, therefore spanning the entire
injury area.
Blood brain barrier compromise: For identification of extravasation, animals were injected with
Evans blue (EB, 100µL of 4%) 15min prior to the injury or sham surgery. One hour post injury,
animals were perfused. Brains were removed, post-fixed, cyroprotected, and frozen. Equally
spaced, serial tissue sections of the brain were mounted on slides and rinsed several times in
phosphate-buffered saline (PBS). The slides were coverslipped with ProLong Gold (Invitrogen,
USA; #P36934). Sections were imaged with a Leica SP5 confocal microscope (Leica, Germany).
The same laser settings were used with all sections.
Neuronal degeneration: Fluoro-jade® B (FJB) labeling detected degenerating neurons.
Histological sections were rehydrated in graded ethanols (100%, 95%, 80% 70%; 2 min each)
followed by distilled water. They were then incubated in a solution of 0.06% potassium
permanganate on a rotating stage for 20 min. The sections were then rinsed in distilled water for 2
min and placed in fresh 0.0005% FJB solution made by adding 5mL of a 0.01% stock solution of
FJB to 95 mL of 0.1% acetic acid. After 30 min in the FJB staining solution, the sections were
rinsed through three changes of distilled water for 1 min per change. Excess water was drained
onto a paper towel, and the sections were then air dried in an oven at 37° for 30 min. The dry
sections were cleared by immersion in xylene for at least 2 minutes before coverslipping with
permount (Fisher Scientific, USA). The sections were viewed with a Leica SP5 confocal
microscope (Leica, Germany).
Astrocyte and microglial reactivity: Sections were rehydrated in 1×PBS (3x 5min) and then
incubated with 10% normal goat serum for 30 mins with 0.1% triton-X. To measure astrocyte
reactivity, sections were incubated overnight at room temperature in polyclonal anti-GFAP
(Neuromics, MN, USA; #CH22102; 1:500). Microglial reactivity was assessed using the
polyclonal anti-Iba-1 (Wako, VA, USA; #019-19741; 1:1000). After rinsing with 1×PBS,
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sections were then incubated with Alexa 546 conjugated secondary antibodies (Invitrogen, USA;
#A-11035; 1:250) for 1hr at room temperature. Sections were mounted with ProLong Gold
antifade (Invitrogen, USA; #P36934).
Axonal injury: Sections were dried and washed in 0.1M TBS for 5 minutes. Sections were heated
in 10mM sodium citrate at 75°C for 30 minutes and allowed to cool to room temperature.
Endogenous peroxidase activity was blocked with incubation in 3% hydrogen peroxide in
methanol for 30 minutes with shaking. Sections were rinsed with running water for 10min, after
which they were placed in blocking buffer (0.1M TBS and 2% FBS) for 5 minutes before
blocking with 10% NGS for 30 minutes in 0.1M TBS with 0.2% Triton-X. This was followed by
overnight incubation at 4°C with anti-APP (Invitrogen, USA; #36-3900; 1:1000). Sections were
washed in 0.1M TBS, placed in blocking buffer and then incubated in biotinylated goat anti rabbit
secondary (Jackson Labs,#111-065-003; 1:250). Sections were washed and placed in blocking
buffer again prior to incubation in Elite ABC (Vectastain, CA, USA; #PK-6100) for 30 minutes.
Sections were washed and incubated in DAB (Vectastain, CA, USA; #SK-4100) for 5min.
Sections were washed in running water for 5 minutes and stained with Hematoxylin for 30
seconds. Sections were washed, dehydrated (alcohol 70%, 80%, 95% 2x, 100% 2x, xylene 2x)
and coverslipped in Permount.

Behavior Tests
A series of behavior tests were conducted in the order that placed the test that required the least of
amount of mouse handing first and the most stressful test last. The behavior schedule is listed in
Table 2.1. The rotarod training was conducted the day before the injury. On the day of injury, no
behavioral test was given. On days 1 – 3 after injury, mice were tested on the rotarod; on days 4 –
5, mice were tested on the spatial object recognition (SOR), on days 7 – 8; mice were trained and
tested in contextual fear conditioning (CFC).
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Table 2.1. Behavioral Schedule
Day -1

Day 0

Day 1

Day 2

Day 3

Day 4

Day 5

RR
training

Injury

RR

RR

RR

SOR

SOR

Day 6

Day 7

Day 8

CFC

CFC

Cortical motor function: The rotarod protocol was adapted from Oliveira et al 2011
(Oliveira et al., 2011). In short, the rotarod apparatus (Med Associates Inc, VT, USA) has a 3.2
cm diameter rotating rod raised 16.5 cm above a platform and divided into five sections for
testing multiple mice simultaneously. The rotarod gradually increased its rotation speed from 4 to
40 rpm over the course of 5 minutes. Latency to first fault (defined as the mouse riding with the
platform in a single rotation) and fall time was recorded. Mice were trained on the rotarod at 4
rpm for 60 seconds one day before injury. Three trials a day were given during three consecutive
days with an inter-trial interval of 1 hour. Each trial started at the same time every day and ended
when mice fell or when mice ran for 300 seconds.
Hippocampal function: The SOR protocol was adapted from Oliveira et al (2010). In
short, the experimental apparatus consisted of a gray rectangular open field (60 cm × 50 cm × 26
cm) with a visual cue placed on the arena wall. Prior to training, mice were handled for 1 minute
per day for 3 days. During the training day, mice received four 10 minute training sessions.
Between sessions, mice were placed back in their home cage for 3 minutes. During the first
session, mice were habituated to the gray rectangular open field in the absence of objects, but
with an internal cue on one of the four walls. For the next three sessions, mice were placed in the
same box but now with two distinct objects. The objects consisted of a glass bottle (100 mL
volume) and a metal tower (1.5625 square inches). Mice were allowed to freely explore the
environment and the objects for 10 minutes. Mice that climbed the objects were eliminated from
behavioral analysis. After 24 h, mice were placed back in the rectangular environment for testing.
The two objects were again present, but one of the two objects was now displaced to a novel
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spatial location. Mice were again allowed to freely explore the environment and the objects for 10
minutes. Both the object identity and spatial location was balanced between subjects. The
response to changing the spatial location was assessed by comparing the mean time the mice
spent exploring the objects (when mice were facing and sniffing the objects within very close
proximity and/or touching them) belonging to each category (displaced and non-displaced) in the
test session minus the mean time spent in contact with the same object category in the last
training session. A positive value indicates recognition of the spatial change.
In the CFC test, mice were placed in a testing chamber (Coulbourn, PA, USA) on training
day for 3 minutes. Two minutes and 28 seconds after mice were placed into the testing
environment, mice were given a single 2 second, 1.5mA shock. Twenty four hours later, mice
were place in the same testing chamber and their percent freezing was calculated across the
course of 5 minutes.

Statistical Analysis
All statistical tests were carried out using JMP10. The variance among groups was first tested for
normality (Shapiro-Wilks test) and then equality (Bartlett test). When the variance among groups
was not similar, the two sample t test was used, otherwise a one way analysis of variance
(ANOVA) was used. A linear regression model was used to look for significance between injured
and uninjured groups. A repeated measures ANOVA was used in the rotarod behavior test.
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Figure 2.3. mCCI induces extravasation of the blood brain barrier (BBB) at the injured
region.
The pattern of extravasation is shown and pictorially depicted (A). Co-labeling of EB and
Neurotrace® for the cortex (B), CA3 (C) and dentate gyrus (D) show that the EB positive cells
are mostly neurons.
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Figure 2.4. Degeneration at 24hr after injury shows a FJB staining pattern that was similar
to the EB staining.
FJB positive cells in the cortex (iv), dentate gyrus (v), and CA3 (vi) on the ipsilateral side was not
seen on the contralateral side (i, ii, iii, respectively) (A). (B) The number of FJB positive cells in
injured animals was significantly increased compared to sham in both the cortical and
hippocampal regions for bregma sections -1.5 to -3.0 (cortex p<0.001 for each section -1.5 to -3.0,
for section -3.5 p=0.0635; hippocampus p=0.0113 for section 1.5, p<0.001 for sections -2.0 to 3.5; n=5 sham, n=10 injured).
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RESULTS
mCCI induces blood brain barrier extravasation
The modification of the CCI technique produced little to no visible lesion and no visible
hemorrhaging immediately after impact, but Evans Blue (EB) staining appeared throughout the
lesion site (Figure 2.3A). In the cortex there was an approximate hemispherical pattern of EB
staining in all animals, and there was a higher concentration of EB at the subcortical white matter
directly below the impact site. No EB staining appeared in the region of cortex that was in direct
contact with the impactor, consistent with no visible hemorrhage after injury. In the hippocampus,
the dorsal CA3 region (stratum pyramidal) and the dentate gyrus (some staining seen in the
granular but most staining occurred in the polymorphic layer) also showed EB staining. All
animals subject to injury had EB loading in the dentate across all five bregma sections analyzed.
However staining in the CA3 was only visible around bregma -1.5 and -2.0. No EB staining was
seen in any of the sham animals (supplemental figure) or on the contralateral side.
At higher magnification, many of the cells in these regions were labeled positive for EB.
Upon first inspection, it would seem likely that the EB positive cells were astrocytes due to the
physical connection between astrocytes and vasculature (Abbott et al., 2006). However, triple
labeling with glial fibrillary acidic protein (GFAP), Neurotrace™, and EB showed that across all
regions of interest (cortex, dentate gyrus, and CA3), a majority of EB stained cells were neurons
(Figure 2.3B-D). Together, these data demonstrate that EB-labeled albimun that extravasates
from the injured vasculature was preferentially taken up by neurons.

mCCI induces neurodegeneration patterns that matches the EB patterns and persist
for at least 8 days after injury
One day after injury, FJB staining showed a similar pattern to the EB staining (Figure 2.4A i-vi),
with a hemispherical degeneration pattern reminiscent of the EB pattern. In comparison, the
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cortical surface in direct contact with the impactor had no FJB staining. Elevated FJB staining in
the subcortical white matter appeared directly below the impact site. In the hippocampus, similar
to the EB staining patterns, there were FJB positive cells in CA3 regions (stratum pyramidal) in
bregma sections -1.5 and -2.0 but not in subsequent sections (Figure2.4Avi). Staining in the
dentate gyrus was apparent in all five bregma sections analyzed with the staining localized more
to the polymorphic layer (Figure 2.4Av). While FJB is noted to stain degenerating neurons, it has
been shown to co-label with astrocytes (Anderson et al., 2003). Therefore sections were triple
labeled with GFAP, FJB, and a fluorescent nissl stain to determine which cell type(s) were FJB
positive (Figure 2.5). All FJB positive cells were positive for the nissl stain and not GFAP. There
was little to no FJB stained positive cells in the sham and on the contralateral side (Figure 2.4A iiii). In the sections imaged across the lesion, most showed significant levels of FJB positive cells
between sham and injured animals (Figure 2.4B). Sections -1.5 to -3.0 showed significant FJB
positive cells for both the cortex and hippocampus (cortex p<0.001 for each section -1.5 to -3.0;
hippocampus p=0.0113 for section 1.5, p<0.001 for sections -2.0 to -3.5). For section -3.5, the
cortex trended towards significance at p=0.0635.

Figure 2.5. FJB, GFAP, Nissl triple label
In all regions examined – cortex, CA3, and dentate gyrus (DG) – the FJB colabeled with the
fluorescent Nissl stain and not GFAP.
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Neurodegeneration indicated with FluorJadeB (FJB) staining was sustained 8 days post
injury, although reduced in number relative to 24 hour labeling. Although the level of positively
stained cells in the cortex was reduced (Figure 2.6A), the pattern of FJB positive cells was still
similar to that seen in at the 24hr time point. The number of FJB positive cells in injured brains
remained significantly elevated compared to sham controls (for cortical degeneration, Figure
2.6Ai,ii,B, p<0.001 for all sections). Neuronal degeneration in the CA3 and the dentate gyrus was
also significantly higher compared to sham (Figure 2.6Aiii,iv,C, bregma -1.5=0.0105, -2.0
p=0.0018, -2.5 p= 0.0102, -3.0 p=0.0058, -3.5 p=0.0338). Moreover, a new area of significant
labeling appeared in the thalamus at this time point (Figure 2.6Av,vi,D, bregma -1.5 p=0.0024,2.0 and -2.5 p<0.001, -3.0 p=.0081, -3.5 p=0.0323). However, a Nissl stain revealed no obvious
neuronal loss in these regions (data not shown).

mCCI induces axonal injury in the subcortical white matter
To document the level of axonal injury in the subcortical white matter, tissue at the 24hr survival
time were labeled for amyloid precursor protein (APP) (Figure 2.7A,B). A significant number of
axonal varicosities were seen on the ipsilateral side in comparison to sham and the contralateral
side (p<0.001 for all sections analyzed) (Figure 2.7Ai,ii,B). The number of varicosities tended to
decrease in coronal sections located more distant from the center of the impact site. Abnormal
axonal swellings were not observed in other areas. Further, APP expression was not elevated in
other regions – cortex hippocampus, thalamus – in comparison to contralateral. The axonal
varicosities present at 24hrs were no longer apparent at 8 days (data not shown).
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Figure 2.6. FJB 8 days after injury was diffuse and had decreasing level of degeneration.
At this time point, FJB staining was located in the cortex (ii), dentate gyrus (iv), and thalamus (vi)
A). Punctate staining in these regions could be due to debris from previously dying neurons. The
contralateral regions did not show similar FJB staining (i, iii, v). (B) Degeneration in the cortex
was still significantly elevated at 8 days compared to sham (p<0.001 for all sections). In the
hippocampus, all sections show significant increase in FJB staining (bregma -1.5=0.0105, -2.0
p=0.0018, -2.5 p= 0.0102, -3.0 p=0.0058, -3.5 p=0.0338, n=4). In the thalamus, all sections
showed significant levels of FJB staining (-1.5 p=0.0024,-2.0 and -2.5 p<0.001, -3.0 p=.0081, 3.5 p=0.0323). Samples sizes were n=5 for sham, n=11 for injured.
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Figure 2.7. Axonal injury.
(A) APP staining was localized to the subcortical white matter on the ipsilateral side (i).
Contralateral (ii) regions in of injured brains and sham brains (B) failed to have similar axonal
pathologies. (C) Quantification of the axonal injuries show significant number of APP
varicosities near and at the epicenter of impact (p<0.001 for all three bregma sections, n=5 sham,
n=11 injured).
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mCCI produces increase in gliosis that closely match EB and FJB patterns
On the cortex of the ipsilateral side, Iba-1 and GFAP staining patterns were also reminiscent of
the EB and FJB staining patterns at 24hr and 8 day (Figure 2.8Ai,ii,iii,iv,v,vi), showing reactivity
for both cell types in areas that also showed EB staining and neuronal degeneration. GFAP
expression immediately under the impact site was less than the surrounding region, a pattern
similar to that seen in EB and FJB. Increased GFAP expression in the cortex was more diffusely
elevated but still showed similar patterning seen in FJB staining. It is important to note that there
was a general increase in GFAP expression throughout the cortex, even at distal regions,
compared to the contralateral side. GFAP expression in the hippocampus was also significantly
elevated especially at and around the dentate gyrus (Fig 2.8Aiii,iv) and in the thalamus (Fig
2.8Av,vi). Across all five bregma sections imaged, the average GFAP expression was
significantly elevated when compared with sham and the contralateral side (Figure 2.8B, p<0.001
between cortex, hippocampus, thalamus between sham and injured; p<0.001 between
contralateral and ipsilateral for cortex and thalamus).
Similarly, staining for microglia with Iba-1 showed increased presence of microglia in
the same regions that had elevated GFAP expression, FJB and EB labeling (Figure 2.9A). In the
cortex, the region directly subject to impact showed increased microglia migration and the
presence of some activated microglia. However, the regions surrounding the directly impact site
showed a higher incidence of activated microglia (Figure 2.9E). Increased microglia presence was
also found in the ipsilateral hippocampus and thalamus compared to the contralateral side (Figure
2.9F,G). There was no evidence of activated microglia or increased microglia presence on the
contralateral side (Figure 2.9B-D).
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Figure 2.8. GFAP staining patterns were reminiscent of FJB degeneration pattern .
(A)The GFAP staining pattern is shown and pictorially depicted. In the ipsilateral cortex, there
was no prominent glial scar (ii). The lesion center (LC) also exhibited less GFAP expression than
the lesion edge (LE). (i) The contralateral cortex did not have much GFAP staining. In the
hippocampus, there was slight increase of GFAP expression in the ipsilateral compared to
contralateral (iv versus iii), especially in the dentate gyrus. The thalamus also saw an increased
GFAP expression (vi versus v). (B) Comparing the contralateral and ipsilateral GFAP expression
averaged across all five sections was significant in the injured group (p<0.001 for each brain
region); between sham and injured on the ipsilateral side, there was a significant increase for all
three brain regions (p<.0001). Sample size n=5 sham, n=11 injured.
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Figure 2.9. Microglia localized to site of injury .
(A) The ipsilateral side showed increased microglia migration, especially to regions that also
showed FJB staining at 8 days. The ipsilateral cortex showed greater presence of activated
microglia in the lesion edge (LE) compared to the lesion center (LC) (E). (B) The contralateral
cortex showed minimal microglia presence and no activated microglia. The ipsilateral
hippocampus (F) and thalamus (G) show increased microglia migration compared to contralateral
(hippocampus (C), thalamus (D)) but both had less presence of activated microglia compared to
the cortex.

mCCI produces slight behavioral deficits in motor dependent tasks but not in
hippocampal dependent tasks
In all, mCCI produced very mild early behavioral deficits (Figure 2.10A). Injured mice showed
vestibulomotor impairment after injury. A repeated measures ANOVA showed significantly
lower fault and fall times on the rotarod compared to sham mice (p=0.0009, 0.0017 respectively,
Figure 2.10B). The interaction between time and injury was not significant but was significant for
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time alone (p<0.0001) showing that injured animals did not learn at a different rate than sham
animals. At 4-5 days post injury, injured mice did not show a significant decreased preference for
the displaced object than sham mice (p=0.2345, Figure 2.10C) in the hippocampus dependent
behavioral task, SOR. Additionally, the CFC task administered 7-8 days post injury also failed to
elicit significant behavioral difference between injured and sham mice (p=0.2182, Figure 2.10D).
In all, mCCI produced early motor behavioral deficits.

DISCUSSION
In this chapter, we developed a model of mild TBI that was modeled on the estimated
biomechanical conditions of mild TBI. Using an impact velocity range and an indentation depth
that created tissue strain and strain rates in the hippocampus and cortex associated with
concussion in humans, our modified CCI technique produced an injury that results in early and
delayed neurodegeneration, axonal injury in the subcortical white matter, and glioreactivity. In
comparison to CCI conditions commonly used in mice (2-6 m/s; 1 mm depth), the mCCI did not
cause obvious tissue tears, primary hemorrhage at the impact site, or a necrotic lesion at the
impact site. Although mCCI caused BBB extravasation indicated by EB dye extravasation, the
EB labeling was not diffusely spread across the injured region. Rather EB labeling was confined
to individual cells in the dorsal CA3 and the dentate gyrus (DG). Only the cortex, DG, and CA3
initially showed neuronal degeneration one day after injury, diminishing over the course of 8 days
after injury. Delayed dorsolateral thalamic degeneration is prevalent in both forms of CCIs but
with tCCI damage to this region as detected by silver staining and FJB was apparent by 24hrs
(Hall et al., 2008); mCCI causes a greater delay in the development of thalamic damage. In terms
of inflammation, both types of CCIs produce reactive astrocytes and microglia. With mCCI,
regions of increased GFAP expression and microglia migration closely followed regions of
neurodegeneration in the cortex, hippocampus, and thalamus. Mild tCCI too produced a gliotic
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Figure 2.10. The results of behavioral testing.
Mild controlled cortical impact leads to a transient behavioral impairment. A behavioral testing
paradigm to examine both cortical and hippocampal function after impact is shown in A. Rotarod
(RR) training occurred the day before injury; RR was given on days 1-3 post injury. Spatial
object recognition (SOR) was implemented on days 4 (training) and 5 (test day). Contextual fear
conditioning (CFC) was given on day 7 (training) and 8 (test). The animals were perfused on day
8 after CFC. The rotarod results (B) indicate injured animals faulted at lower speeds with
significantly lower fault and fall latency times as determine by a repeated measures ANOVA
(p=0.0009 and 0.0017 respectively). In neither the SOR nor the CFC (p=0.2345, p=0.2182
respectively) did injured mice show significant level of altered behavior. Sample size n=17 sham,
n=19 injured.
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response that was limited to only the cortex (Baldwin and Scheff, 1996; Ekmark-Lewén et al.,
2010; Hinkle et al., 1997) whereas for moderate/severe tCCI, astrogliosis was more widespread,
encompassing the whole ipsilateral cortex, hippocampus and most of the thalamus (Chen et al.,
2003). Axonal injury in the mCCI was localized to the subcortical white matter region below the
impact site. In contrast tCCI studies showed APP varicosities in not only the corpus callosum but
also had increased expression in the hippocampal commissure (Macdonald et al., 2007), the
peripheral neocortex (Pleasant et al., 2011), the cortex and hippocampus (Ciallella et al., 2002).
This difference between mCCI and tCCI APP staining is not unlike clinical studies comparing
mild and severe TBI. In the clinical population, mild TBI and severe TBI patients displayed
axonal injury in the same brain regions; the severe TBI patients more extensive axonal injury in
these and other brain regions (Blumbergs et al., 1994, 1995).
Biomechanically, our review of the literature shows that our new CCI technique (mCCI)
shares some similarities to FPI. Both mCCI and FPI have similar biomechanical loading rates,
and these rates are in the range of human mTBI (Figure 2.1). Although both models produce
direct cortical deformation requiring craniotomies, loading on the brain between the two models
is very different. FPI produces variable loading on the dura as the fluid spreads unevenly and
extensively across the surface of the ipsilateral hemisphere (Dixon et al., 1988) whereas the rigid
indenter of a CCI provides reproducible injury patterns. There are two type of FPI: midline and
lateral (Thompson et al., 2005). The midline FPI (MFPI) produces diffuse injuries. Low level
MFPI often cause slight hemorrhages on the parieto-occipital cortex, corpus callosum, fimbria
hippocampi, thalamus, and brain stem whereas high level injures produce similar but more
extensive hemorrhaging patterns also encompassing the frontal, parietal, and occipital cortices (C.
Edward Dixon et al., 1987; McIntosh et al., 1987). Neither low nor high MFPI injuries produce
focal contusive injuries. Lateral FPI (LFPI) is more similar to mCCI as it produces focal injuries
in addition to diffuse injuries. More severe lateral FPI injuries cause contusions (Goodman et al.,
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1994); mild LFPI do not (Hylin et al., 2013; McIntosh et al., 1989). Mild LFPI produced BBB
extravasation but the pattern was different than those of mCCI. Hemorrhage typically occupied
the external capsule bordering the lateral ventricle from approximately the level of the caudateputamen to the level of the subthalamic nucleus (McIntosh et al., 1989). There was minimal EB
extravasation in the left cortical hemisphere. In one mild LPFI study, researchers noted no overt
changes in neuronal density or dendritic damage, APP bulbs in the corpus callosum, and
increased GFAP and Iba-1 staining in the corpus callosum and thalamus (Hylin et al., 2013).
Another mild LFPI study (Spain et al., 2010) showed cell death only in the cortex at 24hrs which
dropped to below sham by 72 hrs. There was no cell death in the thalamus at any time point and
only a few animals showed hippocampal damage. 24hr staining of APP showed no significantly
elevation of APP bulbs in any region although the cingulum showed increased bulbs at 4hrs and
the thalamus at 6 weeks. Shultz et al (2011) showed activated microglia in the ipsilateral cortex
and only saw significantly elevated GFAP expression in the cortical area directly below the
impact region. While FPI model reliability between laboratories is poor as evidenced by the
different resulting pathologies produced (Thompson et al., 2005), generally mild LPFI produces
more focal damage with most of the damage concentrated in the cortex and less in the
hippocampus and thalamus. While both mild FPI and mCCI produced axonal damage, increased
gliosis, and neuronal cell loss, the largest difference between the two models is in the correlation
of injury patterns between each of the histopathological stains. In mCCI, the regions of gliosis,
degeneration, and BBB extravasations were very similar, something that has never been noted for
mild FPI injuries.
With an ability to create cellular changes without more distinct hemorrhagic injury, this
new CCI technique will allow us to extend our knowledge of tissue injury thresholds for the brain.
Currently CCI type models and the direct cortical deformation (DCD) model from Shreiber et al
(1997) are the only ones that can independently alter strain versus strain rate in the rodent. For the
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cortex, strain, strain rate, and post-injury length of time have been shown to all affect cell death
(Elkin and Morrison III, 2007). For the hippocampus, only strain and post-injury length of time
and not strain rate, affect cell death (Cater et al., 2006). All three factors can be simulated with
the mCCI to validate tissue thresholds found in vitro and determine if the regional anatomical
vulnerabilities also occur in vivo. For instance, if neuronal degeneration in the hippocampus was
not sensitive to strain rate, then a tCCI injury of 1.0mm impact depth should cause less injury to
the hippocampus than an injury of 2.0mm impact depth. However tCCI produce greater
histopathological and hippocampal dysfunction than mCCI suggesting that there other factors that
affect injury thresholds that are not replicated in vitro. In this comparison of tCCI with mCCI
loading conditions, the most striking difference is the presence of primary hemorrhage for the
tCCI model. Although not explored directly in any biomechanical study, the presence of
hemorrhage has been a focus of study in the past as a possible source that enhances neuronal
degeneration (Alonso et al., 2011; Matz et al., 2001; Nadal et al., 1995; Sasaki and Dunn, 2001).
Past studies found axonal injury thresholds to be 18% strain (Bain and Meaney, 2000) which was
similar to the 17.2% strain threshold for vascular damage (Shreiber et al., 1997). mCCI seems to
support this as the EB and FJB patterns were so similar.
mCCI can also be used to correlate biomechanics to biochemical changes. The concept of
mechanoporation as it relates to strain and strain rate can be explored with mCCI and the results
compared to in vitro studies. Cell cultures studies into mechanoporation, the process by which a
traumatic insult produces sublethal pores or defects in the membrane, occurs within seconds to
minutes of initial injury. The degree of mechanoporation being dependent on strain and strain rate
(Cullen et al., 2011; Geddes et al., 2003). High strain rate loading causes cells to behave in a
more rigid manner while at low strain rates cellular structural components are able to comply
with even deformation. Authors concluded that mechanoporation studies could be used to
determine the stress/strain concentrations in tissue. An in vivo model of TBI and
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mechanoporation showed that neurons had immediate and prolonged membrane disruption due to
uptake of pre and post injury dextran or HRP uptake (Farkas et al., 2006). However newer studies
have shown that dextran and HRP uptake into neurons were due to NMDAR dependent
endocytosis (Vaslin et al., 2007) and that this excitotoxic induced endocytosis could be used to
deliver neuroprotective peptides (Vaslin et al., 2011) as a treatment for TBI. This may explain
why Farkas et al showed only neurons being susceptible to mechanoporation as other cell types,
not containing NMDARs, would not be subject to NMDAR induced endocytosis. Injection of the
dextran dye pre and post injury as used by Farkas et al with this model, could help further define
in vivo and validate in vitro functional tissue thresholds by comparing regions of dye labeled
neurons and their stress/strain concentration.
Finally, the relative simplicity of the mCCI technique also suggests this technique would
be useful in determining strain/strain rate thresholds following repeated TBI. Several studies with
repeated TBI show the brain is much more susceptible in a subsequent injury, yet the exact
mechanical threshold that changes over multiple injuries is not known (Laurer et al., 2001;
Longhi et al., 2005). Recent studies using either a cortical impact or fluid percussion model show
that repeated TBI will lead to changes that are observable with clinical imaging tools,
ultrastructural tools including electron microscopy, and behavioral screening (Bennett et al., 2012;
Shitaka et al., 2011; Shultz et al., 2011). Overall, repetitive TBI models show transient or no
behavioral deficits, minimal histopathology with the first injury and significant behavioral
dysfunction and prolonged histopathology; these features are similar to our modified CCI model
described in this chapter. Therefore, this mCCI technique appears ideally positioned to expand
our understanding of tissue injury thresholds for single and repeated TBI. The resulting thresholds
that indicate the critical strain and strain rate combinations causing astrogliosis, microglia
reactivity, BBB breakdown after repeated mechanical injuries will provide great insight into the
potential mechanical vulnerability of the brain as it recovers from injury, leading to a much more
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precise estimate of whether the mechanical tolerance of the brain over time changes after injury.
Knowing these dynamic mechanical tolerances will lead to a more precise, injury-dependent
prediction of vulnerability that would lead to better prediction of brain injury tolerance for head
protection technologies. In addition, the evolving state of brain tolerance could inform us about
new biochemical pathways that are activated over time after repeated injuries of the same
mechanical magnitude, leading us into more precise measures of treating the injured brain after
repeated injuries.
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Chapter 3 In vivo imaging of stretch injury
ABSTRACT
Past in vitro work showed that astrocytes respond to mild stretch with an intercellular calcium
wave (ICW) that spread far into the penumbra region. The mechanism of the ICW was dependent
on the severity of injury, but was predominantly due to extracellular ATP activating purinergic
receptors. However, astrocyte cultures are a poor model with which to study true astrocyte
function. Cultured astrocytes have altered morphology and express different genes than astrocytes
in situ, necessitating a validation of in vitro results in vivo. In this chapter, we adapted the mild
CCI model that we created based on human mild TBI biomechanics to allow for real time in vivo
imaging during injury. With the micro CCI model, we found that astrocytes produce a sustained
ICW originating from the site of impact. This response was greatly reduced with application of
apyrase, a nucleotidase, but not with flufenamic acid, a gap junction blocker. Due to limitations
of the setup, we were not able to test multiple injury levels. However, the results suggest that
astrocytes do respond to mechanical injury with a calcium wave similar to that in vitro and at the
injury level tested, the mechanism of the wave was also from extracellular ATP.
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INTRODUCTION
Astrocyte excitability operates via changes in intracellular calcium levels (Agulhon et al., 2012;
Verkhratsky et al., 2012; Zorec et al., 2012). Past work in vitro shows that calcium waves
propagate through the astrocytic syncytium. Based on these results, the hypothesis arose that
calcium could be the mechanism where astrocytes convey information through long distances
(Agulhon et al., 2008).

Figure 3.1. The PLC/IP3 pathway
Once activated, GqGPCR activates PLC which hydrolyzes PIP2 into DAG and IP3. IP3 activates
IP3 receptors on the endoplasmic reticulum (ER) causing calcium to be released from the internal
stores.
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The most widely accepted pathway for intracellular calcium increase in astrocytes is
through the phospholipase C (PLC)/ inositol 1,4,5 –triphosphate (IP3).pathway (Agulhon et al.,
2008; Zorec et al., 2012). Gq G protein coupled receptor (GPCR) activation causes PLC to
hydrolyze the membrane bound lipid phosphatidylinositol 4,5 –bisphosphate (PIP2) into IP3 and
diacylglycerol (DAG) (Figure 3.1). IP3 activates IP3R on the endoplasmic reticulum (ER) causing
calcium release. (Fiacco and McCarthy, 2006; Scemes, 2000; Scemes and Giaume, 2006). Once
triggered, the intracellular calcium can cause intracellular calcium levels to rise in neighboring
astrocytes producing intercellular calcium waves (ICW) (Scemes and Giaume, 2006).
The pathway for ICW transmission is noted to occur through two possible ways
(Agulhon et al., 2008). The first is through “de novo” generation, where intracellular calcium
increase in the cell causes extracellular release of a signaling molecule that can activate the
GqGPCR on nearby cells. In most cases, this extracellular molecule is adenosine triphosphate
(ATP) (Agulhon et al., 2008; Bowser and Khakh, 2007; Scemes, 2000). The second pathway is
through transmission of IP3 through gap junctions, based on extensive in vitro work. Although
intracellular calcium increases occur readily in vitro, the relative incidence of ICW occurring
under physiological conditions in vivo occurs (e.g., Kuga, et al., 2011; Ding et al., 2013) but less
frequently (Agulhon et al., 2008).
Perhaps the most significant for astrocytic ICWs is in mediating pathological states.
Using 2-photon imaging, Ding et al (2009) showed that after induction of ischemia through
photothrombsis, astrocytes in the ischemic region displayed highly synchronous calcium
oscillations that were blunted with the application of 2-methyl-6-(phenylethynyl)-pryidine
(MPEP), a mGluR5 antagonist, and CGP54626, a GABABR antagonist. The induction of status
epilepticus (SE) through application of pilocarpine was able to cause acute and prolonged
calcium waves in vivo which were reduced with the application of MPEP (Ding et al., 2007). In
both cases, blocking the calcium waves in vivo led to neuroprotection. In a cortical spreading
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depression (CSD) model, injection of KCl to trigger CSD also triggered astrocytic calcium waves
which propagated farther than did the CSD wave itself (Peters et al., 2003).
These studies showed that astrocytic ICWs are elicited in a disease state and that blocking
these waves are neuroprotective. Until now, there was no meaningful evaluation of the role for
astrocytic ICWs in recovery after TBI. Mechanical stimulation of a single astrocyte in culture can
cause an outward propagation of ICW that extends beyond neighboring cells (Charles et al., 1991;
Scemes and Giaume, 2006). Astrocyte cultures undergoing stretch display a large sustained
increase in intracellular calcium due to release of calcium from ER stores (Rzigalinski et al.,
1998). Even though calcium levels returned back to the basal levels, subsequent glutamate
induced calcium responses were inhibited. Astrocytes injured by a rapid, transient strain that
simulates mild TBI caused ICWs to spread into the penumbra region and the mechanism of
calcium propagation depended on the level of injury (Choo et al., 2013; Miller, 2009). The
blockade of intercellular wave mechanisms provided neuroprotection in organotypic hippocampal
slices. Inhibiting the same pathway that produce ICWs through pretreatment of purinergic
receptor P2Y1 receptors (P2Y1R) also produced reduced neuronal cell death and improved
behavior after a controlled cortical impact (CCI) injury in mice (Choo et al., 2013).
However, astrocyte cultures serve as a poor model for studying astrocytic functions
(Agulhon et al., 2008; Lange et al., 2012). Gene profiles between astrocytes in culture and in vivo
are dissimilar; cultured astrocyte express genes that are not expressed in vivo (Agulhon et al.,
2008). Cultured astrocytes also express different synaptic proteins (which are involved in
exocytosis of messenger molecules) from in situ and vice versa (Wilhelm et al., 2004). Culturing
conditions can also influence gene and receptor expression, contributing to significant differences
in experimental result between labs (Lange et al., 2012).
In this chapter, we investigated if the mechanically induced calcium waves found in vitro
could be replicated in an in vivo model of injury. Using a 2-photon system to image the pia layer
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of an anesthetized mouse, we created a mechanical device that was capable of imparting an
impact to the cortex. We recorded the acute increase in cytosolic calcium within the astrocytes
after injury, characterized the extent of injury, and also tested to see if the mechanism of the
calcium waves in vivo was similar to mechanisms observed in past in vitro research.

METHODS AND MATERIALS
Cortical Craniotomy and Dye Loading
Mice (C57Bl6, Jackson) were prepared for in vivo imaging as previously described (Tian et al.,
2006). Briefly, mice were anaesthetized with an intraperitoneal (IP) injection of 1.5 g/kg urethane
(Sigma Aldrich, St. Louis, MO). A head plate containing a window for the exposed cortex was
cemented to the skull with VetbondTM. A 1.8-mm craniotomy was produced on the left
hemisphere, midway between bregma and lambda. The dura was gently removed, being careful
not to damage the underlying cortex. The exposed cortex was incubated with 0.65mM of fluo-4AM (Invitrogen, Grand Island, NY) diluted in 20% pluronic in dimethyl sulphoxide (DMSO)
with artificial cerebrospinal fluid (ACSF) for 1.5 hours. Fluo-4 was rinsed with ACSF and was
incubated for an additional 30 min to allow for de-esterification. The cortex was continuously
irrigated with artificial CSF to prevent drying. This loading protocol preferentially labels
astrocytes with Fluo-4 up to a depth of ~150 mm beneath the surface of the cortex (Figure 3.2;
Tian et al., 2006). 100µM Sulforhodamine 101(SR101, Invitrogen, Grand Island, NY) was
topically applied for 5min just prior to setup of the mice on the microscope. SR101 specifically
loads astroctyes in vivo (Nimmerjahn et al., 2004) and was used in our preparations to detect
astrocytes.
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Figure 3.2. Astrocytes loaded with SR101 and Fluo-4AM.
40× objective. The cells labeled with Fluo-4AM co-labeled with SR101 demonstrating that the
cell type of interest were astrocytes.

Adaptation of In Vivo Models for Imaging
To see if a mechanically induced intercellular calcium waves occurred in vivo, we modified an
animal TBI model to fit under a 2-photon microscope. Of all the injury models available, only the
CCI satisfied our needs. The impactor size and impact depth was reduced so that a nonhemorrhagic injury was produced in the cortex as well as fit under the objective. The craniotomy
size used in the in vivo imaging protocol was also much smaller than that used in a typical CCI
injury. As the same solenoid model was used to actuate the micro CCI as used in the mCCI, both
models used similar impact speed.

microCCI injury
Lateral Impact: After the dye was loaded and rinsed away, half the cortex was coverslipped, and
1.5% low temperature agarose was injected between the coverslip and the cortex to minimize
motion artifact during in vivo imaging. The agar covering the half of the cortex that was not
covered by a glass coverslip was cut away and removed. Once mice were mounted in the stage of
the microscope system the impactor, metal conical shaped tip of 1.0mm and 2.0mm in diameter
was put into position into with a 10× objective. The metal tip was driven by a solenoid (SoftShift,
Ledex, USA). With the impactor in the extended position, the tip was lowered until it made
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contact with the cortex at the agar interface (Figure 3.3). Once the impactor was retracted, the
impactor was lowered in by the desired impact depth.

Figure 3.3. Lateral microCCI setup.
Glassslip covered agar filled half the exposed cortex. The angle of impactor ranged between 15° 30° from hortizontal.

Vertical Impact: The craniotomy and the dye loading protocol remained the same. In the vertical
setup, agar was not used. A silicone membrane (Sylgard 184 + 186 mix; Dow Corning, Midland,
MI) between 0.1-0.15mm thick was used to cover the entire cortex. Cortical impacts were
delivered using a custom-built impactor, with a tip diameter of 200 mm. The impact depth (~200300m) was determined by the length of the custom impactor. The 10× objective was used to
position the impactor in the middle of the craniotomy (Figure 3.4). After collecting the data, the
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impactor tip was lowered and a z stack of the cortex in the deformed position was used to
determine impact depth.

Figure 3.4 Vertical impact setup.
A custom made impactor tip impacts the cortex in a vertical downward direction. A thin silicone
membrane covers the cortex to prevent the impactor tip from piercing the brain as well as to
disperse the mechanical force across a wider surface area.

In vivo Imaging
Mice were mounted in a in vivo 2-photon imaging system (Prairie Technologies), and images
were acquired at 3s intervals using a 40× water-immersion infra-red objective with 820nm
excitation wavelength. A three second time lapse between each image was used to reduce the
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amount of photobleaching. We were able to image up to 200µm into the cortex with fluo4-AM.
Imaging of calcium responses with and without impact were taken at around 50-80µm below the
pial surface.

Statistical Analysis
All statistical tests were carried out using JMP10. The variance between groups was first tested
for normality (Shapiro-Wilks test) and then equality (Bartlett test). When the variance between
groups was not similar, the two sample t test was used, otherwise a one way analysis of variance
(ANOVA) was used.

RESULTS
Development of the microCCI Model
The depth of impact was limited by the working distance of the objective used. Initially, the
impactor was oriented at a 15° to 30° angle from horizontal using a metal conical tip. Two
different tip diameters were used, 1mm and 2mm. The original setup (Figure 3.3) was configured
to image half the impacted area and half of the penumbra region. However this setup in many of
test preparations caused contusions or knocked the imaging out of focus.
The lateral impact model was able to show increased calcium activity in astrocytes after impact
(Figure 3.5). However the consistency was low and the spread of the calcium wave was poor.
Many times, the plane of interest was knocked out of focus and did not return. This could be due
to the impactor deforming the agarose, causing it to press on the cortex. Hemorrhaging was also
an issue with this model. Many of the impacts caused small contusions to the cortex, potentially
due to the large lateral distance the impactor needed to travel with respect to the downward
distance (as the angle of the impactor was small), causing greater lateral deformation than vertical.
To ensure that the poor calcium response was not due to the injury model and preparation,
we next pursued a vertical impact (Figure 3.4). However, the severity of the impact was limited
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Figure 3.5. Lateral micro CCI induced a calcium wave in astrocytes immediately after
impact.
(A) 40× time-lapse images of the calcium wave after impact and (B) the graphed response of the
highlighted region.

by the short working distance of the objective, as well as the impactor material. Based on the data
from the lateral impacts, response time of the calcium wave in vivo occurred acutely and
dissipated quickly. Therefore the impactor could not be moved in and out of the field of view
during the time of interest. Pulled micropipettes were used for their near optically transparent
properties as well as their malleability when heated. The same solenoid from the lateral impact
model was used to actuate the tip in a downward motion. The impactor was visible with the 10×
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objective which allowed the impactor to be positioned as close to the center of the craniotomy
field as possible (Figure 3.6). At the 40× objective however, the impactor was not visible which
allowed for unobstructive view of the dye loaded cells and subsequent impact response (Figure
3.6).

Figure 3.6. 2-photon images of the in vivo preparation with the vertical impactor in position.
(A) Under the 10× objective the vertical impactor was visible which allowed for the impactor to
be positioned in the middle of the cortex. In this preparation, rhodamine dextran was injected into
the tail to delineate the vasculature. Fluo4-AM was loaded topically to measure calcium loading
in the cell. The white arrow depicts the location of the impactor tip. (B) 40× objective of the
region directly below the impactor. With this objective the impactor was no longer visible.
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Figure 3.7. Vertical micro CCI induced a strong calcium response immediately after impact.
(A) 40× time-lapse images with SR101 showing labeled astrocytes and Fluo4-AM of the calcium
wave. The lines in the time-lapse dye loaded images are due to perfusion of the brain and motion
of the animal. (B) The impact region shows sustained area of intracellular calcium increase after
injury.

Injury Induced Calcium Wave
A mechanical impact was able to induce an intracellular calcium wave in astrocytes in vivo
(Figure 3.7A). The calcium wave originated from the impact site and extended radially outward.
Due to the fluctuation of the surface of the cortex from vascular perfusion and animal motion,
there were small image plane changes with cells coming in and out of focus. Unlike the lateral
52

injury model, the vertical method did not employ the use of low melting agar to help reduce
motion artifacts. A comparison in time lapse imaging between a vertical impact (Figure 3.7A) to
the lateral impact (Figure 3.5A) shows noticeable lines that run across the image at each time
snapshot. To measure the spread of the ICW, the normalized change in fluorescence (ΔF/Fo) was
thresholded above 0.54. Plotting the thresholded area against time (Figure 3.7B) gave us an idea
on how fast and long the calcium wave lasted.

The Mechanism of Injury Evoked ICW in Astrocytes is Through Extracellular ATP
Next we tested for the mechanism by which the mechanically induced ICW occurs. In vitro
results showed that the mechanism for ICWs depended on the injury level, extracellular ATP was
the dominant pathway for all injury levels tested (Choo et al., 2013; Miller, 2009). Apyrase, a
nucleotidase, breaks down ATP and ADP into adenosine. Flufenamic Acid (FFA) is a gap
channel blocker. Mice were topically treated with each drug prior to injury. FFA treated injury
calcium response was similar in the spread and decay as the untreated animal (Figure 3.8A, B). In
contrast, apyrase treatment reduced the spread of the calcium wave. Both the untreated and FFA
treated mice displayed similar and significant increases in thresholded area post injury compared
to sham animals (Figure 3.9). Apyrase treated injured animals had peak thresholds that were
similar to sham treated and untreated animals. This suggests that the dominant mechanism for
mechanically induced ICWs is through extracellular ATPs. We also tried pretreating with either
pyridoxalphosphate-6-azophenyl-2’, 4’-disulfonic acid (PPADS) or suramin, two broad P2
receptors (P2R). However PPADS reacted to the 2-photon laser and artificially increased the
fluorescence over time (data not shown) and suramin complicated the surgery. Animals pretreated
with suramin would undergo spontaneous bleeding at the craniotomy site, precluding imaging at
the injury site.
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Figure 3.8. Stretch induced calcium wave was attenuated with apyrase.
Topical application of flufenamic acid (FFA) was not able to attenuate the calcium response after
injury. Apryase was able to reduce the level of injury induced fluorescence. Time-lapse imaging
shown in (A) and responses graphed in (B).
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DISCUSSION
Past in vitro research showed ICWs being elicited from astrocytes in culture immediately after
injury, spreading from the injured to the penumbra region. The strains in culture ranged from 5%
to 25% strain (Choo et al., 2013; Miller, 2009). The mechanism for ICW transmission in the
penumbra region was dependent on the injury level. At 5% strain the predominate mechanism
was extracellular ATP through activation of P2 receptors, at 15% strain caused ICW to occur
through both gap junctions and P2 receptors, and at 25% strain mGluR and P2 receptors but not
gap junction caused ICWs. Due to the differences between astrocytes in culture and astrocytes in
vivo (Agulhon et al., 2008; Lange et al., 2012), we needed to determine if the in vitro injury
response can be replicated in vivo.
Toward this goal, we developed a method to image the acute response of a mechanical
impact on cortical astrocytes and study its mechanisms in vivo. Initially we tried a lateral impact
approach. This method allowed us to injure and retract the impactor so as not to interfere with
imaging. This method also covered the imaging side of the craniotomy with a low melting
temperature agarose to help reduce the artifact motion seen in the 2-photon images. The impact
depth with the lateral model could also be easily controlled. While ICWs were seen with this
model, consistency and hemorrhaging were major issues. In the vertical injury model, we used a
custom formed micropipette glass as the new impactor. The glass micropipette was optically
transparent at high magnification but not at low magnification which allowed the tip to be
properly positioned before testing. Immediately after vertical injury impact, a calcium wave was
propagated from the site of injury into the surrounding region. The spread of the ICW could be
blunted by pre- treatment with apryase, but not FFA, suggesting that the main mode of ICW
transmission is through extracellular ATP activation.
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A limiting factor in this vivo study was the severity of the injury produced by the
microCCI. The impact severity was limited by two things: the working distance of the objective
and the need to remain below the threshold for blood brain barrier (BBB) breakdown. The impact
depth in the vertical injury model was set by the length of the pipette which could be no longer
than the 2mm working distance of the objective, making the actual impacting depth the 2mm
minus the width of the impact depth and the height of the walls of the custom made mouse head
plate. The second limiting factor was that all impacts needed to be below the thresholded for BBB
compromise of around 17.2% (Shreiber, 1998; Shreiber et al., 1997). The opaque nature of blood
blocks any fluorescent excitation or emission of the fluorophores.

Figure 3.9. Peak thresholded area after impact.
Untreated and FFA injured mice had significant greater response area than their respective shams
(*, p<0.05, S=Sham, I= Injured, AL= Apyrase, F=Flufenamic Acid).

These two limiting factors place some perspective on the strains produced by the micro
impactor. As FFA was not able to reduce the level of calcium signaling in vivo but apyrase was,
this suggests that the peak strain was below 15%. It is possible that gap junctions is not the
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predominate pathway of calcium waves in vivo impact regardless of strain. To help answer this
question, a finite element analysis of the micro impact could determine the strain and strain rates
the micro impact had on the cortex.
It is important to note the difference in the regions of interest between the in vitro and in
vivo studies. In vitro studies conducted by Miller (2009) focused on understanding the ICWs in
the penumbra region. They note that the response in the injured stretch region was different, on
average lower, but more variable than the calcium response in the penumbra region. In this study,
we focused on the site of injury. With the lateral impact model, we imaged the penumbra region
however the response that we created with the impact was small and did not easily spread to
nearby cells. However, by focusing on the site of impact, we were able to detect strong ICWs
from astrocytes in response to mechanical trauma.
While we showed that extracellular ATP was responsible for the bulk of the ICWs, we
have not shown which P2 receptors – P2X or P2Y – were responsible. In vitro results suggest
P2Y receptors, which are GqGPCRs, as the more likely culprits (Miller, 2009; Morrison et al.,
2011), however P2X receptors have been implicated in inflammation and apoptosis of both
astrocytes and microglia (Franke et al., 2012), and may possibly explain gliosis after TBI.
Furthermore, higher levels of extracellular ATP can also activate P2X7R which can lead to influx
of extracellular calcium into the cell (James and Butt, 2002). We have also not shown if any
glutamatergic receptors might have a role in the ICW transmission in vivo. Despite the limitations
of the small impacted strains, we have shown that the in vivo astrocytic syncytium responds to a
mechanical force with an ICW that propagates from the site of injury outward and the main
mechanism is extracellular ATP.
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Chapter 4 Inhibited IP3 signaling in astrocytes in vivo after TBI leads to
partial alteration of neurological deficits and changes in glial reactivity
ABSTRACT
Intracellular calcium alterations in astrocytes are a major mechanism for controlling a broad
number of astrocyte functions that include trophic factor and neurotransmitter release,
hypertrophy, gliovascular coupling, and neuronal metabolic support. The phospholipase C
(PLC)/inosital 1,4,5 triphosphate (IP3) pathway is a key pathway for communicating calcium
signaling across the astrocyte syncytium in vivo, yet the role of this pathway in controlling
outcome after traumatic brain injury (TBI) is unknown. In this chapter, we tested directly if
actively reducing the IP3 signaling within astrocytes in vivo led to any alteration in either
behavioral or histological outcome after TBI. We used the controlled cortical impact (CCI) model
and examined if the effect of astrocyte specific IP3 signaling was different following either mild
or moderate TBI. We used a transgenic mouse line engineered to expressed venus tagged IP3
phosphatase (VIPP) directly in astrocytes of mature animals, using a tet.On system. In a moderate
CCI injury that include primary contusion and surrounding gliosis, VIPP animals showed worse
behavioral outcome in the watermaze eight days after injury. Moreover, the extent of reactive
astrocytes was reduced in VIPP animals compared to littermate wildtypes. After mild CCI injury,
VIPP animals displayed transient behavioral impairment. Although in vivo 2 photon imaging
showed that VIPP animals showed a reduction of the immediate spread of intercellular calcium
waves from the injury site, this did not lead to an improvement of behavioral deficits after injury
over wildtype. There was also no corresponding change in neuronal degeneration one day after
injury. Eight days after mild injury, astrocyte reactivity was significantly increased in the cortex
of VIPP animals compared to littermate wildtypes. This difference was seen in the ipislateral
hippocampus or thalamus. Together, these data show that IP3 signaling within astrocytes
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contributes partly to outcome over the spectrum of mild to moderate TBI in vivo, potentially as a
mediator in recovery of deficits at more severe levels of injury and as a contributor to early
impairment after mild TBI.
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INTRODUCTION
Astrocytes, the predominate glial cell type and distinguished by the expression of glial
fibrillary acidic protein (GFAP) (Agulhon et al., 2008), are responsible for a variety of functions
ranging from the regulation of blood flow to influencing synaptic transmission (Oberheim et al.,
2006). Although not electrically excitable, astrocytes express a number of G protein coupled
receptors (GPCR) and use calcium as the predominant medium for signaling (Agulhon et al.,
2008; Zorec et al., 2012). The widely accepted mechanism for intracellular calcium increases in
astrocytes is through the phospholipase C (PLC)/inosital 1,4,5 triphosphate (IP3) pathway
(Agulhon et al., 2008). Gq GPCR activation causes PLC to hydrolyze phosphatidylinositol 4,5
bisphosphate (PIP) into diacylglycerol (DAG) and IP3. IP3 activates IP3 receptors (IP3R) causing
the release of calcium from the endoplasmic reticulum (ER) stores (Refer to chapter 3 figure 3.1).
Although the existence of physiologic intercellular calcium waves (ICWs) in astrocytes
in vivo is under debate, it is known that calcium waves in astrocytes occur in a number of
pathophysiologic states that include epilepsy, cortical spreading depression (Fiacco and
McCarthy, 2006), and local ischemia (Ding et al., 2009). Recently, the incidence and progression
of intercellular calcium waves in astrocytes after traumatic brain injury (TBI) was also
demonstrated. The data showed ICWs contributing to both neuronal circuit dynamics and glial
reactivity in the region surrounding the primary mechanical injury (Choo et al., 2013; Miller,
2009).
A primary candidate for mediating the communication of astrocyte intercellular waves in
vivo is the IP3 signaling cascade. In astrocyte cultures, stretch injury causes immediate (5-30min)
and sustained (24 – 48hrs) increases in IP3 (Floyd et al., 2001); inhibiting PLC activity with
neomycin or U73122 reduced the level of reactive astrocytes after biaxial stretch (Floyd et al.,
2004) and also prevented depletion of intracellular calcium stores (Weber et al., 2001).
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Alternatively, blocking a key upstream activator of the IP3 signaling cascade ( metabotropic
glutamate receptors; mGluRs) also reduced stretch induced astrocytic intracellular calcium levels
in vitro as well as prevented depletion of ER calcium stores (Chen et al., 2004). Both of these
pharmacological approaches have shown efficacy when used in experimental TBI models
(Golding and Vink, 1994) (Lyeth et al., 2001), but neither approach provides a direct examination
of how the IP3 signaling within astrocytes specifically contributes to outcome after TBI.
In this chapter, we studied the effect of reducing IP3 signaling in astrocytes on injury
recovery. Unlike prior studies that used the application of drugs, we used transgenic mice
overexpressing a venus tagged IP3 phosphatase (VIPP) gene specifically in cells that expressed
GFAP (Figure 4.1). As a result, this transgenic tool allowed us to directly test for the role of IP3
signaling in astrocytes on the outcome after TBI. Our results show that IP3 signaling contributes
in a complex manner over the spectrum of TBI. It is important for recovery after more severe
forms of TBI, possibly hinders recovery after mild TBI, and contributes to alteration in glial
reactivity.
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Figure 4.1. VIPP prevents IP3 induced calcium release from internal stores.
VIPP catalyzes the reaction of IP3 into IP2 (1-phosphatidyl-1D-myo-inositol 4-phosphate) and a
phosphate. IP2 is unable to activate IP3R, thereby preventing the release of calcium from the ER.
(ER = endoplasmic reticulum).

MATERIALS AND METHODS
VIPP mice were exposed to two different injury levels using the same type of direct cortical
deformation injury model – controlled cortical impact (CCI). For producing moderate injuries, we
used a 6m/s impact velocity and an impact depth of 1mm to create a primary hemorrhagic
contusion that formed a large necrotic lesion 8 days after injury. For studying mild injuries, we
used an impact velocity of 0.43m/s and an impact depth of 2mm to create areas of blood-brain
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barrier breakdown, early neuronal degeneration in the cortex and hippocampus, but no primary
contusion or secondary tissue loss.
We evaluated both the histological and behavioral impairments across these two distinct
TBI injury levels. We developed a separate set of behavioral tasks that allowed us to examine
cortical and hippocampal function in the mild TBI group. The injury and behavior schedule is
shown in Table 4.1. For the more moderate CCI group, the neurological severity score (NSS) and
the Morris water maze (MWM) was used. For the mild CCI group, a three day rotarod protocol
was followed by spatial object recognition (SOR), and then by contextual fear conditioning (FC).

Table 4.1. Behavioral Schedule
Day -1
CCI
mCCI

RR
training

Day
0
NSS

Day
1
NSS

Day
2
NSS

Day
3

RR

RR

RR

Day 4

Day 5

Day 6

Day 7

Day 8

NSS
MWM
SOR

MWM
SOR

MWM

NSS
MWM
FC

Probe
FC

VIPP Breeding
VIPP animals were bred and raised as first described in Halassa (2009). Animals were bred under
12hr light/dark cycles. Pups were weaned at 3 weeks of age and genotyped. Details of producing
GFAP.tTA and tetO.VIPP lines are described elsewhere (Halassa, 2009). These lines were
maintained in a heterozygous state and backcrossed onto a C57B16/J genetic background
(Jackson Laboratories, Bar Harbor, ME). Bigenic offspring of these two lines (VIPP), and their
wildtype littermates, were maintained on 40 mg/kg doxycycline (dox) containing food (Bioserv,
Frenchtown, NJ). They were switched to a regular diet to allow full transgene expression in the
VIPP animals for a minimum of 2 weeks prior to use. A portion of the bigenic animals were kept
on dox for the duration of the experiments, serving as an additional comparison group to both the
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VIPP and littermate wildtype mice. Due to the potential effect progesterone has on the recovery
of brain injury (Feeser and Loria, 2011; Shakeri et al., 2013), only male mice were used.

2-photon imaging and injury
The protocol for in vivo 2-photon imaging during impact was the same as described in chapter 3.
Please refer back for details.

Cortical Impact Brain Injury
All animal procedures were approved by University of Pennsylvania’s Institutional Animal Care
and Use Committee (IACUC). VIPP and littermate wildtype (WT) mice were divided into the
following groups:
Table 4.2 Experimental Groups – Numbers indicate the numbers of animals in each group
Injury
.
Sham
CCI .
mCCI
.
CCI .
mCCI
.
8 day
24hr
8 day
24hr
8 day
14
5
14
11
4
13
VIPP
12
4
11
15
NA
10
on Dox
26
6
14
27
5
13
WT littermates
26
NA
16
25
NA
13
on Dox

On the day of injury, mice were anaesthetized with isoflurane (5% induction, 2% maintenance)
and placed in a stereotaxic frame. A 4-mm craniotomy was produced on the left hemisphere,
midway between bregma and lambda. The moderate CCI injury was produced using a pneumatic
driven device (Smith 1995, Dixon 1991). The impact speed was 5.8-6.0 m/s with a rounded, brass
cylindrical impactor tip 3mm in diameter. Mild controlled cortical impact (mCCI) brain injuries
were produced using an impactor speed of 0.43 m/s and a cortical impact depth of 2mm. The
injury device consists of a solenoid (SoftShift 2EPM, Ledex, Vandalia, OH) attached to a linear
potentiometer (Omega LP803-1, Stamford, CT). A custom Matlab (Mathworks, Natick, MA)
program actuated the solenoid and collected the potentiometer readings. The solenoidpotentiometer was positioned in place with a custom built adjustable angle attached to a digital
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linear stage. The angle of the impactor was measured and set with a digital angle meter to 20°
from vertical. The 4 mm diameter hemispherical impactor tip was made of Sylgard® 184 (Dow
Corning, Midland, MI). After either injury, the cranial exposure was sutured close, and the
animals were placed in a warmed cage to recover until ambulatory.

Histology
Mice were anaesthetized with an overdose of sodium pentobarbital. Animals were transcardially
perfused with 30 ml of ice-cold phosphate buffered saline (PBS) (pH 7.4) and then 40 ml of
freshly hydrolysed ice-cold 4% paraformaldehyde. Brains were harvested, post-fixed overnight in
4% paraformaldehyde at 4°C and then cryoprotected in 24% sucrose. Tissue was mounted in
Tissue-Tek® (Fisher Scientific, Hampton, NH) and was frozen in isopentane cooled with dry ice.
Tissue was cryosectioned at 20 µm. Sections were taken 500µm apart starting from bregma -1.5
to -3.5.
For fluoro-jade® B (FJB; Millipore, Billerica, MA) labeling, sections were rehydrated in
graded ethanols (100%, 95%, 80% 70%; 2 min each) followed by distilled water. Sections were
then incubated in a solution of 0.06% potassium permanganate on a rotating stage for 20 minutes,
rinsed in distilled water for 2 minutes, and placed in a 0.0005% FJB solution (5mL of a 0.01%
stock solution of FJB to 95 mL of 0.1% acetic acid). After 30 minutes in the FJB staining solution,
the sections were rinsed with three changes of distilled water for 1 min per change. Excess water
was drained onto a paper towel, and the sections were air dried in an oven at 37° for 30 min. The
dried sections were cleared by immersion in xylene for at least 2 minutes before coverslipping
with permount (Fisher Scientific, Hampton, NH). The sections were viewed with a Leica SP5
confocal microscope (Leica, Germany).
To stain for astrocytes and microglia, sections were rehydrated in 1×PBS (3times 5min
each) and then incubated with 10% normal goat serum for 30 minutes with 0.1% triton-X. The
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sections were incubated overnight at room temperature in polyclonal anti-GFAP (1:500;
Neuromics, Edina, MN) or anti-Iba-1 (1:1000; Wako, Richmond, VA). After rinsing with 1×PBS,
sections were then incubated with Alexa 546 conjugated secondary for 1hr at room temperature.
Sections were mounted with ProLong Gold antifade (Invitrogen, Grand Island, NY).
To measure the fraction of tissue spared, the total volume of twelve to fourteen sections
across the span of the lesion on the ipsilateral side were divided by the volume of the contralateral
side. Because the ipsilateral side of the brain showed shrinkage, traditional lesion volume was
determined as percent tissue spared.

Behavior Tests
Rotarod :The rotarod protocol was adapted from Oliveira et al (2011). In short, the rotarod
apparatus (Med Associates Inc, St. Albans, VT) has a 3.2 cm diameter rotating rod raised 16.5 cm
above a platform and divided into five sections for testing multiple mice simultaneously. The
rotarod gradually increases its rotation speed from 4 to 40 rpm over the course of 5 min. Latency
to first fault (defined as the mouse riding with the platform in a single rotation) as well as fall
time was recorded. Mice were trained on the rotarod at 4 rpm for sixty seconds twenty-four hours
before injury. Three trials a day were given during three consecutive days with an inter-trial
interval of 1 h. Each trial started at the same time every day and ended when mice fell or when
mice ran for 300 sec.
Spatial Object Recognition: The spatial object recognition (SOR) protocol was adapted from
Oliveira et al (2010). In short, the experimental apparatus consisted of a gray rectangular open
field (60 cm × 50cm × 26 cm) with a visual cue placed on the arena wall. Prior to training, mice
were handled for 1 minute a day for 3 days. During the training day, mice received four 10
minutes training sessions. Between sessions, mice were placed back in their home cage for three
minutes. During the first session, mice were habituated to the gray rectangular open field in the
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absence of objects, but with an internal cue on one of the four walls. During the next three
sessions, mice were placed in the same box but now with two distinct objects - a glass bottle
(100mL volume) and a metal tower (1.5625 in2). Any mouse that successfully climbed either
object was removed from behavioral analysis. Mice were allowed to freely explore the
environment and the objects for 10 minutes. After 24 hours, mice were placed back in the
rectangular environment for the testing phase. The two objects were again present, but one of the
two objects was now displaced to a novel spatial location. Mice were again allowed to freely
explore the environment and the objects for 10 minutes. Time spent exploring the displaced and
non-displaced objects was measured. Exploration was analyzed during both the training and
testing phases. The identity of the objects, as well as the spatial location in which the objects were
located, was balanced between subjects. The response to spatial change was assessed by
comparing the mean time the mice spent exploring the objects (when mice were facing and
sniffing the objects within close proximity and/or touching them) belonging to each category
(displaced and non-displaced) in the test session minus the mean time spent in contact with the
same object category in the last training session. A positive value indicates recognition of the
spatial change.
Contextual Fear Conditioning: In the contextual fear conditioning (CFC) test, mice were placed
in a testing chamber (Coulbourn, Whitehall, PA) on training day for 3 minutes. Two minutes and
twenty-eight seconds into the three minute period, mice were given a single 2 seconds long,
1.5mA shock. Twenty four hours later, mice were place in the same testing chamber and their
percent freezing was calculated across the course of 5 minutes.
Morris Water Maze: The Morris water maze (MWM) was used to test spatial learning and
memory as a measure of hippocampal functionality (D’Hooge and De Deyn, 2001; Vorhees and
Williams, 2006). The maze was conducted over the course of 5 days with the first day of MWM
occurring 4 days after injury. On each of the first four days of watermaze testing, mice were
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expected to find a hidden platform in four trials from each of the four directions (N, S, E, W). The
order of the starting direction was altered each day so as not to accustom the animals to the
procedure. The time required for each mouse to find the platform is the latency time. The four
trials on each day were averaged. A mouse that could not find the platform in 90 sec was given
latency time of 90 sec and then led to the platform by hand. Each mouse was required to stay on
the platform for 15sec before being picked up so they may learn that getting on and staying on the
platform was required for exiting the maze. The probe trail was conducted on the fifth day (Day 8
post injury). The platform was removed and the mouse allowed to swim for 30 seconds. The
memory score was determined based on Smith et al (1991).
Neurological Severity Score: The neurological severity score (NSS) was used to assess motor
function and reflex at specific time points after injury: 1hr, 4hrs, 1day, 2days, 4 days, and 7days.
The NSS used here was composed of 10 tasks (Flierl et al., 2009). Each failed task received a
score of 1 for a total of 10 for failing all ten tasks. The tasks are listed in Table 4.3.

Table 4.3 Neurological Severity Score Task List
Task
Description
Exit circle
The ability to exit a 30cm diameter circle within 3min
Mono/Hemiparesis
Paresis of upper and or lower limb on the contralateral side
Straight walk
Ability to walk in a straight path when placed on the floor
Startle reflex
Measures innate reflex. Mouse will bounce in response to a loud
noise
Seeking behavior
Physiological behavior as a sign of “interest” in the environment
Beam balancing
Ability to balance on a 7mm wide beam for at least 10sec
Round stick balancing Ability to balance on a round 5mm diameter stick for at least 10 sec
Beam walk: 3cm
Ability to walk across a 30cm long beam
Beam walk: 2cm
Ability to walk across a 30cm long beam
Beam walk: 1cm
Ability to walk across a 30cm long beam. Most difficult of the
three beams
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Statistical Analysis
All statistical tests were carried out using JMP10 (SAS Institute, Cary, NC). The variance among
groups was first tested for normality (Shapiro-Wilks test) and then equality (Bartlett test). When
the variance among groups was not similar, the two sample t test was used; otherwise a one way
analysis of variance (ANOVA) was used. A two way ANOVA was used to look for significance
between genotype and injury. A repeated measures ANOVA was used in the rotarod and
watermaze behavioral tests.

RESULTS
VIPP mice show worse behavioral deficits after moderate cortical impact injury
A minimum of two weeks before any procedures, mice were taken off the dox diet to allow the
transgene to fully express (Halassa, 2009). Moreover, the normal grooming behavior and general
activity of the VIPP mice did not differ from their WT counterparts, nor did this behavior
different between VIPP animals maintained on a dox diet.
Following moderate cortical impact injury, both VIPP mice and littermate wildtype mice
showed no difference in performing the NSS tasks, but did show significant differences with their
surgical sham counterparts (p<.0001). VIPP and WT littermates sham animals showed no
difference in performance suggesting that in these simple neurological scoring tasks, the
transgene does not affect baseline NSS behavior. In addition, there was no significant difference
in NSS scores between VIPP and WT on dox injured and sham animals from their off dox
counterparts suggesting that dox did not measurably affect NSS outcome (Figure 4.2). At the one
hour time point after injury, all injured groups had averaged an NSS score of 8 (VIPP injured
7.9±0.4, VIPP on dox injured 7.8±0.3, VIPP sham 1.6±0.3. VIPP on dox sham 2.0±0.4, WT
injured 8.2±0.2, WT on dox injured 7.6±0.2, WT sham 1.5±0.2, WT on dox sham 1.0±0.2).
Almost all animals maintained their startle reflex and most animals in the injured group
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maintained seeking behavior. Sham animals performed almost all tasks. The most difficult task
was the round stick balancing; almost all mice failed to accomplish this task.

Figure 4.2. VIPP did not affect NSS behavior.
NSS behavior did not vary across genotype for either sham or injured groups. All injured groups
were significantly different from sham groups (p<0.0001). There was no effect from genotype or
genotype×injury. Data are expressed as Media ± Standard Error of the Mean (S.E.M.).

The impact of IP3 signaling through astrocytes became apparent when measuring animal
performance in the Morris water maze. In the MWM, sham groups performed similarly across all
four days (Figure 4.3). There was no significant difference between VIPP and WT littermate
shams. In the injured groups, the initial performances were similar. On average the animals had a
latency of around 70 sec (VIPP injured 72.7±4.6 sec, WT injured 69 ±3.1 sec, VIPP on dox
injured 66.5 ±4.7 sec, WT on dox injured 65.8 ±4.5 sec). Over the course of the four days, all
sham groups displayed similar learning behavior and the injured groups showed similar learning
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behavior. A repeated measures ANOVA comparing the off dox groups (VIPP injured, WT
injured, VIPP sham, WT sham; all off dox) showed significance between subjects with injury
(p<0.0001) but not with genotype (p=0.0697) or genotype×injury (p=0.1492). Within subjects,
there was significance with time (p<0.0001) and time×injury (p=0.0165) but not with
time×genotype (p=0.4016) or time×genotype×injury (p=0.1820). Together these results suggest
that the expression of the transgene alone had little to no effect MWM behavior and that the bulk
of effects came from injury. However, when we compare the MWM performance on the first day
(Day 4) with each of the subsequent days, we see that the performance at Day 7 compared to Day
4 showed a significant effect from injury (p=0.0288) as well that of the interaction between
genotype and injury (p=0.0412). This suggested that by the last day of the watermaze, VIPP
expressing injured animals performed significantly different from WT injured.

Figure 4.3. VIPP negatively affected MWM performance.
VIPP did not affect MWM latency scores until the last day. A repeated measures ANOVA was
not significant except for injury between and within subjects. A repeated measures ANOVA
comparing Day 7 latency to Day 4 latency times showed a significant interaction between
genotype and injury. Data are expressed as Media ± S.E.M.
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The on dox groups (VIPP on dox injured, WT on dox injured, VIPP on dox sham, WT on
dox sham) in a repeated measures ANOVA between subjects showed significance due to injury
(p<0.0001) and genotype (p=0.0457) but had no significance in the interaction (genotype×injury,
p=0.582). Within subjects, the repeated measures ANOVA showed injury contributed
significantly to behavioral changes over time (time×injury, p=0.0065) but not genotype
(time×genotype, p=0.6254) or the interaction of all three (time×genotype×injury, p=4575). These
results suggest that while the transgene on dox may have differed in behavior from WT on dox,
their behavioral over time with and without injury did not differ.
In examining the probe trial on day 8, we saw VIPP injured animals performing
significantly worse, averaging a memory score of 14±3.0 compared to the WT littermates’
average of 45±5.1. A two way ANOVA test showed significant interaction between genotype and
injury (p=0.0155) (Figure 4.4A). The VIPP on dox injured animals averaged a much higher
memory score at 63.7±9.2, almost near sham memory scores. In contrast WT on dox injured only
averaged 46.5±8.2. The similar performance between WT injured and WT injured on dox
suggested that dox did not significantly alter behavioral performance and likely did not contribute
to the improved performance to the VIPP injured on dox. The similar swim speeds between the
injured groups (VIPP injured 16.9±1.5 cm/s, WT injured 16.42±0.6 cm/s, VIPP on dox injured
17.4±1.0 cm/s, WT on dox injured 17.9±0.7 cm/s, Figure 4.4B) suggested that the improved
memory score of VIPP on dox injured group cannot be attributed to faster swim speeds. It is
possible that the improved probe trial performance of the VIPP on dox injured group may
potentially be due to elevated leaky transgene expression (Figure 4.5) as a result of increased
GFAP expression after injury potentially driving increased VIPP expression (the VIPP transgene
is driven off the GFAP promoter). VIPP on dox injured high memory scores compared to the
other injured groups also could possibly be due to these mice relying on other memory paradigms
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(taxonomy, or procedural; (Crawley, 2007)) rather than spatial memory to find their way to the
platform location.

Figure 4.4 VIPP mice had decreased probe trial performance.
(A)VIPP mice performed significantly lower memory score on probe trial than either the
transgenic WT or VIPP on dox animals. The WT and VIPP injured mice performed significantly
worse than sham animals (p<0.0001). (B) Swim speeds were not different between genotype but
were different between injured and sham (p<0.0001). Data are expressed as Media ± S.E.M.

Summarizing the behavioral results from the NSS and the watermaze showed that the
overexpression of the IP3 phosphatase did not affect baseline behavior. Blunting IP3 signaling
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after injury decreased spatial learning and memory. The difference in both the latency times at
day 7 and the lower probe scores a day 8 suggested contrary to in vitro and in vivo neomycin
studies, inhibition of IP3 signaling to blunt calcium signaling in astrocytes impedes the recovery
of brain injury in spatial learning and memory.

Figure 4.5. Expression of venus fluorescent protein in CCI injured VIPP on dox mice.
The regions adjacent to the lesion (in the cortex and hippocampal remanants) showed presence of
venus fluorescent protein suggesting leaky transgene expression occured in the on dox animals
subject to CCI.
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Figure 4.6. GFAP expression after CCI
VIPP animals showed significantly less GFAP expression than the WT CCI injured animals. The
GFAP expression averaged across all regions (A), the cortex (B), the hippocampus (C), and the
thalamus (D) all show that injury significantly increased GFAP expression in the ipsilateral
compared to contralateral. CCI injured VIPP mice had reduced GFAP expression compared to
WT (geno×inj) in the hippocampus and when averaging all regions together.
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Astrocyte specific IP3 signaling does not influence either cortical lesion size or the
extent of astrocyte reactivity after moderate cortical impact injury
One indicator of damage is the amount of tissue loss that appears in the injured hemisphere after
CCI. The lesion volumes among all three CCI injured groups were not significantly different
(Figure 4.7). VIPP injured mice had slightly but not significantly increased tissue sparing
compared to WT or VIPP on dox injured mice.
Comparing the results of a whole model ANOVA analysis yielded the following results:
VIPP mice overall had lower GFAP expression than the WT counterparts. There was regional
differences in GFAP expression; the hippocampus overall had the highest levels of GFAP
expression across all regions and conditions compared to the cortex and thalamus. This trend was
not different between VIPP and WT mice. Injury significantly increased GFAP expression. VIPP
mice also had significantly reduced GFAP expression when injured (genotype×injury). Different
brain regions also responded differently to injury (region×injury) but VIPP mice had similar
trends in GFAP expression across the different brain region as WT mice after injury
(genotype×region×injury).
Comparing only the results of the cortex showed that the contralateral and the ipsilateral
GFAP expression were significantly different (region, region×injury) and that VIPP mice showed
similar GFAP expression trends between contralateral and ipsilateral (genotype,
genotype×region), with and without injury (genotype×injury, genotype×region×injury). Post hoc
analysis using Tukey’s honest significant difference (HSD), showed that
Analysis of the hippocampus showed that the contralateral and the ipsilateral regions had
different GFAP expression after injury (region, region×injury). Similar to the cortex, the
hippocampus had increased GFAP expression after injury (injury, region×injury). Unlike the
cortex, the presence of the transgene significantly decreased GFAP expression after injury
(genotype×injury).
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Across all animal groups, we observed a significant increase in the extent of astrocyte
reactivity in the ipsilateral hemisphere compared to surgical sham samples (p<0.0001). As
expected, VIPP animals maintained on dox had similar levels of GFAP expression after moderate
CCI injury when compared to WT injured counterparts. However, we saw no significant
interaction between genotype and injury using linear regression analysis testing (Figure 4.6). In
CCI injured animals, there was significantly greater GFAP expression on the contralateral
hippocampus compared to sham animals (p<0.01) potentially suggesting that VIPP reduced the
spread of the injury into the contralateral side.
In summary, these data on moderate cortical impact show the suppressing IP3 signaling
within astrocytes leads to an enhancement in neurobehavioral impairment measured in the Morris
water maze and a related deficit in the probe trial. However, neither of these was accompanied by
significant changes in the tissue spared or changes in astrocyte reactivity measured 8 days after
injury. With these changes after moderate cortical impact injury recorded, we next examined if
there were significantly different effects of IP3 signaling in astrocytes after mild CCI injury.
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Figure 4.7. Lesion Volume. The fraction of spared tissue on the ipsilateral side compared to the
contralateral side was not different between the injured groups. Data are expressed as Media ±
S.E.M.
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Figure 4.8. Expression of VIPP reduced mechanically induced intercellular calcium waves
in astrocytes.
Mechanical injury produced a more robust response in VIPP single gene animal (VIPP+/-)
compared to the bigenic animal (VIPP+/+) (A). The percent thresholded area of the cortical
calcium response is plotted in (B). (C) The percent thresholded area of a VIPP bigenic animal had
significantly reduced calcium response after impact compared to VIPP single gene and WT
animals (*, p<0.05 compared to WT injured). Data are expressed as Media ± S.E.M.
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Suppression of IP3 signaling in astrocytes limits injury induced intercellular calcium
waves
Previous work shows that a focused impact to the cortex will cause a propagation of intercellular
waves in vivo through the astrocyte syncytium. This in vivo impact model to the superficial
cortical layers does not cause any bleeding, and the mechanical conditions are similar to the mild
CCI injury technique we developed previous (see chapter 2). Therefore, we used this model to
study the role of IP3 astrocyte signaling in propagating mechanically induce intercellular waves
in vivo after injury. VIPP and WT littermates were injured using the micro CCI technique (see
chapter 3). Compared to single gene VIPP mice, bigenic VIPP (VIPP+/+) mice showed a
reduction in the spread of the intercellular calcium wave throughout the astrocyte network after
injury (Figure 4.8A). Immediately after impact, the VIPP bigenic calcium response was smaller
and decayed faster than the VIPP single gene (Figure 4.8B). The peak thresholded area after
impact was significantly greater in WT mice and in the single gene mice than in bigenic VIPP
mice (Figure 4.8C, p<0.05 compared to WT injured).
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Figure 4.9. VIPP had a mild effect on rotarod behavior.
There was a significant difference in the performance of injured mice. However a lack of
significant interaction between genotype and injury suggested that the transgene did not alter post
injury behavior on the rotarod. The VIPP on dox injured mice did not perform significantly
different from the WT injured mice across all three days for both fall and fault parameters. WT
injured mice performed significantly worse compared to sham in both fault and fall parameters
whereas VIPP injured mice did not show a deficit compared to VIPP sham mice in the fall
parameter. No significant interaction was observed between genotype and injury in a linear
regression test. Data are expressed as Media ± S.E.M.
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Reduction in astrocyte IP3 signaling leads to a modest, but not significant, reduction
in some behavioral deficits after mCCI Injury
For the initial rotarod testing over the first three days after injury, WT littermate injured animals
displayed significantly time to fault for all three days (Figure 4.9A). A repeated measure ANOVA
showed no significant interaction between genotype and injury or between genotype, injury, and
time. There was a significant deficit in behavior due to the injury (p=0.0005 off Dox, p=0.04285
on Dox) and with time (p<0.0001 for both off and on Dox groups) suggesting that over the course
of the three days, all animals improved their rotarod performance. In the fall parameter of the
rotarod (Figure 4.9B), a repeated measures ANOVA showed an effect due to injury (p=0.0005) in
the off Dox groups but not in the on Dox groups (p=0.1037). Both off and on Dox groups had a
significant effect from time (p<0.0001 for both off and on Dox groups) suggesting that all groups
improved fall latency scores over the three days. As expected, VIPP animals maintained on dox
injured had both fault and fall times that were not significantly different from WT injured across
all three days of testing. VIPP sham animals had shorter but not significant fault and fall times
than WT sham suggesting that genotype did not affect motor coordination and memory, similar to
NSS sham results.
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Figure 4.10. Behavior during session 1 of SOR.
All groups had similar total ambulation distances. Off dox injured animals spent significantly
more time on average than off dox sham animals in the periphery (p=0.0212) but on dox injured
and sham groups spent a similar amount of time in the center; there was no effect of genotype on
exploratory behavior. Data are expressed as Media ± S.E.M.

In the first session of the SOR test, mice were allowed to explore the empty test arena to
acclimate them to the testing environment. Examining their exploratory behavior in an open arena
during these 10 minutes can shed light on their levels of anxiety (Bailey and Crawley, 2009).
During this training session, all animals – sham or injured – show similar ambulation distances
(Figure 4.10). There were no differences in any of the groups in the total amount of distance
traveled in the box suggesting that neither injury nor transgene expression affected basic motor
function. However, injured mice spent significantly less time in the center region than sham mice
(p=0.0212), suggesting that injury increased anxiety levels in mice. There was no effect of
genotype in these parameters.
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Figure 4.11. VIPP did not affect preference for the displace object in SOR.
The transgenic WT nor the VIPP sham animals did not have significant preference for the
displace object more than injure animals. The VIPP on dox injured animals had similar percent
preference as the injured transgenic WT. Data are expressed as Media ± S.E.M.

Behavior and interaction with the objects in the SOR test were measured in session 4,
with the expectation that no and the test session to determine the effect of injury and genotype on
spatial memory. There was no significant behavioral difference between injured and sham for any
of the groups (Figure 4.11) in a one way ANOVA.
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Figure 4.12. Time exploring SOR objects in session 4 and test session.
Animals in all groups had similar total exploration times. Injury or genotype had no affect on the
animal exploration behavior. The amount of time spent exploring both objects for session 4 also
did not greatly differ 24hrs later when one of the objects was displaced, during the test session.
Data are expressed as Media ± S.E.M.

A two way ANOVA showed significant effect of injury (p=0.0474). VIPP injured
animals tended to perform worse than the VIPP dox and WT littermates. Although not significant,
VIPP injured on average had almost no preference for the displaced object compared to either
WT or VIPP on dox injured. The time spent exploring both objects in the area were
approximately the same for all groups for both sessions (Figure 4.12). The difference in displaced
object preference was not due to decreased interest in the objects in either session 4 or test session.
These results in combination with the CCI injury suggested that the outcome for blocking IP3
signaling in astrocytes is regions specific: worsen outcome in the hippocampus and little effect in
the cortex.
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In CFC, all groups tested had similar freeze fraction (Figure 4.13). This suggests that
neither injury nor genotype had an effect on this hippocampal dependent task on day 8 post injury.
There is evidence in the literature that contextual fear condition and other fear conditioning tests
are a ventral hippocampal function and spatial tasks are more dorsal (Bannerman et al., 2003;
Biedenkapp and Rudy, 2009; Fanselow and Dong, 2010; Richmond et al., 1999; Rudy and
Matus-Amat, 2005). None of the mCCI mice showed damage in the ventral portion of the
hippocampus supporting the lack of behavioral effect from CFC.

Figure 4.13. Overall freeze fraction in CFC.
All the groups, sham and injured, had similar freezing fractions. Neither injury nor genotype had
an effect on contextual fear conditioning. Data are expressed as Media ± S.E.M.
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Figure 4.14. Neurodegeneration at 24 hours.
Injured animals had a significant greater number of FJB positive cells than sham animals in both
the cortex (A, p<0.0001) and the hippocampus (B, p<0.0001). There was no effect of genotype.
The VIPP injured on dox group also had significantly lowered FJB positive cells in the cortex
compared to WT injured (p=0.0016). Data are expressed as Media ± S.E.M.
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Reducing astrocyte IP3 signaling does not significantly alter neuronal degeneration
but does change astrocyte reactivity after mild cortical impact injury
Acute neuronal degeneration indicated with FJB staining at the 24hr time point showed all injured
groups showed significantly elevated number of FJB positive cells (p<0.0001) relative to surgical
sham animals. Moreover, the VIPP injured on dox group had significantly less FJB positive cells
in the cortex (p=0.0015). However, we observed no difference in the level of degenerating
neurons between WT and VIPP injured animals in either the cortical or hippocampal regions
(Figure 4.14). In the hippocampus, the number of FJB positive cells in VIPP on dox did not differ
from the other injured groups. In off dox sham mice, the venus fluorescent protein was slight but
visible (Figure 4.15). On dox VIPP animals had lower baseline venus fluorescent expression than
off dox sham however there was elevated fluorescent protein expression in cortex of on dox
mCCI injured animals but not in the hippocampus (Figure 4.16).
GFAP expression at 8 days
In the cortex, mCCI induced greater GFAP expression in VIPP injured mice than WT injured
(p=0.0263) in a linear regression test for significant interaction between genotype and injury. This
suggested that blunting IP3 signaling in astrocytes may have different consequences when
depending on the injury severity. We saw no significant difference on astrocyte reactivity in
either the hippocampus or thalamus of the injured hemisphere between VIPP and WT animal
groups.
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Figure 4.15. Sham VIPP mice showing baseline VIPP expression.
Baseline VIPP expression is very low. GFAP merged with VFP expression. VFP = venus
fluorescent protein.
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Figure 4.16. VIPP expression in on dox mice subjected to mCCI injury compared to sham
off dox.
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Figure 4.17. GFAP expression in mCCI.
VIPP on dox mice did not have significantly different GFAP expression from WT injured mice
for all brain regions and both injury types. mCCI injured VIPP mice had greater GFAP
expression in the cortex (p=0.0263) but similar levels in the hippocampus and thalamus.
Contralateral sham and injured regions were not different for each group with the exception of the
hippocampus. Data are expressed as Media ± S.E.M.
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DISCUSSION
In this study, we evaluated the role of IP3 signaling within astrocytes on both the behavioral and
histological outcome after controlled cortical impact brain injury. In moderate cortical impact
injury, we observed that suppressing IP3 signaling in astrocytes led to a significantly worse
hippocampal deficit eight days after injury, but without any overt change in the extent of
astrocyte reactivity in the injured hemisphere. CCI injured VIPP mice did have reduced, but not
significant, GFAP expression compared to WT. In contrast, with mild cortical impact injury, we
demonstrated that IP3 signaling reduction in astrocytes was enough to block the immediate
propagation of an intercellular calcium wave through astrocytes, but this led only to a modest
reduction in cortical and hippocampal dysfunction over the first 8 days after injury. Furthermore,
the GFAP expression in the cortex was significantly increased in VIPP injured over WT injured.
VIPP on dox animals had better memory retention on WT littermates potentially due to
noted neuroprotective effects of minocycline and doxycycline (Elewa et al., 2006; Jantzie et al.,
2005; Siopi et al., 2012a, 2012b). It is also possible that the VIPP on dox effects could be due to
leaky transgene expression (Figure 4.8). If this is the case, then this suggests that the level of IP3
reduction is important. The swim speed for the injured groups were significantly worse compared
to sham (p<0.0001) but there was no effect from genotype. This suggested that VIPP affected
memory and spatial navigation but not motor recovery. This was supported by NSS results. The
lack of effect on motor recovery could be due to the magnitude of injury to the motor cortex from
the CCI. Too much of the motor cortex on the ipsilateral side could have been damaged and
prevented any effect the transgene could have.
It is possible that dox had a neuroprotective effect on injury in this model as tetracyclines
have been shown to be neuroprotective after a brain injury (Elewa et al., 2006; Jantzie et al., 2005;
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Siopi et al., 2012b). It is also possible that the leaky expression in on dox animals may have
affected cell death outcome, or a combination of both dox and leaky VIPP expression.
Overall, these in vivo results demonstrate that suppressing IP3 signaling in astrocytes after
TBI produce differential outcomes up to one week after injury depending on injury severity. In
vitro results showed that increasing strains alter the mechanism for astrocytic calcium signaling.
The greater the strain, the more pathways that are involved in the propagation of the calcium
wave (Choo et al., 2013). Neary et al (2003) showed that extracellular signal-regulated protein
kinase (ERK) activation in astrocytes depended on level of strain as well as strain rate. Increasing
strain and strain rate independently increase ERK activation. Cullen et al (2007) also showed that
astrogliosis to be dependent on strain rate. The difference between GFAP expression of mCCI
and CCI supported these in vitro findings. The mCCI with the higher strains but lower strain rates
did not produce the same level of astrogliosis as CCI, with the higher strain rate but lower strain.
However, Cater et al (2006) showed that organotypic hippocampal slices was susceptible to strain
and not strain rate. The CCI parameters used in the study produced a much higher strain rate but
much less strain in the hippocampus than mCCI. Yet CCI injured VIPP mice had significantly
worse water maze performance whereas mCCI injured animals did not show significant
behavioral difference (WT or VIPP) compared to sham. Based on the Cater et al study, the
injured animals in the mCCI should have much experience more hippocampal damage than CCI
histologically as well as functionally. This discrepancy between hippocampal in vitro and in vivo
results suggested that either organotypic cultures cannot accurately determine tissue tolerances or
more likely, that the presence of blood and blood products have a large effect on neuronal
survival that cannot be accounted in vitro. It also highlights the importance of accurately
modeling injury biomechanics.
IP3 signaling is responsible for a number of functions and one of the reasons for our
mixed outcome could be due to these other functions. One in particular is microvascular control.
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After CCI injury, there is decreased localized cerebral blood flow (lCBF) in the injured region
(Kochanek et al., 1995). Calcium increases in astrocytic endfeet cause vasoconstriction and
dilation (Mulligan and MacVicar, 2004). It is possible that VIPP reduce calcium increases in
endfeet limiting astrocytic control of vasculature. If VIPP asrtrocytes have reduced capacity to
control vasculature, there may be increased cerebral blood flow dysregulation causing greater
dysfunction of neuronal activity. Other downstream effects of IP3 signaling are also currently not
well understood and it may be possible that the effects of inhibiting IP3 are differentially
countered by downstream pathways depending on injury severity. We also cannot ignore the
possibility that while we showed that VIPP mice subject to micro CCI injury reduced intracellular
calcium in asrocytes, it is possible the with the level of injury produced by mCCI and CCI, VIPP
may have failed to reduced the calcium levels in the manner seen with micro CCI.
While the outcome of our VIPP studies may not support past in vitro findings,
comparisions to other in vivo studies also show differing trends. In vivo studies with PLC
inhibitor, Neomycin, showed pretreated fluid percussion injury (FPI) rats showed improved
bioenergetic, magnesium level, and motor function compared to saline treated (Golding and Vink,
1994). Similarly VIPP was able to preserve some motor function in mCCI injured mice. This
suggests that reducing IP3 was partially successful in preserving cortical function but that
reducing the levels of DAG is also important. Levels of DAG have been shown to be increased
after TBI. Furthermore, DAG can activate protein kinase C (PKC) which can influence receptor
activity and enhance further calcium influx into the cell (Weber, 2012). Increased DAG levels
also induce vesicle ATP release independent of PKC activity (Mungenast, 2011). If VIPP were
able to reduce the initial intracellular astrocytic calcium rise in both CCI and mCCI injured mice,
it is possible that high levels of DAG could cause subsequent influx of extracellular calcium into
the cell. If this did occur, then VIPP would only delay neuronal degeneration.
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However, drugs are receptor specific and not cell type specific. Neomycin and U73122
cannot preferentially target and blunt astrocytic PLC activity. The VIPP transgene was
specifically targeted to astrocytes and the use of transgenic animals can help to discern the
contribution of astrocytic IP3 calcium signaling on recovery after TBI. The discrepancy in results
between using neomycin and in this study could be due from a combined effect of blocking IP3
signaling in both astrocytes and neurons.
Solely targeting astrocytic calcium may still be a potential therapeutic treatment. An in
vitro BAPTA-AM loading protocol was able to specifically load astrocytes and doing so reduced
cell death at 24hrs (Choo et al., 2013). However, BAPTA-AM chelates calcium and effectively
attenuates the effect of pathways other than ER store release of calcium. VIPP can only block IP3
induced calcium and is unable to block other sources of calcium. Neuroprotection from BAPTAAM treated cultures suggests that ER store calcium release may not be the predominant pathway
to ICW in astrocytes after a moderate to severe injury. Additionally, blocking only IP3 in
astrocytes can potentially worsen outcome by further increasing the biochemical in-balance in the
cell after TBI.
Future studies with VIPP should look at long-term effects. For our studies we are careful
to not consider or speculate longer term effects with VIPP. At 7 days NSS, the three injured
groups were starting to show deviation. At day 7 watermaze, VIPP showed differences from the
other two injured groups. The probe trial on day 8 showed VIPP mice had significantly reduced
capacity for spatial memory. It is of interest to note that across the three days on rotarod, the gap
in performance between VIPP sham and injured increased, although the repeated measure
ANOVA was not significant. These results potentially suggest that VIPP in astrocytes produce
long term effects and may not be seen in a short 8 day survival study.
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Chapter 5 Inhibited astrocytic vesicular release and the effect on TBI
ABSTRACT
Research into gliotransmission has shown that astrocyte release of adenosine triphosphate (ATP)
and glutamate can affect neuronal signaling. In TBI, overactivation of ionotropic glutamate
receptor, N-methyl-D-asapartate receptor (NMDAR), has been a major mechanism leading to
neurodegeneration. Astrocytes have been hypothesized to contribute to this excitotoxic
environment through stretch induced release of ATP and glutamate. dnSNARE have inhibited
vesicular release and have been shown to improve outcome in ischemic and sleep deprivation
models. In the CCI injured mice, dnSNARE mice did not improve the neurological severity score
but did improve watermaze outcome on day 7. The rate of spatial learning across time was also
significantly improved compared to WT injured. In mild CCI injured mice, dnSNARE prevented
motor deficits seen in WT injured but failed to provide any improvement in the more
hippocampal based tasks. A caveat to this study is that dnSNARE mice do show a reduced
surface expression of NMDARs. The reduced surface expression in NMDARs in the dnSNARE
could be the main mechanism of neuroprotection although the histopathology did not support this
theory. dnSNARE injured animals have decreased GFAP expression in both models, an effect
typically attributed to inhibited purinergic signaling. The level of neuronal cell death was also not
significantly decreased in dnSNARE mice, an effect that is prevalent in NMDAR inhibition pre
and immediately post injury.
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INTRODUCTION
Research from the past two decades have shown that astrocytes can modulate the neuronal
network through the release of gliotransmitters such as glutamate (Parpura et al., 1994) and
adenosine triphosphate (ATP) (Newman, 2003) through a calcium dependent process called
gliotransmission (Agulhon et al., 2012). Gliotransmitters can be released through a number of
different mechanisms, one of which is exocytosis. Formation of soluble N-ethylmaleimidesensitive fusion protein attachment protein receptor (SNARE) complex allows the docking and
fusion of vesicles to the plasma membrane and is the main pathway of regulated exocytosis
(Halassa, 2009). Calcium dependent glutamate and ATP release is dependent on exocytosis
through the SNARE complex mediating vesicular release (Zorec et al., 2012). Inhibiting this
process prevents gliotransmission (Pascual et al., 2005).
Why is gliotransmission so important? Gliotransmission has been shown to strengthen
and weaken neuronal signaling through modulation of receptors on both pre and post synapses
(Perea et al., 2009). In pathophysiology, abnormal glial calcium excitability has been linked to a
number of neurological disorders (Agulhon et al., 2012). Astrocyte calcium transients in a mouse
model of Alzheimer’s displayed increased frequency, longer duration, and traveled longer
distances than wildtype (WT) littermates (Kuchibhotla et al., 2009). Increased calcium waves
were also noted in an ischemic model (Ding et al., 2009), cortical spreading depression (CSD)
model (Peters et al., 2003), and in status epilpeticus (Ding et al., 2007).
These data together suggest that the release of extracellular ATP and or glutamate from
astrocytes due to injury can potentially cause excitotoxic signaling on neurons. After stretch
injury, astrocytes respond with a far reaching calcium wave that spreads into the penumbra region.
The intercellular calcium rise also induces a release of ATP and glutamate from astrocytes
through vesicular release which may contribute to the excitotoxic environment after stretch.
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Inhibition of purinergic receptors have been shown to be neuroprotective in vitro and in vivo
(Choo et al., 2013). Blocking purinergic signaling in vivo, of which astrocytes are a major source,
has been shown to improve outcome after moderate TBI (Choo et al., 2013). Similarly, blocking
the calcium increase specifically in astrocytes with BAPTA-AM, is also neuroprotective in vitro
stretch injured cultures (Choo et al., 2013; Miller, 2009). Blocking the predominant pathways that
cause intracellular calcium waves (ICW) through P2Y1R antagonism with MRS2179 was able to
reduce cell death with pre and post injury treatment of injured organotypic hippocampal slices
(Choo et al., 2013; Miller, 2009). Treatment of organotypic slices with apyrase, to degrade
extracellular ATP into adenosine was also equally neuroprotective (Choo et al., 2013; Miller,
2009). Together, these data suggest that astrocytes can have significant effects on the resulting
changes in neurons after traumatic brain injury (TBI).
To test the specific contribution of gliotransmitters on cognitive and histological
impairments after TBI, we used a transgenic animal specifically designed to inhibit vesicular
release from brain astrocytes. If the contribution of purinergic signaling from astrocytes after TBI
be a major source of excitotoxic factors, dnSNARE mice would ideally be more resistant to injury
and behavioral changes after TBI. dnSNARE mice have already shown to provide
neuroprotection in a ischemia brain injury model (Hines and Haydon, 2013) and status epilepticus
model (Clasadonte et al., 2013). Given the potential change in mechanisms of cognitive deficits
and neuronal death across the TBI severity spectrum, we studies two different levels of TBI
severity using the controlled cortical impact (CCI) model of TBI. Our results demonstrate that
gliotransmission can affect outcome after both mild and more severe TBI, and the improvement
in outcome when vesicular release from astrocytes is suppressed indicates an important new
direction in designing therapies.
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MATERIALS AND METHODS
dnSNARE mice were exposed to two different injury levels using the same type of direct cortical
deformation injury model, CCI. At the higher end, using a 6m/s impact velocity with an impact
depth of 1mm, a contusion was induced and by 8 days a large necrotic lesion was produced. At
the lower level, using an impact velocity of 0.43m/s with an impact depth of 2mm, no contusion
or lesion was produced. As a result of difference in debilitation of the two injuries, different
behavioral paradigms were necessary to be able to discern between injured and sham. The injury
and behavior schedule is presented in chapter 4, Table 4.1. For the more severely injured group,
the neurological severity score (NSS) and the Morris water maze (MWM) was used. For the mild
injured group, the rotarod was employed followed by the spatial object recognition (SOR), and
contextual fear conditioning (CFC).

dnSNARE Breeding
dnSNARE animals were bred as described in Pascual et al (2005). Animals were bred under 12hr
light/dark cycles. Pups were weaned at 3 weeks of age and genotyped. Details of producing
GFAP.tTA and tetO.dnSNARE lines are as described elsewhere (Halassa, 2009; Halassa et al.,
2007; Pascual et al., 2005). These lines were maintained in a heterozygous state and backcrossed
onto a C57B16/J genetic background (Jackson Laboratories, Bar Harbor, ME). Bigenic offspring
of these two lines (dnSNARE), and their wildtype littermates, were maintained on 40 mg/kg
doxycycline (dox) containing food (Bioserv, Frenchtown, NJ). They were switched to a regular
diet to allow transgene expression in the dnSNARE animals for a minimum of 2 weeks prior to
use. A portion of the bigenic animals were kept on dox for the duration of the experiments. These
animals were the control for the transgenic mice and should have similar results as that of
wildtype littermates. Due to the potential effect progesterone has one the recovery of brain injury
(Feeser and Loria, 2011; Shakeri et al., 2013), only male mice were used.
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Table 5.1. Experimental groups

dnSNARE
on Dox
WT littermates
on Dox

CCI .
8 day
12
13
26
26

Injury
.
mCCI
.
24hr
8 day
4
15
4
16
6
14
NA
16

CCI .
11
13
27
25

Sham
mCCI
.
24hr
8 day
4
13
NA
12
5
13
NA
13

Cortical Injury
All animal procedures were approved by University of Pennsylvania’s Institutional Animal Care
and Use Committee (IACUC). dnSNARE and wildtype (WT) littermate mice were divided into
the groups listed in Table 5.1.
The cortical injury protocol was the same as described in chapter 4.

Histology
Please refer to the previous chapter for the histology protocols.

Behavior Tests
The following behavioral tests were conducted in this study: rotarod, SOR, MWM, and NSS. The
protocol is the same as the previous chapter.

Statistical Analysis
All statistical tests were carried out using JMP10. Two-way ANOVA was used to determine the
effect of the transgene with injury. For behavior, on dox groups were compared independently of
off dox groups where possible. For histology, the on dox transgenic injured group was compared
to the WT injured group with a Student’s t-test. For GFAP staining, a three-way ANOVA was
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used to compare the interaction between genotype, hemisphere of brain, and injury. A two-way
repeated measures ANOVA was used in the rotarod, MWM, and NSS behavioral tests.

RESULTS
Morris water maze deficits after moderate cortical impact injury are significantly
improved in dnSNARE animals
Cortical impact injury created immediate impairments in both MWM and NSS by increasing time
to platform in the former and by decreasing the number of tasks accomplished in the later. The
NSS outcome immediately after injury or in the days following did not differ between littermate
wildtype and dnSNARE animals (Figure 5.1, repeated measures ANOVA). Over time, there was
a significant interaction between time and injury for both dnSNARE and WT injured groups,
indicating both groups were significantly improving in their NSS outcome over the first week
postinjury. However a lack of significance with geno×injury or geno×injury×time suggests that
the transgene did not cause immediate behavioral changes or change rate of recovery.
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Figure 5.1. dnSNARE injured and sham mice had similar NSS performace as WT injured
and sham mice.
NSS behavior did not vary across genotype for either sham or injured groups. All injured groups
were significantly different from sham groups (p<0.0001, repeated measures ANOVA). There
was no effect from genotype or genotype×injury. Data are expressed as Media ± Standard Error
of the Mean (S.E.M.).

Figure 5.2. Morris watermaze behavior across day 4 through day 7 post injury.
Injury and not genotype cause a significant difference in watermaze performance (p<0.0001). A
repeated measures ANOVA showed a significant interaction between time and injury (p<0.0001)
and time, genotype and injury (p=0.0181). On day 7, there was a significant interaction between
genotype and injury (p=0.0070). Data are expressed as Media ± S.E.M.
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Over the four day Morris water maze evaluation period, all injured groups showed
significantly higher latency times relative to sham surgery groups (p<0.0001). Injured mice had a
different recovery rate from sham (time×injury, p=0.0001); sham mice reached a learning plateau
by the second day of MWM testing whereas the injured mice did not show reaching a similar
learning plateau within the four days tested. A repeated measures ANOVA also showed
significant interaction for time×injury×genotype (p=0.0181). When comparing the performance
on Day 4 with Day 7, there was a significant interaction between genotype and injury (p=0.0070)
suggesting that dnSNARE showed significant improvement in their latency times compared to
WT injured animals over the course of the four days. There was no difference between the on dox
groups. The statistics suggest that while dnSNARE injured animals had higher latency times over
the course of the first three days, they had significantly better recovery rate than the other injured
groups (on dox groups and WT injured) and significantly improved their performace by the end
of the test. While dnSNARE on dox injured animals showed leaky transgene expression (Figure
5.3), this did not seem to translate to altered behavioral performance compared to WT on dox
injured.
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Figure 5.3. dnSNARE on dox with CCI
The transgene expression was not completely blocked in dnSNARE animals after CCI. GFP
expression was detected in the hippocampus as well as the cortex.

A probe trial conducted one day after the completion of the water maze testing showed
that injured animals performed significantly worse than sham across all groups, but there was no
significant difference between dnSNARE and wildtype animals for this outcome measure after
injury (Figure 5.4). We considered if these changes were influenced by a difference in swim
speed among the groups, but we found that no differences existed among injured dnSNARE
animals on dox, injured WT animals, or injured dnSNARE animals. Together, these data show
that while dnSNARE mice might have faster recovery of spatial learning, this did not translate to
improved spatial memory 24hrs later.
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Figure 5.4. dnSNARE did not perform any differently on the probe trial.
There was significant difference between injured and sham memory score for all groups
(p<0.0001, two-way ANOVA) (A) and for probe trial swim speed (B). Baseline performance
between dnSNARE and WT transgenic animals were not different. There was no effect from
genotype. Data are expressed as Media ± S.E.M.
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Figure 5.5. GFAP expression with CCI
dnSNARE injured animals showed significantly less GFAP expression than the WT CCI injured
animals. The GFAP expression averaged across all regions (A), the cortex (B), the hippocampus
(C), and the thalamus (D) all show that injury significantly increased GFAP expression in the
ipsilateral compared to contralateral in a three-way ANOVA. CCI injured dnSNARE mice had
reduced GFAP expression compared to WT and this reduction was mostly located on the
ipsilateral side in the cortex and thalamus and on both contralateral and ipsilateral in the
hippocampus. Data are expressed as Media ± S.E.M.
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dnSNARE animals a significant reduction in GFAP reactivity, but no alteration in
lesion volume eight days following moderate cortical impact injury
Examining the extent of GFAP reactivity across the ipsilateral and contralateral hemispheres
revealed a significant difference between the injured and sham groups, and between injured WT
and injured dnSNARE animals (Figure 5.5). Three-way ANOVA showed a significant difference
in the volume of GFAP reactivity measured across 3 regions (cortex, hippocampus, thalamus) in
both hemispheres across sham and injured groups (geno×side×inj, p=0.0339). Moreover,
dnSNARE animals showed a significant reduction in GFAP expression for CCI injured mice in
the ipsilateral cortex (p=0.0424), ipsilateral thalamus (p=0.0090), and both hippocampi (p<0.0001)
when compared to injured, littermate wildtype animals. Individually comparing dnSNARE on
dox injured to WT injured with t-tests showed that dnSNARE on dox had significantly reduced
GFAP expression in the ipsilateral cortex (p=0.0027), the contralateral hippocampus (p=0.0024),
and in the ipsilateral thalamus (p=0.0452). This reduction in dnSNARE dox injured animals could
be due to the leaky transgene expression (Figure 5.3). There was also a larger error in the
ipsilateral hippocampus of WT CCI injured mice due to the loss of the hippocampus in many of
the mice reducing the number images taken from each sample from three down to two or one.
These results suggeste that dnSNARE was able to reduce the level and spread of astrogliosis in
CCI injured tissue. The reduction in GFAP expression was not matched by a change in lesion
volume. Eight days after moderate cortical impact injury, the lesion volumes between all three
CCI injured groups were not significantly different (Figure 5.6, Students’s t-tests). dnSNARE
injured mice had slight but not significantly increased tissue sparing compared to WT or
dnSNARE on dox injured mice.
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Figure 5.6. Lesion Volume.
The fraction of spared tissue on the ipsilateral side compared to the contralateral side was not
different between the injured groups. Data are expressed as Media ± S.E.M.

Early behavioral impairments are eliminated in dnSNARE mice after mild cortical
impact injury
Mice injured with the mild CCI (mCCI) exhibited early neuronal degeneration but no
hemorrhagic contusion. There was a significant reduction in rotarod latency as measured with the
fault parameter. In the mCCI test schedule (refer to chapter 3 and 4), mice were first tested on the
rotarod. In this motor behavior test, dnSNARE injured mice on average performed better than
dnSNARE sham mice, although not significantly (Figure 5.7, one-way repeated measures
ANOVA). WT groups in contrast showed the opposite trends. In a two way repeated measures
ANOVA, there was a significant interaction between genotype and injury for the fault parameter
(p=0.0201) and trended toward significance for the fall parameter (p=0.0675). This suggests that
dnSNARE was able to prevent early cortical injury deficits in mCCI. Comparison of the on dox
groups revealed no statistical differences between dnSNARE and WT for both fault and fall
latencies (in a two-way ANOVA). dnSNARE on dox injured animals also performed similarly to
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WT injured (off dox) using a one-way ANOVA. dnSNARE on dox injured also significantly
differed from dnSNARE injured (p=0.0077, one-way repeated measures ANOVA) but dox×time
was not significant suggesting that both groups learned at a similar rate. These results suggest that

Figure 5.7. dnSNARE mice did not have motor deficits in either the fault or fall parameter.
(A) or in the fall (B) parameters. In both fault and fall parameters, dnSNARE injured mice on
average had slightly greater latency times than dnSNARE sham, although not significant. There
was a significant interaction between genotype and injury in a repeated measures ANOVA. Data
are expressed as Media ± S.E.M.
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Figure 5.8. Analysis of exploratory behavior in session one of the SOR.
A two way ANOVA showed a significant interaction with injury (p=0.0295) but not with injury
and genotype. Total ambulation data are depicted in blue bars; fraction of center region time data
are depicted in contected data points. Data are expressed as Media ± S.E.M.

dnSNARE provides a significantly protective but acute effect after injury. The similarity in
rotarod performance between the on dox injured and WT injured groups suggests that the
transgene was being regulated properly. The dnSNARE expression also did not seem to affect
baseline behavior.
Analyzing the exploratory behavior in session 1 of the SOR can determine the level of
anxiety of the animal (Bailey and Crawley, 2009). There was no difference amongst the groups
when comparing the total distance traveled in the SOR (Figure 5.8). This suggested that all the
groups showed a similar level of exploratory activity. Although dnSNARE injured mice spent a
greater fraction of time in the center region compared to WT injured (p=0.0308), a two way
ANOVA failed to show a significant interaction for injury×genotype. The only significant
interaction was due to the injury (p=0.0295).
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Figure 5.9. dnSNARE did not affect preference for the displace object in SOR.
The transgenic WT nor the dnSNARE sham animals did not have significant preference for the
displace object more than injure animals. The dnSNARE on dox injured animals had similar
percent preference as the injured transgenic WT. Data are expressed as Media ± S.E.M.

The SOR also looks at hippocampal dependent memory. A comparison between
preference for the displaced objection in session 4 (object in original position) versus test day
(object moved to new location), mice with better memory of the object in the original location
will show renewed interest in the displaced object (Oliveira et al., 2010). Comparing the
preference for the displace object between dnSNARE and WT mice showed no significant
difference between the groups (Figure 5.9). As previously mentioned in chapter 2, the mCCI did
not produce a significant behavioral difference in displaced object preference. dnSNARE animals
show similar behavioral trends to WT mice as well as VIPP mice (Chapter 4). Comparing the
time the mice spent exploring the two objects we can see if the groups had any differences in
exploratory behavior which may affect overall performance in the SOR. All groups, injured and
sham, showed similar amounts of time exploring the objects in both session 4 and in the test
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session (Figure 5.10). Altogether, these data suggest that neither injury nor genotype had any
effect on general exploratory behavior.

Figure 5.10. All groups spent similar amounts of times exploring the objects in session 4 and
on test day.
There was no significance from genotype, injury, or in their interaction in a two-way ANOVA.
Data are expressed as Media ± S.E.M.
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Figure 5.11. Overall freeze fraction in CFC.
There was no significant effect of injury or genotype on CFC. Data are expressed as Media ±
S.E.M.
When looking at another hippocampal dependent task – the CFC – all groups displayed
similar freezing fractions (Figure 5.11). As stated in chapter 4, dorsal hippocampus seems to be
more involved in spatial behavior and ventral hippocampus seems to be involved in more fear
conditioning behavior. The lack of damage to the ventral part of the hippocampus or the
amygdale region might explain why mCCI did not have an effect on CFC. It could also mean that
by day 8 that any behavioral dysfunction was recovered. Majority of mTBI symptoms recover
within a week (McCrea M et al., 2003) and the lack of behavioral significance in the SOR and in
the CFC may reflect this recovery.
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Figure 5.12. Cell death at 24hr from mCCI.
In the cortex, injured groups had significantly greater cell death in both the cortex (A) and the
hippocampus (B). In neither regions was there a significant interaction between injury and
genotype although for the hippocampus it was close to significance (p=0.0714, two way
ANOVA). On dox injured mice had significantly reduced FJB cells in the cortex than WT injured
mice (p=0.0292) but not in the hippocampus. Data are expressed as Media ± S.E.M.
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Figure 5.13. GFP expression in dnSNARE mTBI groups.
dnSNARE on dox injured animals have small amounts of leaky expression. Off dox animals
show high levels of GFP expression. dnSNARE CCI show the highest level of GFP expression
which corresponds to GFAP expression. Scale bars are 100µm. (GFP = green fluorescent protein)
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Figure 5.14. GFAP expression at day 8 after mTBI injury.
Baseline GFAP expression in dnSNARE mice was different from WT in the hippocampus
(p<0.0001). dnSNARE on dox had elevated GFAP expression than WT injured in the
contralateral hippocampus (p=0.0063) and ipsilateral cortex (p=0.0103). In mCCI dnSNARE on
dox had reduced GFAP expression in the ipsilateral cortex (p=0.0027) and contralateral
hippocampus (p=0.0024). There was an interaction between genotype and injury in the ipsilateral
thalamus (p=0.0220) for mCCI injury. Data are expressed as Media ± S.E.M.
116

After mTBI, dnSNARE mice had increased cell death trends in the hippocampus
and significantly reduced GFAP expression
Injury did cause significant neuronal degeneration in both the hippocampus and the cortex
however dnSNARE did not provide any protection from neuronal degeneration. There was no
significant interaction in a two way ANOVA between injury and genotype (Figure 5.12). In the
hippocampus, genotype×injury was almost but not significant (p=0.0714) suggesting that
dnSNARE potentially could increase cell death in the hippocampus. dnSNARE injured mice did
perform slightly worse on average than WT animals in the SOR but this was not significant.
dnSNARE on dox injured mice had significantly less cell death than WT injured in the cortex
(p=0.0292), similar to VIPP on dox injured. The reduction in cell death in both dnSNARE and
VIPP on dox mice suggests that the presence of dox and less likely the leaky transgene expression
was responsible for the neuroprotection. Both CCI and mCCI injured on dox animals showed
small levels of leaky dnSNARE expression as measured by the presence of green fluorescent
protein (GFP) (Figure 5.13).
dnSNARE baseline GFAP expression was significantly elevated from when averaging
across all three regions (p=0.0236) and more specifically in the hippocampus (p=0.0003); the
other regions did not have significantly different baseline expression (Figure 5.14). dnSNARE
also affected the GFAP expression levels after injury. After CCI, dnSNARE expression reduced
GFAP expression and this was also the case after mCCI. For mCCI injured mice, GFAP
expression was reduced in the ipsilateral thalamus (p=0.0036). The GFAP expression in the
ipsilateral hippocampus of mCCI injured mice showed a potential significant interaction between
genotype and injury (p=0.0748). Generally dnSNARE on dox injured GFAP expression followed
those of WT injured with the following exceptions. In mCCI injured mice, dnSNARE on dox had
significantly elevated expression in the contralateral hippocampus (p=0.0063) and in the
ipsilateral cortex (p=0.0103). In contrast, CCI injured mice, dnSNARE on dox had significantly
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reduced GFAP expression in the ipsilateral cortex (p=0.0027) and in the contralateral
hippocampus (p=0.0024). These results suggested that dnSNARE in injury was able to reduce the
level and spread of astrogliosis in both mCCI and CCI injured tissue. In mCCI, dnSNARE
reduced glial reactivity in more distal areas to impact as seen by the reduction in the thalamus and
slight reduction in the contralateral hippocampus. In CCI, dnSNARE significantly reduced
astrogliosis in all regions where injury induced GFAP expression. Doxycycline also seemed to
reduce the level of GFAP expression in CCI injured mice. This is likely in due to the noted antiinflammatory effects of tetracyclines, minocycline (Jin et al., 2013; Siopi et al., 2012a, 2012b)
and doxycycline (Bernardino et al., 2009; Jantzie et al., 2005; Lazzarini et al., 2013). However, in
these studies, doxycycline did not seem to affect behavior as dnSNARE on dox animals largely
performed on par with WT injured. It is also important to note that the relative expression of GFP
correlated with the relative expression of GFAP (Figure 5.13 and 5.14).
The data suggests that while dnSNARE was able to preserve cortical motor function, the
main mechanism was not due to a reduction of neuronal death. This is further supported by the
fact that dnSNARE on dox mice had significantly less cell death than either WT injured and
dnSNARE injured but most of the time had the worst latency times than either injured group.

DISCUSSION
In this study, we evaluated if controlling the release of gliotransmitters during the first week
following TBI influenced either the histological or behavioral consequences of TBI. We evaluate
the broad spectrum of injury severity using the controlled cortical impact model to either create a
direct contusive injury with more widespread injury throughout the ipsilateral hemisphere, or a
milder, non-hemorrhagic injury that created only a transient opening of the blood-brain barrier
and transient behavioral deficit. In both injury models, dnSNARE showed aspects of improved
behavior after injury. In the moderate CCI, dnSNARE animals had greater improvement of
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Morris water maze latency over time. However, this improved learning did not transition to
hippocampal memory in the probe trial. Moreover, we observed a significant reduction in the
extent of GFAP reactivity eight days following injury in dnSNARE animals. In comparison, for
mild cortical impact injury we observed that dnSNARE mice showed preservation of motor
behavior in rotarod testing within the first three days of injury, a contrast to significant
impairments observed in WT animals. We did not observe a significant effect of mild TBI on
either SOR or CFC in WT mice, and therefore could not detect an improvement in either measure
with dnSNARE mice. Overall, the improved behavior in both the CCI and mCCI injuries suggest
that astrocyte gliotransmission through vesicles contribute significantly to outcome after TBI,
although the histological mechanism(s) that mediate this improvement need further definition.
However dnSNARE have a hypofunction of NMDARs (Deng et al., 2011; Fellin et al.,
2009). This is a major caveat in determining whether astrocytic release of gliotransmitters after
mechanical injury is a major contributor to excitotoxicity because reducing NMDAR surface
expression would also be neuroprotective after TBI. dnSNARE mice have already been shown to
be neuroprotective in both stroke and NMDA excitotoxic injuries (Hines and Haydon, 2013).
In CCI injured rats, NMDAR antagonists reduced cell death, lowered brain edema, and
improved BBB recovery (Dempsey et al., 2000; Raghavendra Rao et al., 2001). In FPI injury,
NMDAR antagonists improved spatial memory and motor performance (Okiyama et al., 1997,
1998). CCI injured dnSNARE mice did not experience similar level of neuroprotection. There
was no difference in NSS and there was only a small improvement in watermaze performance.
This is likely due to the CCI being a hemorrhagic injury. Blood is toxic and is a source of
excitotoxicity (Hawkins, 2009; Jaremko et al., 2010) and delayed BBB repair has been linked to
worse behavioral outcome (Bush et al., 1999; Faulkner et al., 2004). Thrombin in blood activates
protease activated recptor 1 (PAR1) (Coughlin, 1999) which phosphorylates and activates Src
kinases. Phosphorylated Src kinates potentiates NMDAR activation and in turn α-amino-3119

hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) (Sharp et al., 2008). The
neuroprotection from a hypofunction of NMDARs may have been negated by the presence of
thrombin leading to a potentiation of NMDAR activity in the cells. In contrast, mCCI injured
mice show preservation of motor function. mCCI injury also did not cause hemorrhaging and
limited BBB extravastaion. The lack of blood and blood proteins in the brain parenchyma in the
mCCI injury may have preserved the neuroprotective effects from dnSNARE induced NMDAR
hypofunction.
Past research with NMDAR antagonists and TBI showed reduction of lesion volume and
cell death. However, there was increased neurodegeneration in the hippocampus of dnSNARE
injured mice in comparison to WT injured that was almost significant. This could potentially be
due to a difference in cell death mechanism between dnSNARE and WT mice. Studies have
shown that NMDAR dependent death leads to necrosis whereas NMDAR independent cell death
pathways are apoptotic (Portera-Cailliau et al., 1997). Necrosis peaks at an earlier time point
(Bien et al., 1999) and can be cleared away in a matter of hours (Rink et al., 1995) unlike
apoptosis. With dnSNARE having reduced NMDAR surface expression in the cortex (Deng et al.,
2011; Fellin et al., 2009), this could result in greater NMDAR independent cell death pathways in
dnSNARE mice. FJB cannot differentiate between necrosis and apoptosis. It is possible that the
increased cell death in dnSNARE hippocampus could be reflective of greater delayed cell death
due to more apoptosis than necrosis. dnSNARE cortical degeneration was not greater than WT.
This could be due to the difference in time course in degeneration between the brain regions. In
vitro organotypic slice stretch models, cortical cells displayed faster degeneration (Elkin and
Morrison III, 2007) than the hippocampus (Cater et al., 2006). The 24hr FBJ measure may not
have accurately captured the peak cell death in the cortex for either dnSNARE or WT injured
mice.
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In addition to neurodegeneration as detected by FJB, we also looked at GFAP expression
post injury for both CCI and mCCI. In both cases, we saw a significant reduction in GFAP
expression of dnSNARE mice after injury compared to WT controls. These results suggest that
the inhibition of vesicular release through dnSNARE expression resulted in a major effect in the
pathophysiology after injury. NMDAR antagonism in vivo TBI studies have not shown a
significant reduction in GFAP expression. In a focal ischemia model, rats treated with MK-801
did not have reduced GFAP in regions near the lesion (Schroeter et al., 1995). MK801 has also
been shown to increase GFAP expression in a dose dependent manner in the cortex (O’Callaghan,
1994). If the sole effects from dnSNARE expression were from a hypofunction of NMDARs in
the brain, then GFAP expression would not be so significantly reduced, especially in the CCI
injured animals. Purinergic signaling in contrast has been shown to affect GFAP expression both
in vitro and in vivo (Franke et al., 2012). Treatment with apyrase reduced the level of GFAP
expression in injured cultures to that of naïve (Miller et al., 2009). Activation of P2Y1 and P2Y12
receptors have a role in the activation of astrocytes (Franke et al., 2001). Blocking P2 receptor
signaling with PPADS or suramin decreased GFAP expression in a spinal cord injury (RodríguezZayas et al., 2012) and in a cortical stab wound (Franke et al., 1999; Di Prospero et al., 1998).
Inhibition of purinergic signaling by antagonizing P2Y1 receptors with MRS2179 in vitro and in
vivo reduced cell death after stretch and improved behavior after CCI injury (Choo et al., 2013).
Furthermore, the FJB cell death count in the mCCI also did not match behavior as there
was not an increase in cortical FJB positive cells in WT compared to dnSNARE. This suggested
that the level of cellular degeneration likely did not drive the behavioral dysfunction. It is possible
that mCCI induced sublethal signaling dysfunction in neurons. Sublethal stretch injury has been
shown to affect neuronal activity synchronicity which was blocked by treatment with apyrase or
BAPTA-AM (Choo et al., 2013). This suggests that extracellular ATP can affect neuronal
function that does not necessarily lead to cell death. Together this data suggests that the
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behavioral preservation seen in dnSNARE animals was likely due to a reduction of astrocytic
ATP.
If under mechanical input, astrocytes release of gliotransmitters was a major source of
excitotoxic factors and drove neurodysfunction, then dnSNARE injured animals would reduce
these effects. It would also suggest that if there was another greater source of excitoxic factors,
then dnSNARE would not be able to block the subsequent dysfunction and degeneration. Our
results show this. In a non-hemorrhagic injury, mCCI injured dnSNARE mice were essentially
able to preserve behavior. However, in a hemorrhagic injury, CCI injured dnSNARE mice
showed little neuroprotective effect. Blood is a major source of excitotoxic factors and
complicates outcome. In clinical TBI, the increased presence of intracranial bleeding is associated
with an increased risk of mortality (Perel et al., 2009) and worse prognosis (Godoy, 2013).
Complicated mTBIs, as defined by having an intracranial abnormality on a MRI or CT scan, had
significantly longer recovery times than those with uncomplicated mTBIs (Iverson et al., 2012).
It is important to note that dnSNARE expression can also block endogenous
neuroprotective pathways. While dnSNARE inhibited release of extracellular ATPs could have
the beneficial role of preventing neuronal signaling dysfunction, a reduction of extracellular ATP
also leads to a reduction of extracellular adenosine. Reduced release of adenosine from astrocytes
significantly reduced sleep pressure in sleep deprived mice (Halassa et al., 2009). Adenosine
through activation of A1 and A2A receptors is also neuroprotective after injury (Cunha, 2005). CCI
injured mice treated with 2-CA, a broad P1 receptors agonist had improved motor function and
reduced cell death compared to untreated mice (Varma et al., 2002). Chronic treatment of
caffeine, A1 and A2A receptor agonist, improved neurological deficits, histopathology, and
reduced inflammation in CCI injured mice (Li et al., 2008). dnSNARE reduces a significant
source of extracellular adenosine through inhibition of astrocytic ATP release (Florian et al., 2011;
Halassa et al., 2009) and may reduce endogenous neuroprotective mechanisms after TBI.
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We showed that targeting glial transmission prevented trauma induced behavioral deficits
after mild CCI and improved the rate of spatial learning in more severe CCI injury. Regardless of
the mechanism of neuroprotection (hypofunction of NMDAR, reduced excitotoxicity, or both)
targeting astrocytes and gliotransmission is a potential theraputic strategy for TBI. The use of two
injury models with different severities showed that the effectiveness of targeting astrocytes is
greater in milder, non-hemorrhagic injuries.
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Chapter 6 Summary and Conclusions
Past research on the astrocytic response to TBI was largely done in vitro cultures. This
dissertation looks to expand this field into in vivo models. To do so, we first needed to create an
injury model that had greater biomechanical fidelity to human mild TBI. Then by modifying the
mild injury model we were able to simultaneously image and injure under a 2-photon microscope
to determine if impact injury caused astrocytic calcium waves. Once we had established in vivo
that stretch does induce intercellular calcium waves (ICW) similar to those in vitro, we wanted to
determine if the ICWs release of extracellular adenosine triphosphate (ATP) contributed to
degeneration and dysfunction after TBI. In vitro and in vivo studies both showed blocking
purinergic signaling to be a potential therapeutic target. However, the use of drugs cannot
differentiate the effect of astrocytes from other cell types. Using two transgenic animals with
inhibited gliotransmission we were able to test the effect of astrocytic signaling on the recovery
of TBI.

SUMMARY AND KEY CONCLUSIONS
New animal models of TBI need to incorporate aspects of human TBI biomechanics
Past animal TBI models studied the effect of brain injury types on dysfunction and degeneration.
The exact mechanism used to create the injury was considered less important (Gennarelli, 1994).
For this dissertation work, we needed an injury model that would allow us to study mild human
TBI in the mouse and could also be adapted for in vivo imaging. Instead of using past strategies
that relied on mimicking behavioral deficits or injury types to create the mild TBI in the mouse,
we incorporated mild human TBI biomechanics. The resulting injury shares many of the same
behavioral and histopathological symptoms as human mild TBI.
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In vitro injury threshold studies showed that strain rate is a factor that affects cell death
(Elkin and Morrison III, 2007) and that injury severity can affect which biochemical pathways
dominate (Choo et al., 2013). These data make a case for needing to incorporate human TBI
biomechanics to properly model human injury in animals. Comparing our mild controlled cortical
impact (mCCI) to current CCI injury models we show the impact of varying strain rate on injury.
The impact depth of mCCI was double the CCI impact depth used in these studies (2mm versus
1mm respectively). However comparing actual behavior and histopathology post injury, the strain
rate difference between the two models largely dictated injury severity. A large contusion and
lesion was created with CCI. But with impact speeds that create strain rates found in human mild
TBI, greater injury depths can be achieved with less neurological damage. The similar staining
patterns with the different histological stains in mCCI injured animals potentially show a link
between injury mechanics and subsequent biochemical pathways.

Impact injury causes intercellular calcium waves in astrocytes in vivo
Astrocytes have been noted to have altered calcium signaling dynamics in different
neuropathological states like ischemia (Ding et al., 2009) and status epilepticus (Ding et al., 2007).
In vitro TBI research also showed astrocytes responding to stretch injury with a large ICW (Choo
et al., 2013). With astrocyte cultures being a poor model for studying astrocytic functions
(Agulhon et al., 2008; Lange et al., 2012), we needed to first validate that this stretch injury
response occurred in vivo. We modified the mCCI device to conduct simultaneous in vivo
imaging during the injury. With impact, the cortical astrocytes immediately responded with an
ICW that originated from the site of impact. Without impact, the cortical astrocytes remained
quiescent. We next tested to see what mechanism caused the ICW in vivo. The in vitro studies
showed that percent stretch affected the signaling pathway responsible for ICW generation. At all
levels of sublethal stretch tested, purinergic signaling was a dominant mechanism of ICWs.
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Pretreating the cortex with apyrase reduced the injury response to near baseline levels. This
suggests that the dominate mechanism of in vivo ICW was from extracellular ATP. Due to the
limitations of 2-photon imaging, we were not able to test multiple levels of injury. However,
based on the sublethal injury tested, we were able to partially validate in vitro results in vivo.

Reducing IP3 signaling in vivo worsen behavioral outcome in a moderate severity
injury
With venus tagged inosital triphosphatase (VIPP) mice, in the moderate CCI, there was a worse
behavioral deficit in the watermaze compared to wildtype (WT). This was an unexpected finding.
Past research with phospholipase C (PLC) inhibitors showed that blocking the inosital-1,4,5triphosphate (IP3) pathway provided both behavioral and histopathological protection. VIPP mice
failed not only to improve behavioral outcome but worsened it. In the mCCI injury, VIPP fared
slightly better. While the behavior did not show a significant interaction between genotype and
injury, VIPP mice did not experience the same level of mild TBI induced deficit. This suggests
that injury severity will dictate whether targeting IP3 is an effective approach.

Reducing astrocytic vesicular release preserves motor behavior after TBI.
With dnSNARE mice, in both mCCI and CCI injuries, we showed improved behavior but not
improved histopathology. Preventing vesicular release specifically in astrocytes was able to
reduce behavioral deficits. In CCI injury, acute time points showed no improvement. It was not
until the last day of the watermaze (day7 post-injury) was there any difference in the dnSNARE
injured group. With mCCI, the first few days post injury showed the greatest retention in
behavior. These results suggest that preventing gliotransmitter release is neuroprotective. While it
is possible the protection was from the inherent hypofunction of N-methyl-D-aspartate receptors
(NMDAR) in dnSNARE mice, the reduction of gliosis is symptomatic of inhibited purinergic
signaling and less of inhibited ionotropic glutamatergic signaling.

126

Severity of brain injury is an important factor to consider in the effectiveness of
therapies.
The data in this dissertation together show that the biomechanics of the injury affects which
downstream biochemical pathways dominate, affecting the efficacy of potential therapies. The
difference between mCCI and CCI results with VIPP mice suggest that the level of injury can
affect downstream signaling pathways and highlights the need to create models that reproduce the
human TBI biomechanics to more accurately study subsequent biochemical changes. With
dnSNARE, the difference in the time course of protection between the two injury levels again
suggests that biomechanics will alter the effectiveness of the pathway in question. The data in this
dissertation together with past in vitro work together suggest that the level of injury is an
important consideration when looking at the treatment. Treatment methods that may work for
milder injuries may not work for more severe injuries and vice versa. This is likely due to the
differences in pathways that are activated in response to the difference in mechanism used to
create the injury.

LIMITATIONS AND FUTURE WORK
The work in this thesis showed that astrocytic calcium signaling can potentially be a theraputic
target for TBI. However, there are limitations to this work and much more research is needed
before this strategy can become a therapy. The first is to have better understanding of the
connection between mechanical input and the subsequent biochemical processes. In chapter three,
we were able to validate some of the in vitro stretch results in vivo. Much of our understanding of
the pathobiological pathways post TBI are derived from in vitro research ranging from tissue
tolerances to changes in signaling. Future work needs to expand on the research into tissue
tolerances and finding the link between the biomechanics and the biochemistry. What are the
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results of blood brain barrier (BBB) breakdown? Will the injury response be different with and
without BBB extravasation? With and without hemorrhage? With and without neuronal death?
Altered calcium signaling has been found to occur in vitro. We validate that this event
also occurs in vivo. However, we were only able to test a limited injury spectrum. There needs to
be more work in understanding the acute response under different injury conditions and how this
acute response evolves long term.
The use of transgenic animals is also a major limitation. While transgenic mice in this
study allowed us to specifically test the contribution of astrocyte signaling in contrast to using
drugs which would affect multiple cell types, the presence of transgenes might also have other
unanticipated effects. For instance with dnSNARE mice, an unintended effect was a hypofunction
of N-methyl-D-aspartate receptor (NMDAR) in neurons. To study TBI, this unintended effect
makes it difficult to determine which pathway or both provided the neuroprotective results. The
VIPP transgene might also have other affects that have yet to be discovered that may affect the
interpretation of our results.
While we found that the astrocytic signaling can be a therapeutic target in TBI, it is
difficult to translate into a clinical treatment. Furthermore, the effects of the transgene are
constitutive and present prior to injury. For a treatment to be effective, it must work post-injury.
Future work needs to determine if targeting these pathways are effective in the hours to days post
injury.

CONCLUSIONS
TBI is a potentially debilitating disorder with lifelong effects for many patients. Our work
provided a method to better understand biochemical differences between mild TBI and
moderate/severe TBI. The mCCI model will help to create greater understanding of tissue
tolerances and the link between biomechanics and subsequent evoked biochemical pathways.
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Having injury models that are modeled after human TBI biomechanics may allow us to study the
right biochemical pathways post-injury and in this manner create better treatment strategies.
We also show that astrocyte signaling can be a potential theraputic target. While
transgenic mice research is not directly translatable into clinical therapies, these studies do show
that targeting astrocytes can preserve or reduce injury induced behavioral deficits. The transgenes
also did not affect baseline behaviors which may imply that targeting astrocytes may cause
minimal side effects, unlike the therapies that target neurons. We also show that injury severity
does change the effectiveness of astrocytes as a theraputic target. At more severe injuries, the
effectiveness was reduced and in some cases worsened outcome. Much more work needs to be
done and hopefully the insights here contributed to the body of TBI research and guides future
work.

129

Bibliography
Abbott, N.J., Rönnbäck, L., and Hansson, E. (2006). Astrocyte–endothelial interactions at the
blood–brain barrier. Nat. Rev. Neurosci. 7, 41–53.
Agulhon, C., Petravicz, J., McMullen, A.B., Sweger, E.J., Minton, S.K., Taves, S.R., Casper,
K.B., Fiacco, T.A., and McCarthy, K.D. (2008). What Is the Role of Astrocyte Calcium
in Neurophysiology? Neuron 59, 932–946.
Agulhon, C., Sun, M.-Y., Murphy, T., Myers, T., Lauderdale, K., and Fiacco, T.A. (2012).
Calcium Signaling and Gliotransmission in Normal vs. Reactive Astrocytes. Front.
Pharmacol. 3.
Albert-Weissenberger, C., and Sirén, A.-L. (2010). Experimental traumatic brain injury. Exp.
Transl. Stroke Med. 2, 16.
Albert-Weissenberger, C., Várrallyay, C., Raslan, F., Kleinschnitz, C., and Sirén, A.-L. (2012).
An experimental protocol for mimicking pathomechanisms of traumatic brain injury in
mice. Exp. Transl. Stroke Med. 4, 1.
Alexander, M.P. (1995). Mild traumatic brain injury: pathophysiology, natural history, and
clinical management. Neurology 45, 1253–1260.
Alonso, A., Reinz, E., Fatar, M., Hennerici, M.G., and Meairs, S. (2011). Clearance of albumin
following ultrasound-induced blood–brain barrier opening is mediated by glial but not
neuronal cells. Brain Res.
Anderson, K.J., Fugaccia, I., and Scheff, S.W. (2003). Fluoro-Jade B Stains Quiescent and
Reactive Astrocytes in the Rodent Spinal Cord. J. Neurotrauma 20, 1223–1231.
Andriessen, T.M.J.C., Jacobs, B., and Vos, P.E. (2010). Clinical characteristics and
pathophysiological mechanisms of focal and diffuse traumatic brain injury. J. Cell. Mol.
Med. 14, 2381–2392.
Bailey, K.R., and Crawley, J.N. (2009). Anxiety-Related Behaviors in Mice. In Methods of
Behavior Analysis in Neuroscience, J.J. Buccafusco, ed. (Boca Raton (FL): CRC Press),.
Bain, A.C., and Meaney, D.F. (1999). Thresholds for Mechanical Injury to the in Vivo White
Matter (Warrendale, PA: SAE International).
Bain, A.C., and Meaney, D.F. (2000). Tissue-Level Thresholds for Axonal Damage in an
Experimental Model of Central Nervous System White Matter Injury. J. Biomech. Eng.
122, 615–622.
Baldwin, S.A., and Scheff, S.W. (1996). Intermediate filament change in astrocytes following
mild cortical contusion. Glia 16, 266–275.
Bannerman, D.., Grubb, M., Deacon, R.M.., Yee, B.., Feldon, J., and Rawlins, J.N.. (2003).
Ventral hippocampal lesions affect anxiety but not spatial learning. Behav. Brain Res.
139, 197–213.
Bayly, P.V., Black, E.E., Pedersen, R.C., Leister, E.P., and Genin, G.M. (2006). In vivo imaging
of rapid deformation and strain in an animal model of traumatic brain injury. J. Biomech.
39, 1086–1095.
Beauchamp, K., Mutlak, H., Smith, W.R., Shohami, E., and Stahel, P.F. (2008). Pharmacology of
traumatic brain injury: where is the “golden bullet”? Mol. Med. 14, 731.
Bennett, R.E., Mac Donald, C.L., and Brody, D.L. (2012). Diffusion tensor imaging detects
axonal injury in a mouse model of repetitive closed-skull traumatic brain injury. Neurosci.
Lett. 513, 160–165.

130

Bernardino, A.L.F., Kaushal, D., and Philipp, M.T. (2009). The Antibiotics Doxycycline and
Minocycline Inhibit the Inflammatory Responses to the Lyme Disease Spirochete
Borrelia burgdorferi. J. Infect. Dis. 199, 1379–1388.
Biedenkapp, J.C., and Rudy, J.W. (2009). Hippocampal and extrahippocampal systems compete
for control of contextual fear: Role of ventral subiculum and amygdala. Learn. Mem. 16,
38–45.
Bien, A., Seidenbecher, C.I., Böckers, T.M., Sabel, B.A., and Kreutz, M.R. (1999). Apoptotic
versus necrotic characteristics of retinal ganglion cell death after partial optic nerve injury.
J. Neurotrauma 16, 153–163.
Bigler, E.D., and Maxwell, W.L. (2012). Neuropathology of mild traumatic brain injury:
relationship to neuroimaging findings. Brain Imaging Behav. 6, 108–136.
Blumbergs, P.C., Scott, G., Manavis, J., Wainwright, H., Simpson, D.A., and McLean, A.J.
(1994). Stalning af amyloid percursor protein to study axonal damage in mild head Injury.
The Lancet 344, 1055–1056.
Blumbergs, P.C., Scott, G., Manavis, J., Wainwright, H., Simpson, D.A., and McLean, A.J.
(1995). Topography of axonal injury as defined by amyloid precursor protein and the
sector scoring method in mild and severe closed head injury. J. Neurotrauma 12, 565–572.
Bowser, D.N., and Khakh, B.S. (2007). Vesicular ATP Is the Predominant Cause of Intercellular
Calcium Waves in Astrocytes. J. Gen. Physiol. 129, 485–491.
Brody, D.L., Mac Donald, C., Kessens, C.C., Yuede, C., Parsadanian, M., Spinner, M., Kim, E.,
Schwetye, K.E., Holtzman, D.M., and Bayly, P.V. (2007). Electromagnetic Controlled
Cortical Impact Device for Precise, Graded Experimental Traumatic Brain Injury. J.
Neurotrauma 24, 657–673.
Bush, T.G., Puvanachandra, N., Horner, C.H., Polito, A., Ostenfeld, T., Svendsen, C.N., Mucke,
L., Johnson, M.H., and Sofroniew, M.V. (1999). Leukocyte Infiltration, Neuronal
Degeneration, and Neurite Outgrowth after Ablation of Scar-Forming, Reactive
Astrocytes in Adult Transgenic Mice. Neuron 23, 297–308.
C. Edward Dixon, Bruce G. Lyeth, John T. Povlishock, Robert L. Findling, Robert J. Hamm,
Anthony Marmarou, Harold F. Young, and Ronald L. Hayes (1987). A fluid percussion
model of experimental brain injury in the rat. J. Neurosurg. 67, 110–119.
Carbonell, W.S., Maris, D.O., McCall, T., and Grady, M.S. (1998). Adaptation of the fluid
percussion injury model to the mouse. J. Neurotrauma 15, 217–229.
Cater, H.L., Sundstrom, L.E., and Morrison III, B. (2006). Temporal development of
hippocampal cell death is dependent on tissue strain but not strain rate. J. Biomech. 39,
2810–2818.
Cernak, I. (2005). Animal Models of Head Trauma. NeuroRx 2, 410–422.
Charles, A.C., Merrill, J.E., Dirksen, E.R., and Sandersont, M.J. (1991). Intercellular signaling in
glial cells: Calcium waves and oscillations in response to mechanical stimulation and
glutamate. Neuron 6, 983–992.
Chen, S., Pickard, J.., and Harris, N.. (2003). Time course of cellular pathology after controlled
cortical impact injury. Exp. Neurol. 182, 87–102.
Chen, T., Willoughby, K.A., and Ellis, E.F. (2004). Group I metabotropic receptor antagonism
blocks depletion of calcium stores and reduces potentiated capacitative calcium entry in
strain-injured neurons and astrocytes. J. Neurotrauma 21, 271–281.
Chen, Y., Constantini, S., Trembovler, V., Weinstock, M., and Shohami, E. (1996). An
experimental model of closed head injury in mice: pathophysiology, histopathology, and
cognitive deficits. J. Neurotrauma 13, 557–568.

131

Choo, A.M., Miller, W.J., Chen, Y.-C., Nibley, P., Patel, T.P., Goletiani, C., Morrison, B., 3rd,
Kutzing, M.K., Firestein, B.L., Sul, J.-Y., et al. (2013). Antagonism of purinergic
signalling improves recovery from traumatic brain injury. Brain J. Neurol. 136, 65–80.
Ciallella, J.R., Ikonomovic, M.D., Paljug, W.R., Wilbur, Y.I., Dixon, C.E., Kochanek, P.M.,
Marion, D.W., and DeKosky, S.T. (2002). Changes in expression of amyloid precursor
protein and interleukin-1β after experimental traumatic brain injury in rats. J.
Neurotrauma 19, 1555–1567.
Clasadonte, J., Dong, J., Hines, D.J., and Haydon, P.G. (2013). Astrocyte control of synaptic
NMDA receptors contributes to the progressive development of temporal lobe epilepsy.
Proc. Natl. Acad. Sci. 110, 17540–17545.
Cloots, R.J., van Dommelen, J.A., Kleiven, S., and Geers, M.G. (2012). Multi-scale mechanics of
traumatic brain injury: predicting axonal strains from head loads. Biomech. Model.
Mechanobiol. 1–14.
Coughlin, S.R. (1999). How the protease thrombin talks to cells. Proc. Natl. Acad. Sci. 96,
11023–11027.
Crawley, J.N. (2007). What’s Wrong With My Mouse?: Behavioral Phenotyping of Transgenic
and Knockout Mice, Second Edition (John Wiley & Sons, Inc.).
Creed, J.A., DiLeonardi, A.M., Fox, D.P., Tessler, A.R., and Raghupathi, R. (2011). Concussive
Brain Trauma in the Mouse Results in Acute Cognitive Deficits and Sustained
Impairment of Axonal Function. J. Neurotrauma 28, 547–563.
Cullen, D.K., Simon, C.M., and LaPlaca, M.C. (2007). Strain rate-dependent induction of reactive
astrogliosis and cell death in three-dimensional neuronal-astrocytic co-cultures. Brain Res.
1158, 103–115.
Cullen, D.K., Vernekar, V.N., and LaPlaca, M.C. (2011). Trauma-Induced Plasmalemma
Disruptions in Three-Dimensional Neural Cultures Are Dependent on Strain Modality
and Rate. J. Neurotrauma 28, 2219–2233.
Cunha, R.A. (2005). Neuroprotection by adenosine in the brain: From A1 receptor activation to
A2A receptor blockade. Purinergic Signal. 1, 111–134.
D’Hooge, R., and De Deyn, P.P. (2001). Applications of the Morris water maze in the study of
learning and memory. Brain Res. Rev. 36, 60–90.
Dempsey, R.J., Başkaya, M.K., and Doğan, A. (2000). Attenuation of brain edema, blood-brain
barrier breakdown, and injury volume by ifenprodil, a polyamine-site N-methyl-Daspartate receptor antagonist, after experimental traumatic brain injury in rats.
Neurosurgery 47, 399–404; discussion 404–406.
Deng, Q., Terunuma, M., Fellin, T., Moss, S.J., and Haydon, P.G. (2011). Astrocytic activation of
A1 receptors regulates the surface expression of NMDA receptors through a Src kinase
dependent pathway. Glia 59, 1084–1093.
Dikmen, S., Machamer, J., and Temkin, N. (2001). Mild Head Injury: Facts and Artifacts. J. Clin.
Exp. Neuropsychol. 23, 729–738.
Ding, S., Fellin, T., Zhu, Y., Lee, S.-Y., Auberson, Y.P., Meaney, D.F., Coulter, D.A.,
Carmignoto, G., and Haydon, P.G. (2007). Enhanced Astrocytic Ca2+ Signals Contribute
to Neuronal Excitotoxicity after Status Epilepticus. J. Neurosci. 27, 10674–10684.
Ding, S., Wang, T., Cui, W., and Haydon, P.G. (2009). Photothrombosis ischemia stimulates a
sustained astrocytic Ca2+signaling in vivo. Glia 57, 767–776.
Dixon, C.E., Lighthall, J.W., and Anderson, T.E. (1988). Physiologic, Histopathologic, and
Cineradiographic Characterization of a New Fluid–Percussion Model of Experimental
Brain Injury in the Rat. J. Neurotrauma 5, 91–104.

132

Dixon, C.E., Clifton, G.L., Lighthall, J.W., Yaghmai, A.A., and Hayes, R.L. (1991). A controlled
cortical impact model of traumatic brain injury in the rat. J. Neurosci. Methods 39, 253–
262.
Dokko, Y., Anderson, R., Manavis, J., Blumburgs, P., McLean, J., Zhang, L., Yang, K.H., and
King, A.I. (2003). Validation of the human head FE model against pedestrian accident
and its tentative application to the examination of the existing tolerance curve. In The 18
Th International Technical Conference on the Enhanced Safety of Vehicles (ESV)
Proceedings, Nagoya, Japan, May, pp. 19–22.
Duhaime, A.-C., Gennarelli, L.M., and Yachnis, A. (1994). Acute subdural hematoma: is the
blood itself toxic? J. Neurotrauma 11, 669–678.
Ekmark-Lewén, S., Lewén, A., Israelsson, C., Li, G.L., Farooque, M., Olsson, Y., Ebendal, T.,
and Hillered, L. (2010). Vimentin and GFAP responses in astrocytes after contusion
trauma to the murine brain. Restor. Neurol. Neurosci. 28, 311–321.
Elewa, H.F., Hilali, H., Hess, D.C., Machado, L.S., and Fagan, S.C. (2006). Minocycline for
Acute Neuroprotection. Pharmacotherapy 26, 515–521.
Elkin, B.S., and Morrison III, B. (2007). Region-specific tolerance criteria for the living brain.
Stapp Car Crash J 51, 127–138.
Ellingson, B.M., Fijalkowski, R.J., Pintar, F.A., Yoganandan, N., and Gennarelli, T.A. (2005).
New mechanism for inducing closed head injury in the rat. Biomed. Sci. Instrum. 41, 86–
91.
Fanselow, M.S., and Dong, H.-W. (2010). Are The Dorsal and Ventral Hippocampus functionally
distinct structures? Neuron 65, 7.
Farkas, O., Lifshitz, J., and Povlishock, J.T. (2006). Mechanoporation Induced by Diffuse
Traumatic Brain Injury: An Irreversible or Reversible Response to Injury? J. Neurosci. 26,
3130–3140.
Faul, M., Wald, M., and Coronado, V. (2010). Traumatic brain injury in the United States:
emergency department visits, hospitalizations, and deaths.
Faulkner, J.R., Herrmann, J.E., Woo, M.J., Tansey, K.E., Doan, N.B., and Sofroniew, M.V.
(2004). Reactive astrocytes protect tissue and preserve function after spinal cord injury. J.
Neurosci. 24, 2143–2155.
Feeney, D.M., Boyeson, M.G., Linn, R.T., Murray, H.M., and Dail, W.G. (1981). Responses to
cortical injury: I. Methodology and local effects of contusions in the rat. Brain Res. 211,
67–77.
Feeser, V.R., and Loria, R.M. (2011). Modulation of traumatic brain injury using progesterone
and the role of glial cells on its neuroprotective actions. J. Neuroimmunol. 237, 4–12.
Fellin, T., Pascual, O., Gobbo, S., Pozzan, T., Haydon, P.G., and Carmignoto, G. (2004).
Neuronal Synchrony Mediated by Astrocytic Glutamate through Activation of
Extrasynaptic NMDA Receptors. Neuron 43, 729–743.
Fellin, T., Halassa, M.M., Terunuma, M., Succol, F., Takano, H., Frank, M., Moss, S.J., and
Haydon, P.G. (2009). Endogenous nonneuronal modulators of synaptic transmission
control cortical slow oscillations in vivo. Proc. Natl. Acad. Sci. 106, 15037–15042.
Fiacco, T.A., and McCarthy, K.D. (2006). Astrocyte calcium elevations: Properties, propagation,
and effects on brain signaling. Glia 54, 676–690.
Fijalkowski, R.J., Stemper, B.D., Pintar, F.A., Yoganandan, N., Crowe, M.J., and Gennarelli, T.A.
(2007). New Rat Model for Diffuse Brain Injury Using Coronal Plane Angular
Acceleration. J. Neurotrauma 24, 1387–1398.
Fijalkowski, R.J., Yoganandan, N., Zhang, J., and Pintar, F.A. (2009). A finite element model of
region-specific response for mild diffuse brain injury. Stapp Car Crash J. 53, 193–213.
133

Flierl, M.A., Stahel, P.F., Beauchamp, K.M., Morgan, S.J., Smith, W.R., and Shohami, E. (2009).
Mouse closed head injury model induced by a weight-drop device. Nat. Protoc. 4, 1328–
1337.
Florian, C., Vecsey, C.G., Halassa, M.M., Haydon, P.G., and Abel, T. (2011). Astrocyte-derived
Adenosine and A1 Receptor Activity Contribute to Sleep Loss-Induced Deficits in
Hippocampal Synaptic Plasticity and Memory in Mice. J. Neurosci. Off. J. Soc. Neurosci.
31, 6956–6962.
Floyd, C.L., Rzigalinski, B.A., Weber, J.T., Sitterding, H.A., Willoughby, K.A., and Ellis, E.F.
(2001). Traumatic injury of cultured astrocytes alters inositol (1, 4, 5)–trisphosphatemediated signaling. Glia 33, 12–23.
Floyd, C.L., Rzigalinski, B.A., Sitterding, H.A., Willoughby, K.A., and Ellis, E.F. (2004).
Antagonism of group I metabotropic glutamate receptors and PLC attenuates increases in
inositol trisphosphate and reduces reactive gliosis in strain-injured astrocytes. J.
Neurotrauma 21, 205–216.
Franke, H., Krügel, U., and Illes, P. (1999). P2 receptor-mediated proliferative effects on
astrocytes in vivo. Glia 28, 190–200.
Franke, H., Krügel, U., Schmidt, R., Grosche, J., Reichenbach, A., and Illes, P. (2001). P2
receptor-types involved in astrogliosis in vivo. Br. J. Pharmacol. 134, 1180–1189.
Franke, H., Verkhratsky, A., Burnstock, G., and Illes, P. (2012). Pathophysiology of astroglial
purinergic signalling. Purinergic Signal. 8, 629–657.
Geddes, D.M., Cargill, R.S., and LaPlaca, M.C. (2003). Mechanical stretch to neurons results in a
strain rate and magnitude-dependent increase in plasma membrane permeability. J.
Neurotrauma 20, 1039–1049.
Gennarelli, T.A. (1994). Animate models of human head injury. J. Neurotrauma 11, 357–368.
Gennarelli, T.A., Thibault, L.E., Adams, J.H., Graham, D.I., Thompson, C.J., and Marcincin, R.P.
(1982). Diffuse axonal injury and traumatic coma in the primate. Ann. Neurol. 12, 564–
574.
Godoy, D.A. (2013). Intensive Care in Neurology and Neurosurgery. Pathophysiological Basis
for the Management of Acute Cerebral Injury (SEEd).
Golding, E.M., and Vink, R. (1994). Inhibition of phospholipase C with neomycin improves
metabolic and neurologic outcome following traumatic brain injury. Brain Res. 668, 46–
53.
Goldmsith, W. (1972). Biomechanics of Head Injury. In Biomechanics, Its Foundations and
Objectives, Y. Fung, N. Perrone, and M. Anliker, eds. (Prentice-Hall), pp. 585–634.
Goodman, J.C., Cherian, L., Bryan Jr, R.M., and Robertson, C.S. (1994). Lateral cortical impact
injury in rats: pathologic effects of varying cortical compression and impact velocity. J.
Neurotrauma 11, 587–597.
Halassa, M.M. (2009). Neuromodulatory roles for astrocytes: Synapses, circuits & behavior. Ph.D.
University of Pennsylvania.
Halassa, M.M., Fellin, T., Takano, H., Dong, J.-H., and Haydon, P.G. (2007). Synaptic Islands
Defined by the Territory of a Single Astrocyte. J. Neurosci. 27, 6473–6477.
Halassa, M.M., Florian, C., Fellin, T., Munoz, J.R., Lee, S.-Y., Abel, T., Haydon, P.G., and Frank,
M.G. (2009). Astrocytic Modulation of Sleep Homeostasis and Cognitive Consequences
of Sleep Loss. Neuron 61, 213–219.
Hall, E.D., Bryant, Y.D., Cho, W., and Sullivan, P.G. (2008). Evolution of post-traumatic
neurodegeneration after controlled cortical impact traumatic brain injury in mice and rats
as assessed by the de Olmos silver and fluorojade staining methods. J. Neurotrauma 25,
235–247.
134

Hamilton, N.A., and Keller, M.S. (2010). Mild traumatic brain injury in children. Semin. Pediatr.
Surg. 19, 271–278.
Hashmi, A.M., Butt, Z., and Umair, M. (2013). Is depression an inflammatory condition? A
review of available evidence. JPMA J. Pak. Med. Assoc. 63, 899–906.
Hawkins, R.A. (2009). The blood-brain barrier and glutamate. Am. J. Clin. Nutr. 90, 867S–874S.
Hines, D.J., and Haydon, P.G. (2013). Inhibition of a SNARE-Sensitive Pathway in Astrocytes
Attenuates Damage following Stroke. J. Neurosci. 33, 4234–4240.
Hinkle, D.A., Baldwin, S.A., Scheff, S.W., and Wise, P.M. (1997). GFAP and S100beta
expression in the cortex and hippocampus in response to mild cortical contusion. J.
Neurotrauma 14, 729–738.
Ho, J., and Kleiven, S. (2007). Dynamic response of the brain with vasculature: A threedimensional computational study. J. Biomech. 40, 3006–3012.
Huh, J.W., Widing, A.G., and Raghupathi, R. (2007). Repetitive Mild Non-Contusive Brain
Trauma in Immature Rats Exacerbates Traumatic Axonal Injury and Axonal Calpain
Activation: A Preliminary Report. J. Neurotrauma 24, 15–27.
Hylin, M.J., Orsi, S.A., Zhao, J., Bockhorst, K., Perez, A., Moore, A.N., and Dash, P.K. (2013).
Behavioral and Histopathological Alterations Resulting from Mild Fluid Percussion
Injury. J. Neurotrauma 30, 702–715.
Iverson, G.L., Lange, R.T., Wäljas, M., Liimatainen, S., Dastidar, P., Hartikainen, K.M.,
Soimakallio, S., and Öhman, J. (2012). Outcome from Complicated versus
Uncomplicated Mild Traumatic Brain Injury. Rehabil. Res. Pract. 2012, 1–7.
James, G., and Butt, A.M. (2002). P2Y and P2X purinoceptor mediated Ca2+ signalling in glial
cell pathology in the central nervous system. Eur. J. Pharmacol. 447, 247–260.
Jantzie, L.L., Cheung, P.-Y., and Todd, K.G. (2005). Doxycycline reduces cleaved caspase-3 and
microglial activation in an animal model of neonatal hypoxia-ischemia. J. Cereb. Blood
Flow Metab. 25, 314–324.
Jaremko, K.M., Chen-Roetling, J., Chen, L., and Regan, R.F. (2010). Accelerated hemolysis and
neurotoxicity in neuron-glia-blood clot co-cultures. J. Neurochem. no–no.
Jin, W.-J., Feng, S.-W., Feng, Z., Lu, S.-M., Qi, T., and Qian, Y.-N. (2013). Minocycline
improves postoperative cognitive impairment in aged mice by inhibiting astrocytic
activation: NeuroReport 1.
Kilbourne, M., Kuehn, R., Tosun, C., Caridi, J., Keledjian, K., Bochicchio, G., Scalea, T.,
Gerzanich, V., and Simard, J.M. (2009). Novel model of frontal impact closed head
injury in the rat. J. Neurotrauma 26, 2233–2243.
Kimpara, H., and Iwamoto, M. (2012). Mild Traumatic Brain Injury Predictors Based on Angular
Accelerations During Impacts. Ann. Biomed. Eng. 40, 114–126.
Kleiven, S. (2007). Predictors for traumatic brain injuries evaluated through accident
reconstructions. Stapp Car Crash J. 51, 81–114.
Kleiven, S., and Hardy, W.N. (2002). Correlation of an FE Model of the Human Head with Local
Brain Motion--Consequences for Injury Prediction. Stapp Car Crash J. 46, 123–144.
Kochanek, P.M., Marion, D.W., Zhang, W., Schiding, J.K., White, M., Palmer, A.M., Clark,
R.S.B., O’Malley, M.E., Styren, S.D., and Ho, C. (1995). Severe controlled cortical
impact in rats: assessment of cerebral edema, blood flow, and contusion volume. J.
Neurotrauma 12, 1015–1025.
Kuchibhotla, K.V., Lattarulo, C.R., Hyman, B.T., and Bacskai, B.J. (2009). Synchronous
Hyperactivity and Intercellular Calcium Waves in Astrocytes in Alzheimer Mice. Science
323, 1211–1215.
Kushner, D. (1998). Mild traumatic brain injury: Toward understanding manifestations and
treatment. Arch. Intern. Med. 158, 1617–1624.
135

Laird, M.D., Vender, J.R., and Dhandapani, K.M. (2008). Opposing Roles for Reactive
Astrocytes following Traumatic Brain Injury. Neurosignals 16, 154–164.
Lamy, M., Baumgartner, D., Yoganandan, N., Stemper, B.D., and Willinger, R. (2013).
Experimentally validated three-dimensional finite element model of the rat for mild
traumatic brain injury. Med. Biol. Eng. Comput. 51, 353–365.
Lange, S.C., Bak, L.K., Waagepetersen, H.S., Schousboe, A., and Norenberg, M.D. (2012).
Primary Cultures of Astrocytes: Their Value in Understanding Astrocytes in Health and
Disease. Neurochem. Res. 37, 2569–2588.
Laurer, H.L., Bareyre, F.M., Lee, V.M., Trojanowski, J.Q., Longhi, L., Hoover, R., Saatman,
K.E., Raghupathi, R., Hoshino, S., and Grady, M.S. (2001). Mild head injury increasing
the brain’s vulnerability to a second concussive impact. J. Neurosurg. 95, 859–870.
Lazzarini, M., Martin, S., Mitkovski, M., Vozari, R.R., Stühmer, W., and Bel, E.D. (2013).
Doxycycline restrains glia and confers neuroprotection in a 6-OHDA Parkinson model.
Glia 61, 1084–1100.
Le, T.H., and Gean, A.D. (2009). Neuroimaging of traumatic brain injury. Mt. Sinai J. Med. J.
Transl. Pers. Med. 76, 145–162.
Lee, B., and Newberg, A. (2005). Neuroimaging in Traumatic Brain Imaging. NeuroRx 2, 372–
383.
Levchakov, A., Linder-Ganz, E., Raghupathi, R., Margulies, S.S., and Gefen, A. (2006).
Computational studies of strain exposures in neonate and mature rat brains during closed
head impact. J. Neurotrauma 23, 1570–1580.
Li, W., Dai, S., An, J., Li, P., Chen, X., Xiong, R., Liu, P., Wang, H., Zhao, Y., Zhu, M., et al.
(2008). Chronic but not acute treatment with caffeine attenuates traumatic brain injury in
the mouse cortical impact model. Neuroscience 151, 1198–1207.
Lighthall, J.W. (1988). Controlled cortical impact: a new experimental brain injury model. J.
Neurotrauma 5, 1–15.
Lindgren, S., and Rinder, L. (1966). Experimental studies in head injury. II. Pressure propagation
in “percussion concussion.”Biophysik 3, 174–180.
Longhi, L., Saatman, K.E., Fujimoto, S., Raghupathi, R., Meaney, D.F., Davis, J., McMillan, A.,
Conte, V., Laurer, H.L., Stein, S., et al. (2005). Temporal Window of Vulnerability to
Repetitive Experimental Concussive Brain Injury. Neurosurgery 56, 364–374.
Lusardi, T.A., Smith, D.H., Wolf, J.A., and Meaney, D.F. (2003). The separate roles of calcium
and mechanical forces in mediating cell death in mechanically injured neurons.
Biorheology 40, 401–409.
Lyeth, B.G., Gong, Q.-Z., Shields, S., Muizelaar, J.P., and Berman, R.F. (2001). Group I
Metabotropic Glutamate Antagonist Reduces Acute Neuronal Degeneration and
Behavioral Deficits after Traumatic Brain Injury in Rats. Exp. Neurol. 169, 191–199.
Macdonald, C., Dikranian, K., Song, S., Bayly, P., Holtzman, D., and Brody, D. (2007).
Detection of traumatic axonal injury with diffusion tensor imaging in a mouse model of
traumatic brain injury. Exp. Neurol. 205, 116–131.
Malec, J.F., Brown, A.W., Leibson, C.L., Flaada, J.T., Mandrekar, J.N., Diehl, N.N., and Perkins,
P.K. (2007). The Mayo Classification System for Traumatic Brain Injury Severity. J.
Neurotrauma 24, 1417–1424.
Manley, G.T., Rosenthal, G., Lam, M., Morabito, D., Yan, D., Derugin, N., Bollen, A., Knudson,
M.M., and Panter, S.S. (2006). Controlled Cortical Impact in Swine: Pathophysiology
and Biomechanics. J. Neurotrauma 23, 128–139.
Mao, H., and Yang, K.H. (2011). Investigation of brain contusion mechanism and threshold by
combining finite element analysis with in vivo histology data. Int. J. Numer. Methods
Biomed. Eng. 27, 357–366.
136

Mao, H., Zhang, L., Yang, K.H., and King, A.I. (2006). Application of a finite element model of
the brain to study traumatic brain injury mechanisms in the rat. Stapp Car Crash J. 50,
583–600.
Mao, H., Jin, X., Zhang, L., Yang, K.H., Igarashi, T., Noble-Haeusslein, L.J., and King, A.I.
(2010a). Finite Element Analysis of Controlled Cortical Impact-Induced Cell Loss. J.
Neurotrauma 27, 877–888.
Mao, H., Yang, K.H., King, A.I., and Yang, K. (2010b). Computational neurotrauma--design,
simulation, and analysis of controlled cortical impact model. Biomech. Model.
Mechanobiol. 9, 763–772.
Margulies, S.S., and Thibault, L.E. (1992). A proposed tolerance criterion for diffuse axonal
injury in man. J. Biomech. 25, 917–923.
Margulies, S.S., Thibault, L.E., and Gennarelli, T.A. (1990). Physical model simulations of brain
injury in the primate. J. Biomech. 23, 823–836.
Marmarou, A., Foda, M.A.A.-E., Brink, W. van den, Campbell, J., Kita, H., and Demetriadou, K.
(1994). A new model of diffuse brain injury in rats: Part I: Pathophysiology and
biomechanics. J. Neurosurg. 80, 291–300.
Matz, P.G., Lewén, A., and Chan, P.H. (2001). Neuronal, but not microglial, accumulation of
extravasated serum proteins after intracerebral hemolysate exposure is accompanied by
cytochrome c release and DNA fragmentation. J. Cereb. Blood Flow Metab. 21, 921–928.
McAllister, T.W., Ford, J.C., Ji, S., Beckwith, J.G., Flashman, L.A., Paulsen, K., and Greenwald,
R.M. (2012). Maximum Principal Strain and Strain Rate Associated with Concussion
Diagnosis Correlates with Changes in Corpus Callosum White Matter Indices. Ann.
Biomed. Eng. 40, 127–140.
McCrea M, Guskiewicz KM, Marshall SW, and et al (2003). Acute effects and recovery time
following concussion in collegiate football players: The ncaa concussion study. JAMA
290, 2556–2563.
McIntosh, T.K., Noble, L., Andrews, B., and Faden, A.I. (1987). Traumatic brain injury in the rat:
characterization of a midline fluid-percussion model. Cent. Nerv. Syst. Trauma 4, 119–
134.
McIntosh, T.K., Vink, R., Noble, L., Yamakami, I., Fernyak, S., Soares, H., and Faden, A.L.
(1989). Traumatic brain injury in the rat: Characterization of a lateral fluid-percussion
model. Neuroscience 28, 233–244.
McKinlay, A. (2010). Controversies and outcomes associated with mild traumatic brain injury in
childhood and adolescences. Child Care Health Dev. 36, 3–21.
Meaney, D., and Thibault, L.E. (1990). Physical model studies of cortical brain deformation in
response to high strain rate inertial loading. (Lyon, France: International Conference on
the Biomechanics of Impacts).
Meaney, D.F., Ross, D.T., Winkelstein, B.A., Brasko, J., Goldstein, D., Bilston, L.B., Thibault,
L.E., and Gennarelli, T.A. (1994). Modification of the cortical impact model to produce
axonal injury in the rat cerebral cortex. J. Neurotrauma 11, 599–612.
Meaney, D.F., Smith, D.H., Shreiber, D.I., Bain, A.C., Miller, R.T., Ross, D.T., and Gennarelli,
T.A. (1995). Biomechanical analysis of experimental diffuse axonal injury. J.
Neurotrauma 12, 689–694.
Miller, W.J. (2009). Mechanism of Astrocytic Calcium Wave Propagation and In Vitro
Hippocampal Cell Death are Determined by the Magnitude of Mechanical Injury.
University of Pennsylvania.
Miller, R.T., Margulies, S.S., Leoni, M., Nonaka, M., Chen, X., Smith, D.H., and Meaney, D.F.
(1998). Finite Element Modeling Approaches for Predicting Injury in an Experimental
Model of Severe Diffuse Axonal Injury (Warrendale, PA: SAE International).
137

Miller, W.J., Leventhal, I., Scarsella, D., Haydon, P.G., Janmey, P., and Meaney, D.F. (2009).
Mechanically Induced Reactive Gliosis Causes ATP-Mediated Alterations in Astrocyte
Stiffness. J. Neurotrauma 26, 789–797.
Morrison, B., Elkin, B.S., Dollé, J.-P., and Yarmush, M.L. (2011). In Vitro Models of Traumatic
Brain Injury. Annu. Rev. Biomed. Eng. 13, 91–126.
Morrison III, B., MEANEY, D.F., Margulies, S.S., and McINTOSH, T.K. (2000). Dynamic
Mechanical Stretch of Organotypic Brain Slice Cultures Induces Differential Genomic
Expression: Relationship to Mechanical Parameters. Tech. BRIEFS.
Morrison III, B., Cater, H.L., Wang, C.C.-B., Thomas, F.C., Hung, C.T., Ateshian, G.A., and
Sundstrom, L.E. (2003). A tissue level tolerance criterion for living brain developed with
an in vitro model of traumatic mechanical loading. Stapp Car Crash J. 47, 93–105.
Morrison III, B., Cater, H.L., Benham, C.D., and Sundstrom, L.E. (2006). An in vitro model of
traumatic brain injury utilising two-dimensional stretch of organotypic hippocampal slice
cultures. J. Neurosci. Methods 150, 192–201.
Mulligan, S.J., and MacVicar, B.A. (2004). Calcium transients in astrocyte endfeet cause
cerebrovascular constrictions. Nature 431, 195–199.
Mungenast, A.E. (2011). Diacylglycerol Signaling Underlies Astrocytic ATP Release. Neural
Plast. 2011.
Myer, D.J., Gurkoff, G.G., Lee, S.M., Hovda, D.A., and Sofroniew, M.V. (2006). Essential
protective roles of reactive astrocytes in traumatic brain injury. Brain 129, 2761–2772.
Nadal, A., Fuentes, E., Pastor, J., and McNaughton, P.A. (1995). Plasma albumin is a potent
trigger of calcium signals and DNA synthesis in astrocytes. Proc. Natl. Acad. Sci. 92,
1426–1430.
National Center for Injury Prevention and Control (2003). Report to Congress on Mild Traumatic
Brain Injury in the United States: Steps to Prevent a Serious Public Health Problem.
Neary, J.T., Kang, Y., Willoughby, K.A., and Ellis, E.F. (2003). Activation of Extracellular
Signal-Regulated Kinase by Stretch-Induced Injury in Astrocytes Involves Extracellular
ATP and P2 Purinergic Receptors. J. Neurosci. 23, 2348–2356.
Newman, E.A. (2003). New roles for astrocytes: Regulation of synaptic transmission. Trends
Neurosci. 26, 536–542.
Nimmerjahn, A., Kirchhoff, F., Kerr, J.N.D., and Helmchen, F. (2004). Sulforhodamine 101 as a
specific marker of astroglia in the neocortex in vivo. Nat. Methods 1, 31–37.
O’Callaghan, J.P. (1994). Biochemical analysis of glial fibrillary acidic protein as a quantitative
approach to neurotoxicity assessment: advantages, disadvantages and application to the
assessment of NMDA receptor antagonist-induced neurotoxicity. Psychopharmacol. Bull.
30, 549–554.
Oberheim, N.A., Wang, X., Goldman, S., and Nedergaard, M. (2006). Astrocytic complexity
distinguishes the human brain. Trends Neurosci. 29, 547–553.
Okiyama, K., Smith, D.H., White, W.F., Richter, K., and McIntosh, T.K. (1997). Effects of the
novel NMDA antagonists CP-98,113, CP-101,581 and CP-101,606 on cognitive function
and regional cerebral edema following experimental brain injury in the rat. J.
Neurotrauma 14, 211–222.
Okiyama, K., Smith, D.H., White, W.F., and McIntosh, T.K. (1998). Effects of the NMDA
antagonist CP-98,113 on regional cerebral edema and cardiovascular, cognitive, and
neurobehavioral function following experimental brain injury in the rat. Brain Res. 792,
291–298.
Oliveira, A.M.M., Hawk, J.D., Abel, T., and Havekes, R. (2010). Post-training reversible
inactivation of the hippocampus enhances novel object recognition memory. Learn. Mem.
17, 155–160.
138

Oliveira, A.M.M., Estévez, M.A., Hawk, J.D., Grimes, S., Brindle, P.K., and Abel, T. (2011).
Subregion-specific p300 conditional knock-out mice exhibit long-term memory
impairments. Learn. Mem. 18, 161–169.
Ommaya, A.K., and Gennarelli, T.A. (1974). Cerebral concussion and traumatic unconsciousness.
Correlation of experimental and clinical observations of blunt head injuries. Brain J.
Neurol. 97, 633–654.
Ommaya, A.K., Hirsch, A.E., Flamm, E.S., and Mahone, R.H. (1966). Cerebral concussion in the
monkey: an experimental model. Science 153, 211–212.
Ommaya, A.K., Yarnell, P., Hirsch, A.E., and Harris, E.H. (1967). Scaling of Experimental Data
on Cerebral Concussion in Sub-Human Primates to Concussion Threshold for Man
(Warrendale, PA: SAE International).
Paradise, M.B., Naismith, S.L., Norrie, L.M., Graeber, M.B., and Hickie, I.B. (2012). The role of
glia in late-life depression. Int. Psychogeriatr. 24, 1878–1890.
Parpura, V., Basarsky, T.A., Liu, F., Jeftinija, K., Jeftinija, S., and Haydon, P.G. (1994).
Glutamate-mediated astrocyte–neuron signalling. Nature 369, 744–747.
Pascual, O., Casper, K.B., Kubera, C., Zhang, J., Revilla-Sanchez, R., Sul, J.-Y., Takano, H.,
Moss, S.J., McCarthy, K.D., and Haydon, P.G. (2005). Astrocytic Purinergic Signaling
Coordinates Synaptic Networks. Science 310, 113–116.
Patki, G., Solanki, N., Atrooz, F., Allam, F., and Salim, S. (2013). Depression, anxiety-like
behavior and memory impairment are associated with increased oxidative stress and
inflammation in a rat model of social stress. Brain Res. 1539, 73–86.
Peña, A., Pickard, J.D., Stiller, D., Harris, N.G., and Schuhmann, M.U. (2005). Brain tissue
biomechanics in cortical contusion injury: a finite element analysis. Acta Neurochir.
Suppl. 95, 333–336.
Perea, G., Navarrete, M., and Araque, A. (2009). Tripartite synapses: astrocytes process and
control synaptic information. Trends Neurosci. 32, 421–431.
Perel, P., Roberts, I., Bouamra, O., Woodford, M., Mooney, J., and Lecky, F. (2009). Intracranial
bleeding in patients with traumatic brain injury: A prognostic study. BMC Emerg. Med. 9,
15.
Peters, O., Schipke, C.G., Hashimoto, Y., and Kettenmann, H. (2003). Different Mechanisms
Promote Astrocyte Ca2+ Waves and Spreading Depression in the Mouse Neocortex. J.
Neurosci. 23, 9888–9896.
Pfister, B.J., Weihs, T.P., Betenbaugh, M., and Bao, G. (2003). An In Vitro Uniaxial Stretch
Model for Axonal Injury. Ann. Biomed. Eng. 31, 589–598.
Pifarré, P., Prado, J., Giralt, M., Molinero, A., Hidalgo, J., and Garcia, A. (2010). Cyclic GMP
phosphodiesterase inhibition alters the glial inflammatory response, reduces oxidative
stress and cell death and increases angiogenesis following focal brain injury. J.
Neurochem. 112, 807–817.
Pleasant, J.M., Carlson, S.W., Mao, H., Scheff, S.W., Yang, K.H., and Saatman, K.E. (2011).
Rate of Neurodegeneration in the Mouse Controlled Cortical Impact Model Is Influenced
by Impactor Tip Shape: Implications for Mechanistic and Therapeutic Studies. J.
Neurotrauma 28, 2245–2262.
Portera-Cailliau, C., Price, D.L., and Martin, L.J. (1997). Non-NMDA and NMDA receptormediated excitotoxic neuronal deaths in adult brain are morphologically distinct: Further
evidence for an apoptosis-necrosis continuum. J. Comp. Neurol. 378, 88–104.
Powell, J.M., Ferraro, J.V., Dikmen, S.S., Temkin, N.R., and Bell, K.R. (2008). Accuracy of Mild
Traumatic Brain Injury Diagnosis. Arch. Phys. Med. Rehabil. 89, 1550–1555.

139

Di Prospero, N.A., Zhou, X.R., Meiners, S., McAuliffe, W.G., Ho, S.Y., and Geller, H.M. (1998).
Suramin disrupts the gliotic response following a stab wound injury to the adult rat brain.
J. Neurocytol. 27, 491–506.
Raghavendra Rao, V.L., Dogan, A., Todd, K.G., Bowen, K.K., and Dempsey, R.J. (2001).
Neuroprotection by memantine, a non-competitive NMDA receptor antagonist after
traumatic brain injury in rats. Brain Res. 911, 96–100.
Rákos, G., Kis, Z., Nagy, D., Lür, G., Farkas, T., Hortobágyi, T., Vécsei, L., and Toldi, J. (2007).
Evans Blue fluorescence permits the rapid visualization of non-intact cells in the
perilesional rim of cold-injured rat brain. Acta Neurobiol. Exp. (Warsz.) 67, 149–154.
Rashid, B., Destrade, M., and Gilchrist, M.D. (2012). Mechanical characterization of brain tissue
in tension at dynamic strain rates. J. Mech. Behav. Biomed. Mater.
Raslan, F., Schwarz, T., Meuth, S.G., Austinat, M., Bader, M., Renné, T., Roosen, K., Stoll, G.,
Sirén, A.-L., and Kleinschnitz, C. (2010). Inhibition of bradykinin receptor B1 protects
mice from focal brain injury by reducing blood–brain barrier leakage and inflammation. J.
Cereb. Blood Flow Metab. 30, 1477–1486.
Raslan, F., Albert-Weißenberger, C., Ernestus, R.-I., Kleinschnitz, C., and Sirén, A.-L. (2012).
Focal brain trauma in the cryogenic lesion model in mice. Exp. Transl. Stroke Med. 4, 6.
Richmond, M.A., Yee, B.K., Pouzet, B., Veenman, L., Rawlins, J.N., Feldon, J., and Bannerman,
D.M. (1999). Dissociating context and space within the hippocampus: effects of complete,
dorsal, and ventral excitotoxic hippocampal lesions on conditioned freezing and spatial
learning. Behav. Neurosci. 113, 1189–1203.
Rinder, L. (1969). “Concussive Response” and Intracranial Pressure Changes at Sudden
Extradural Fluid Volume Input in Rabbits. Acta Physiol. Scand. 76, 352–360.
Rink, A., Fung, K.-M., Trojanowski, J.Q., Lee, V.M., Neugebauer, E., and McIntosh, T.K. (1995).
Evidence of apoptotic cell death after experimental traumatic brain injury in the rat. Am.
J. Pathol. 147, 1575.
Rodríguez-Zayas, A.E., Torrado, A.I., Rosas, O.R., Santiago, J.M., Figueroa, J.D., and Miranda,
J.D. (2012). Blockade of P2 Nucleotide Receptors After Spinal Cord Injury Reduced the
Gliotic Response and Spared Tissue. J. Mol. Neurosci. 46, 167–176.
Ross, D.T., Meaney, D.F., Sabol, M.K., Smith, D.H., and Gennarelli, T.A. (1994). Distribution of
Forebrain Diffuse Axonal Injury Following Inertial Closed Head Injury in Miniature
Swine. Exp. Neurol. 126, 291–299.
Ruan, J.S., Khalil, T.B., and King, A.I. (1993). Finite Element Modeling of Direct Head Impact
(Warrendale, PA: SAE International).
Ruan, J.S., Khalil, T., and King, A.I. (1994). Dynamic response of the human head to impact by
three-dimensional finite element analysis. J. Biomech. Eng. 116, 44–50.
Rudy, J.W., and Matus-Amat, P. (2005). The ventral hippocampus supports a memory
representation of context and contextual fear conditioning: implications for a unitary
function of the hippocampus. Behav. Neurosci. 119, 154–163.
Ruff, R.M., Iverson, G.L., Barth, J.T., Bush, S.S., Broshek, D.K., and the NAN Policy and
Planning Committee (2009). Recommendations for Diagnosing a Mild Traumatic Brain
Injury: A National Academy of Neuropsychology Education Paper. Arch. Clin.
Neuropsychol. 24, 3–10.
Rzigalinski, B.A., Weber, J.T., Willoughby, K.A., and Ellis, E.F. (1998). Intracellular free
calcium dynamics in stretch-injured astrocytes. J. Neurochem. 70, 2377–2385.
Saatman, K.E., Duhaime, A.-C., Bullock, R., Maas, A.I.R., Valadka, A., and Manley, G.T. (2008).
Classification of Traumatic Brain Injury for Targeted Therapies. J. Neurotrauma 25, 719–
738.
140

Sasaki, M., and Dunn, L. (2001). A model of acute subdural hematoma in the mouse. J.
Neurotrauma 18, 1241–1246.
Scemes, E. (2000). Components of astrocytic intercellular calcium signaling. Mol. Neurobiol. 22,
167–179.
Scemes, E., and Giaume, C. (2006). Astrocyte calcium waves: What they are and what they do.
Glia 54, 716–725.
Schroeter, M., Schiene, K., Kraemer, M., Hagemann, G., Weigel, H., Eysel, U.T., Witte, O.W.,
and Stoll, G. (1995). Astroglial responses in photochemically induced focal ischemia of
the rat cortex. Exp. Brain Res. Exp. Hirnforsch. Expérimentation Cérébrale 106, 1–6.
Shakeri, M., Boustani, M.R., Pak, N., Panahi, F., Salehpour, F., Lotfinia, I., Meshkini, A.,
Daghighi, S., vahedi, P., Khani, M., et al. (2013). Effect of progesterone administration
on prognosis of patients with diffuse axonal injury due to severe head trauma. Clin.
Neurol. Neurosurg. 115, 2019–2022.
Shapira, Y., Shohami, E., Sidi, A., Soffer, D., Freeman, S., and Cotev, S. (1988). Experimental
closed head injury in rats: mechanical, pathophysiologic, and neurologic properties. Crit.
Care Med. 16, 258–265.
Sharp, F., Liu, D.Z., Zhan, X., and Ander, B.P. (2008). Intracerebral hemorrhage injury
mechanisms: glutamate neurotoxicity, thrombin, and Src. Acta Neurochir. Suppl. 105,
43–46.
Shitaka, Y., Tran, H.T., Bennett, R.E., Sanchez, L., Levy, M.A., Dikranian, K., and Brody, D.L.
(2011). Repetitive Closed-Skull Traumatic Brain Injury in Mice Causes Persistent
Multifocal Axonal Injury and Microglial Reactivity. J. Neuropathol. Exp. Neurol. 70,
551–567.
Shohami, E., Shapira, Y., and Cotev, S. (1988). Experimental closed head injury in rats:
prostaglandin production in a noninjured zone. Neurosurgery 22, 859–863.
Shreiber, D.I. (1998). Experimental and computational modeling of traumatic brain injury: In
vivo thresholds for mechanical disruption of the blood-brain barrier. Ph.D. University of
Pennsylvania.
Shreiber, D.I., Bain, A.C., and Meaney, D.F. (1997). In Vivo Thresholds for Mechanical Injury to
the Blood-Brain Barrier (Warrendale, PA: SAE International).
Shreiber, D.I., Bain, A.C., Ross, D.T., Smith, D.H., Gennarelli, T.A., McIntosh, T.K., and
Meaney, D.F. (1999). Experimental investigation of cerebral contusion: histopathological
and immunohistochemical evaluation of dynamic cortical deformation. J. Neuropathol.
Exp. Neurol. 58, 153–164.
Shultz, S.R., MacFabe, D.F., Foley, K.A., Taylor, R., and Cain, D.P. (2011). A single mild fluid
percussion injury induces short-term behavioral and neuropathological changes in the
Long–Evans rat: Support for an animal model of concussion. Behav. Brain Res. 224,
326–335.
Signoretti, S., Vagnozzi, R., Tavazzi, B., and Lazzarino, G. (2010). Biochemical and
neurochemical sequelae following mild traumatic brain injury: summary of experimental
data and clinical implications. Neurosurg. Focus 29, E1.
Singh, A., Lu, Y., Chen, C., Kallakuri, S., and Cavanaugh, J.M. (2006). A new model of
traumatic axonal injury to determine the effects of strain and displacement rates. Stapp
Car Crash J. 50, 601–623.
Siopi, E., Llufriu-Dabén, G., Fanucchi, F., Plotkine, M., Marchand-Leroux, C., and JafarianTehrani, M. (2012a). Evaluation of late cognitive impairment and anxiety states
following traumatic brain injury in mice: The effect of minocycline. Neurosci. Lett. 511,
110–115.
141

Siopi, E., Calabria, S., Plotkine, M., Marchand-Leroux, C., and Jafarian-Tehrani, M. (2012b).
Minocycline Restores Olfactory Bulb Volume and Olfactory Behavior after Traumatic
Brain Injury in Mice. J. Neurotrauma 29, 354–361.
Smith, D.H., Okiyama, K., Thomas, M.J., Claussen, B., and McINTOSH, T.K. (1991).
Evaluation of Memory Dysfunction Following Experimental Brain Injury Using the
Morris Water Maze. J. Neurotrauma 8, 259–269.
Smith, D.H., Soares, H.D., Pierce, J.S., Perlman, K.G., Saatman, K.E., Meaney, D.F., Dixon, C.E.,
and McINTOSH, T.K. (1995). A Model of Parasagittal Controlled Cortical Impact in the
Mouse: Cognitive and Histopathologic Effects. J. Neurotrauma 12, 169–178.
Sofroniew, M.V., and Vinters, H.V. (2010). Astrocytes: biology and pathology. Acta Neuropathol.
(Berl.) 119, 7–35.
Spaethling, J.M., Geddes-Klein, D.M., Miller, W.J., von Reyn, C.R., Singh, P., Mesfin, M.,
Bernstein, S.J., and Meaney, D.F. (2007). Linking impact to cellular and molecular
sequelae of CNS injury: Modeling in vivo complexity with in vitro simplicity. In
Progress in Brain Research, John T. Weber and Andrew I.R. Maas, ed. (Elsevier), pp. 27–
39.
Spain, A., Daumas, S., Lifshitz, J., Rhodes, J., Andrews, P.J., Horsburgh, K., and Fowler, J.H.
(2010). Mild fluid percussion injury in mice produces evolving selective axonal
pathology and cognitive deficits relevant to human brain injury. J. Neurotrauma 27,
1429–1438.
Sullivan, H.G., Martinez, J., Becker, D.P., Miller, J.D., Griffith, R., and Wist, A.O. (1976). Fluidpercussion model of mechanical brain injury in the cat. J. Neurosurg. 45, 520–534.
Teasdale, G., and Jennett, B. (1974). Assessment of coma and impaired consciousness: a practical
scale. The Lancet 304, 81–84.
Thibault, L.E., Meaney, D.F., Anderson, B.J., and Marmarou, A. (1992). Biomechanical aspects
of a fluid percussion model of brain injury. J. Neurotrauma 9, 311–322.
Thompson, H.J., Lifshitz, J., Marklund, N., Grady, M.S., Graham, D.I., Hovda, D.A., and
McIntosh, T.K. (2005). Lateral fluid percussion brain injury: a 15-year review and
evaluation. J. Neurotrauma 22, 42–75.
Ucar, T., Tanriover, G., Gurer, I., Onal, M.Z., and Kazan, S. (2006). Modified Experimental Mild
Traumatic Brain Injury Model: J. Trauma Inj. Infect. Crit. Care 60, 558–565.
Varma, M.R., Dixon, C.E., Jackson, E.K., Peters, G.W., Melick, J.A., Griffith, R.P., Vagni, V.A.,
Clark, R.S.., Jenkins, L.W., and Kochanek, P.M. (2002). Administration of adenosine
receptor agonists or antagonists after controlled cortical impact in mice: effects on
function and histopathology. Brain Res. 951, 191–201.
Vaslin, A., Puyal, J., Borsello, T., and Clarke, P.G.H. (2007). Excitotoxicity-related endocytosis
in cortical neurons. J. Neurochem. 102, 789–800.
Vaslin, A., Naegele-Tollardo, S., Puyal, J., and Clarke, P.G.H. (2011). Excitotoxicity-induced
endocytosis mediates neuroprotection by TAT-peptide-linked JNK inhibitor. J.
Neurochem. 119, 1243–1252.
Verkhratsky, A., Rodríguez, J.J., and Parpura, V. (2012). Calcium signalling in astroglia. Mol.
Cell. Endocrinol. 353, 45–56.
Viano, D.C., and Pellman, E.J. (2005). Concussion in professional football: biomechanics of the
striking player--part 8. Neurosurgery 56, 266–280; discussion 266–280.
Viano, D.C., Casson, I.R., Pellman, E.J., Zhang, L., King, A.I., and Yang, K.H. (2005).
Concussion in professional football: brain responses by finite element analysis: part 9.
Neurosurgery 57, 891–916; discussion 891–916.
Viano, D.C., Casson, I.R., and Pellman, E.J. (2007). CONCUSSION IN PROFESSIONAL
FOOTBALL. Neurosurgery 61, 313–328.
142

Vorhees, C.V., and Williams, M.T. (2006). Morris water maze: procedures for assessing spatial
and related forms of learning and memory. Nat. Protoc. 1, 848–858.
Ward, C.C., and Thompson, R.B. (1975). The Development of a Detailed Finite Element Brain
Model (Warrendale, PA: SAE International).
Weber, J.T. (2012). Altered Calcium Signaling Following Traumatic Brain Injury. Front.
Pharmacol. 3.
Weber, J.T., Rzigalinski, B.A., and Ellis, E.F. (2001). Traumatic Injury of Cortical Neurons
Causes Changes in Intracellular Calcium Stores and Capacitative Calcium Influx. J. Biol.
Chem. 276, 1800–1807.
Werner, C., and Engelhard, K. (2007). Pathophysiology of traumatic brain injury. Br. J. Anaesth.
99, 4–9.
Wilhelm, A., Volknandt, W., Langer, D., Nolte, C., Kettenmann, H., and Zimmermann, H. (2004).
Localization of SNARE proteins and secretory organelle proteins in astrocytes in vitro
and in situ. Neurosci. Res. 48, 249–257.
Williams, A.J., Hartings, J.A., Lu, X.-C.M., Rolli, M.L., Dave, J.R., and Tortella, F.C. (2005).
Characterization of a New Rat Model of Penetrating Ballistic Brain Injury. J.
Neurotrauma 22, 313–331.
Williams, A.J., Hartings, J.A., Lu, X.-C.M., Rolli, M.L., and Tortella, F.C. (2006). Penetrating
ballistic-like brain injury in the rat: differential time courses of hemorrhage, cell death,
inflammation, and remote degeneration. J. Neurotrauma 23, 1828–1846.
Williams, A.J., Wei, H.H., Dave, J.R., and Tortella, F.C. (2007). Acute and delayed
neuroinflammatory response following experimental penetrating ballistic brain injury in
the rat. J. Neuroinflammation 4, 17.
Willinger, R., Kang, H.S., and Diaw, B. (1999). Three-dimensional human head finite-element
model validation against two experimental impacts. Ann. Biomed. Eng. 27, 403–410.
Xiong, Y., Mahmood, A., and Chopp, M. (2013). Animal models of traumatic brain injury. Nat.
Rev. Neurosci. 14, 128–142.
Yeates, K.O. (2010). Mild Traumatic Brain Injury and Postconcussive Symptoms in Children and
Adolescents. J. Int. Neuropsychol. Soc. JINS 16, 953–960.
Yoganandan, N., Li, J., Zhang, J., Pintar, F.A., and Gennarelli, T.A. (2008). Influence of angular
acceleration–deceleration pulse shapes on regional brain strains. J. Biomech. 41, 2253–
2262.
Zhang, L., Yang, K.H., and King, A.I. (2001). Comparison of Brain Responses Between Frontal
and Lateral Impacts by Finite Element Modeling. J. Neurotrauma 18, 21–30.
Zhang, L., Bae, J., Hardy, W.N., Monson, K.L., Manley, G.T., Goldsmith, W., Yang, K.H., and
King, A.I. (2002). Computational study of the contribution of the vasculature on the
dynamic response of the brain. Stapp Car Crash J. 46, 145–164.
Zhang, L., Yang, K.H., King, A.I., and Viano, D.V. (2003). A new biomechanical predictor for
mild traumatic brain injury–A preliminary finding. In Proc. 2003 Summer
Bioengineering Conference, pp. 137–138.
Zhang, L., Yang, K.H., and King, A.I. (2004). A proposed injury threshold for mild traumatic
brain injury. J. Biomech. Eng. 126, 226–236.
Zhang, L., Gurao, M., Yang, K.H., and King, A.I. (2011). Material Characterization and
Computer Model Simulation of Low Density Polyurethane Foam Used in a Rodent
Traumatic Brain Injury Model. J. Neurosci. Methods 198, 93–98.
Zorec, R., Araque, A., Carmignoto, G., Haydon, P.G., Verkhratsky, A., and Parpura, V. (2012).
Astroglial excitability and gliotransmission: an appraisal of Ca2+ as a signalling route.
ASN NEURO 4, 103–119.
143

